data_2n8m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n8m _Structure_validation_residue.Date_analyzed 2017-01-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' O ' HG21 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HA ' HG13 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB3' HD23 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.51 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.804 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.804 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.538 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.489 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.977 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.55 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.538 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.233 0.214 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.55 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.977 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 7.4 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.482 ' HD3' HG23 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.723 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.627 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB3' HG23 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.739 ' HG2' HG23 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.941 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.941 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.627 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 114.26 0.831 . . . . 0.0 114.26 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' GLU . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' GLU . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.409 ' CG1' HG11 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.514 HG21 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 16.2 mm100 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.495 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.739 HG23 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.791 HG12 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG11 HD12 ' A' ' 87' ' ' ILE . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.549 HG21 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG11 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.866 HG12 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.593 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 38' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 30' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.866 ' HE ' HG12 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.791 ' HB ' HG12 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.437 ' NE2' HG11 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 1.034 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.468 HD12 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.706 ' CD2' HG11 ' A' ' 103' ' ' VAL . 2.2 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.453 HH11 HD12 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.862 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.713 HD12 HG21 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 HD12 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.611 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.529 0.252 0 CA-C-O 121.05 0.354 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.421 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.453 HD12 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 HG11 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA2' ' HZ3' ' A' ' 104' ' ' LYS . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.813 ' H ' ' HB1' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 173' ' ' ILE . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.607 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.587 HD13 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt . . . . . 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.576 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.602 HG13 HG23 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.539 ' O ' HG21 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.611 HD11 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.84 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.7 HG12 HG22 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.83 HG12 HD12 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.736 ' HB2' HG22 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HG11 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.891 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HG3' HD11 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.579 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.579 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.462 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.504 HD12 HG21 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.488 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.515 ' O ' HG21 ' A' ' 120' ' ' ILE . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.572 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.724 HG23 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.792 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 CA--C 1.533 0.433 0 N-CA-C 113.393 0.497 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.792 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.539 ' H ' ' HB2' ' A' ' 162' ' ' ALA . 41.0 m170 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.48 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 HD21 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HA ' HG13 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.85 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.534 ' CB ' ' HG2' ' A' ' 94' ' ' GLU . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.674 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.471 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.674 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.85 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.564 HG22 HG11 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.72 HG22 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.72 ' HG2' HG22 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.497 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.612 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HZ2' ' HB3' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.555 HH11 HD13 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.914 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.702 HG12 HG13 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.538 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.538 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.463 ' HG1' ' HA ' ' A' ' 120' ' ' ILE . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.922 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.909 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.922 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.607 HG12 HG11 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.167 0.403 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 148' ' ' GLU . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 147' ' ' ASP . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.555 HD13 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.702 HG13 HG12 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.511 HD12 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.922 ' H ' ' HB1' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.922 ' HB1' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.77 ' HB3' HG23 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.634 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.511 HD13 HD12 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.617 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.914 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 34' ' ' VAL . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.955 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.512 HD12 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.746 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo . . . . . 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 mtmm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 29' ' ' ILE . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HB2' HG23 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB1' ' HB1' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.746 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.955 ' HG2' ' HB3' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 58.2 m-85 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 91' ' ' LEU . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.551 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.459 ' CG ' HG22 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.557 ' HA ' ' HG1' ' A' ' 126' ' ' THR . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.963 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.963 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.557 ' HG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.458 HD11 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.815 HG23 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.487 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 20.7 Cg_endo . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.695 0.206 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.526 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.514 ' HB3' HE21 ' A' ' 151' ' ' GLN . 15.2 m-80 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.514 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 166' ' ' ALA . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.815 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.41 ' CD1' HD13 ' A' ' 156' ' ' ILE . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.444 HD12 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.03 0.443 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 ' HG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HA ' HG13 ' A' ' 68' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.743 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.627 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.862 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.891 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.903 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.976 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.976 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.879 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.902 ' HA ' HG23 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.758 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.632 HD11 ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.441 ' O ' HD21 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.75 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.82 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.82 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.703 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.666 ' HB2' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.728 ' HZ3' ' HA2' ' A' ' 158' ' ' GLY . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.59 HD13 HD23 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.512 ' CG2' HG13 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.688 ' HB3' HG22 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG21 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.845 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.845 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.894 HG11 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.894 ' HD2' HG11 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.676 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo . . . . . 0 N--CA 1.455 -0.736 0 N-CA-C 114.202 0.808 . . . . 0.0 114.202 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.768 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.728 ' HA2' ' HZ3' ' A' ' 104' ' ' LYS . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.432 ' CD2' HG21 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.738 HG12 HG21 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 48.4 m170 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 33' ' ' ALA . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.549 HG23 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.806 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.957 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG21 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.638 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.806 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.598 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.631 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.506 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.701 ' HB3' ' CE2' ' A' ' 97' ' ' PHE . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 92' ' ' LYS . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.738 HG21 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.534 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.84 ' HD3' HG23 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.733 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.733 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 140' ' ' VAL . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.488 0 CA-C-O 121.522 0.551 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.9 OUTLIER -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 22.8 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.661 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.605 HG12 HG11 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.498 ' O ' HG21 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.84 HG23 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.514 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.62 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' ASP . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.47 ' CG2' HG22 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.906 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.602 ' HB3' HG21 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.906 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.522 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.458 ' C ' ' HG1' ' A' ' 24' ' ' THR . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.733 ' HA ' HE21 ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 81' ' ' PHE . 29.7 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.528 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' A' ' 96' ' ' PHE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.62 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.673 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.482 ' CD2' HG13 ' A' ' 103' ' ' VAL . 93.9 m-85 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.601 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.8 HG22 HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.683 HH11 ' HG3' ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.595 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB1' HG13 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.648 HG11 HG13 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.637 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.648 HG13 HG11 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.663 ' HB3' HG12 ' A' ' 152' ' ' VAL . 58.9 Cg_endo . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 113.54 0.554 . . . . 0.0 113.54 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.715 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 2.2 m80 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.715 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 60.7 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.494 ' HE2' HD12 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.466 ' HD2' HD12 ' A' ' 174' ' ' LEU . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.624 HG23 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 111' ' ' VAL . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HB ' ' HG2' ' A' ' 118' ' ' ARG . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 183' ' ' LYS . 2.2 tmmm? . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.622 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 30.6 m170 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.514 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.487 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.495 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.595 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.622 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HD2' HD11 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.688 ' CD2' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.688 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.849 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.567 HD13 HD22 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.687 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.768 ' HG2' HD21 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.644 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.2 m120 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.402 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.972 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.45 ' HE ' ' HB3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.236 0.4 0 CA-C-O 120.848 0.27 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.419 HG11 ' HB1' ' A' ' 113' ' ' ALA . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.632 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.849 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.469 ' HD2' ' O ' ' A' ' 103' ' ' VAL . 24.0 m170 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.771 ' HB1' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.597 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.644 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.683 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.683 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.796 HG13 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.3 m80 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG12 HG23 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' HG21 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.452 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.786 ' HB3' HG22 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.786 HG22 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.591 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.499 ' C ' ' HB3' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.483 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.642 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.624 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 1.036 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.578 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.602 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 1.036 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.462 ' HB ' ' CE1' ' A' ' 97' ' ' PHE . 9.3 p . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.561 ' HD2' HG21 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.796 HG22 HG13 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.479 HG13 HD12 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.832 ' HG2' HG23 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 1.083 ' HG ' ' HB2' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.668 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 1.083 ' HB2' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.649 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 154' ' ' VAL . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 142' ' ' ARG . 33.9 mtm180 . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.152 0.404 . . . . 0.0 113.152 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 48.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.478 HG12 ' HB1' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.649 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 104' ' ' LYS . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.458 ' CB ' HG11 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.736 ' HD3' HD13 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.445 ' O ' HG22 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.615 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' HG1' ' A' ' 74' ' ' THR . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.899 HG13 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.664 HG13 HG21 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.623 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.596 HG12 ' HG2' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB2' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.555 HG22 HD11 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 43' ' ' GLN . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 41' ' ' ASP . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.893 HD21 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.702 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.415 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.86 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 1.016 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 1.016 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.687 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.586 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 7.3 mtpm? . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.785 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.682 HD13 ' HD3' ' A' ' 57' ' ' LYS . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.86 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.642 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.708 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.841 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.571 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.697 HD13 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.872 HG22 HE21 ' A' ' 167' ' ' GLN . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.899 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.402 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 HD13 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.849 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.624 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.455 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 121.311 0.463 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.666 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 28.1 m170 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.609 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.872 HE21 HG22 ' A' ' 107' ' ' THR . 89.8 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . 0.51 ' HG2' ' HA ' ' A' ' 177' ' ' VAL . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.681 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.416 HG21 HD21 ' A' ' 105' ' ' LEU . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 91' ' ' LEU . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.566 HG13 HG12 ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 9.8 t-80 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.529 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 6.7 ttpm? . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.529 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.681 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.566 HG12 HG13 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CD1' HD11 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.651 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.743 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PHE . . . . . 0.691 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.765 HG11 ' HD2' ' A' ' 159' ' ' HIS . 26.8 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' ' CD2' ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.823 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HZ1' ' HB2' ' A' ' 122' ' ' LYS . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 120' ' ' ILE . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' THR . . . . . 0.475 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.705 ' HB ' HG23 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.541 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 69.3 Cg_endo . . . . . 0 N--CA 1.452 -0.919 0 CA-C-O 121.182 0.409 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HD21 ' A' ' 149' ' ' ASN . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.422 HD21 ' HG3' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.512 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' HIS . . . . . 0.765 ' HD2' HG11 ' A' ' 103' ' ' VAL . 36.6 m80 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.543 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.747 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.775 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.823 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.93 89.91 3.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -85.49 56.96 4.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.402 0.62 . . . . 0.0 111.424 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.45 113.26 3.8 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.519 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 -31.0 79.56 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.913 2.409 . . . . 0.0 112.504 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m 60.57 39.1 18.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.515 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.3 m -63.24 -28.06 69.77 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.187 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.99 123.21 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -125.19 89.02 2.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.231 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 159.76 36.48 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.751 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.54 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 111.243 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.8 42.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.584 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.87 79.8 2.22 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.982 2.455 . . . . 0.0 111.696 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -63.49 107.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -83.57 122.6 28.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.698 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -91.87 1.28 57.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.627 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -101.55 140.49 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.881 0.372 . . . . 0.0 110.566 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.471 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 mmt -124.85 129.98 24.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 2.3 Cg_endo -81.89 115.88 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.132 2.555 . . . . 0.0 111.851 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.752 ' HB2' HG23 ' A' ' 74' ' ' THR . 94.9 Cg_endo -82.45 68.61 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.377 2.051 . . . . 0.0 112.787 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -93.24 32.53 1.31 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 20' ' ' PRO . 25.7 mp0 -87.41 177.04 7.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.924 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.36 119.21 9.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.496 HG21 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' O ' HG21 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.554 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.587 ' HA ' HG13 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.598 ' HB3' HD23 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.504 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.497 ' HB2' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.51 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.804 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.804 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.538 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.484 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.489 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.977 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.552 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.55 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.538 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -73.52 179.02 5.95 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.73 59.91 2.8 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.134 1.89 . . . . 0.0 112.164 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -92.17 -52.2 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.359 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -84.36 145.63 45.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.839 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 66' ' ' SER . 53.0 Cg_exo -55.14 -22.18 30.87 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.914 3.076 . . . . 0.0 113.299 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -83.09 32.38 0.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.417 0.627 . . . . 0.0 109.73 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 64' ' ' PRO . 10.6 t -69.58 10.14 0.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.354 -174.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.88 -18.87 61.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.587 HG13 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.533 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG21 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.752 HG23 ' HB2' ' A' ' 20' ' ' PRO . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.977 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.48 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 7.4 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.637 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.637 ' HB2' HG13 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.482 ' HD3' HG23 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.637 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.449 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.531 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 -141.46 59.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -122.8 -54.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.117 -174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.3 -41.57 3.49 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.359 2.039 . . . . 0.0 112.969 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -103.9 3.83 34.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.657 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.24 155.54 30.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -99.23 133.58 43.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.637 HG13 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m -67.01 122.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.514 ' HE2' HG21 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.723 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.554 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.45 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.622 ' HD2' HD13 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.627 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HB2' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB3' HG23 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.739 ' HG2' HG23 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.611 HD11 HG12 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.941 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.941 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.611 HG12 HD11 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -68.26 108.61 3.25 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 72.15 -70.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.45 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -164.95 -53.44 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.196 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.1 p 44.43 70.2 2.06 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-O 121.484 0.659 . . . . 0.0 110.891 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.627 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo -87.86 149.77 7.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.782 2.988 . . . . 0.0 114.26 -167.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' GLU . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' GLU . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.513 HG23 ' HB3' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.45 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.409 ' CG1' HG11 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.533 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.514 HG21 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.507 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.727 ' HB2' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.507 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 16.2 mm100 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.412 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.622 HD13 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.495 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.739 HG23 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.82 71.3 6.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.66 -132.07 1.63 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.668 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.75 24.89 12.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.6 m 66.41 -74.91 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.477 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -177.92 34.15 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.39 153.13 51.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.511 0.196 . . . . 0.0 110.609 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.23 76.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -95.35 -41.05 9.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.666 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.682 0.916 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.51 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 103.19 1.878 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.856 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 P-O3'-C3' 124.307 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.868 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 O4'-C4'-C3' 102.587 -2.081 OUTLIER-EPSILON 0.015 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.868 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 P-O3'-C3' 123.371 3.059 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.546 " H2'" " O4'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.417 -1.203 . 0.755 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.546 " O4'" " H2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.841 0 C4'-C3'-C2' 103.849 1.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 109.2 8.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.461 0.172 . . . . 0.0 111.024 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 56.75 79.85 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.855 0.722 . . . . 0.0 111.66 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.9 110.44 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.085 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.14 -51.24 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.771 2.314 . . . . 0.0 111.52 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 7' ' ' SER . 9.2 t -168.04 75.88 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 6' ' ' SER . 38.2 t 73.82 149.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.861 -170.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.49 7.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.828 0.347 . . . . 0.0 111.355 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 m -87.02 2.43 49.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.69 -92.9 0.12 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.351 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.95 41.88 20.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.315 0.579 . . . . 0.0 110.195 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.428 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -112.89 138.4 22.17 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.626 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 19.5 Cg_exo -66.64 131.66 26.64 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.615 2.21 . . . . 0.0 111.269 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.08 139.88 50.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.326 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.3 t 70.4 23.81 4.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.806 0.691 . . . . 0.0 111.232 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.64 128.06 34.44 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -96.89 141.9 29.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.24 0.543 . . . . 0.0 111.865 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.2 tpt -158.35 100.95 1.71 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.785 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.49 111.96 3.35 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.878 2.385 . . . . 0.0 111.923 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.622 ' HG2' ' HB2' ' A' ' 55' ' ' SER . 30.2 Cg_endo -91.02 97.89 0.23 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.808 2.339 . . . . 0.0 112.86 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -109.88 40.71 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -85.05 -129.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.564 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 -70.89 140.6 51.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.791 HG12 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG11 HD12 ' A' ' 87' ' ' ILE . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.402 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.549 HG21 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG11 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.559 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.866 HG12 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.41 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.449 HD11 HG21 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.593 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.5 HG23 HD13 ' A' ' 38' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.593 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HB3' HD13 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.471 HD13 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.41 148.8 92.44 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.786 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 58.5 Cg_endo -72.07 61.44 3.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.046 2.497 . . . . 0.0 112.178 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.14 -39.56 65.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 53.7 p -81.57 174.64 5.81 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.518 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.615 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 83.5 Cg_exo -50.23 -18.18 3.19 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.694 2.263 . . . . 0.0 113.432 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.15 31.33 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.865 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.786 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 9.4 m -71.08 -1.81 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -172.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.11 -17.71 54.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 HG11 ' HA ' ' A' ' 30' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.866 ' HE ' HG12 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.418 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 HG21 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.791 ' HB ' HG12 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.523 ' CB ' ' HB3' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.437 ' NE2' HG11 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 1.034 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.468 HD12 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.854 HD12 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.492 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.706 ' CD2' HG11 ' A' ' 103' ' ' VAL . 2.2 m-85 -131.6 147.52 52.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.44 ' HA3' ' HD3' ' A' ' 99' ' ' PRO . . . 178.95 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.686 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.44 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 25.4 Cg_exo -67.26 -48.0 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.149 2.566 . . . . 0.0 113.128 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -92.56 -27.04 17.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.91 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -130.16 139.13 50.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.159 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 41.6 tt0 -90.7 137.68 32.17 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.706 HG11 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m -66.19 121.09 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.53 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' HE3' HG21 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.854 HD21 HD12 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.765 ' HG3' HD12 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.492 HD13 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.453 HH11 HD12 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.622 HG13 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.587 ' HD2' HD13 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.475 ' HB3' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.722 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.862 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.713 HD12 HG21 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.437 ' HA ' H5'' ' B' ' 3' ' ' ' G' . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.67 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.713 HG21 HD12 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.438 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.611 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.438 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.538 ' HB1' ' HB2' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.611 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.624 HG11 HG21 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.609 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.686 ' HG2' ' H62' ' B' ' 5' ' ' ' A' . 0.2 OUTLIER -81.04 143.43 32.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 66.21 -169.75 0.2 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.792 0.683 . . . . 0.0 110.524 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -104.53 117.05 33.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.76 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.578 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 6.6 t -141.93 49.01 1.26 Allowed Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.743 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 145' ' ' THR . 32.0 Cg_exo -54.1 138.15 70.7 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.841 2.361 . . . . 0.0 112.811 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.421 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.722 HG21 ' HB1' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.453 HD12 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.624 HG21 HG11 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.476 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.765 HD12 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.469 ' HA2' ' HZ3' ' A' ' 104' ' ' LYS . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.813 ' H ' ' HB1' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.462 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.813 ' HB1' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.462 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.414 ' O ' HG13 ' A' ' 173' ' ' ILE . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.622 HD11 HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.583 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.607 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.531 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.587 HD13 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.607 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.862 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt 60.55 56.1 3.19 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.98 131.93 5.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.875 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -168.64 138.08 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.7 m 57.07 75.21 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.837 0.71 . . . . 0.0 111.296 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.04 176.36 39.01 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -129.58 -29.92 2.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.945 0.402 . . . . 0.0 110.076 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.8 54.14 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.655 0.74 . . . . 0.0 109.796 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -86.22 79.98 8.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.08 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 -179.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 100.278 -1.358 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.523 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 104.119 2.91 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.869 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 P-O3'-C3' 124.389 3.907 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.931 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.746 0 O4'-C1'-C2' 108.347 1.391 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.931 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.615 0.68 0 P-O3'-C3' 123.492 3.16 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.513 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 107.754 0.967 . 0.375 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 57.68 3.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.919 0.488 . . . . 0.0 111.142 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.17 139.33 31.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.122 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.35 -74.5 0.23 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 6' ' ' SER . 16.6 Cg_endo -59.12 159.91 20.6 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.652 2.234 . . . . 0.0 110.906 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 50.8 m 73.1 -52.31 0.71 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.599 0.562 . . . . 0.0 111.015 -175.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -65.12 -23.67 67.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -86.29 42.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 110.871 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 58.41 42.34 21.45 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.032 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 51.63 0.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.976 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.19 -174.63 4.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.66 78.78 0.36 Allowed Pre-proline 0 C--O 1.235 0.29 0 O-C-N 123.9 0.75 . . . . 0.0 111.674 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.75 111.02 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.593 2.196 . . . . 0.0 111.18 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -78.96 70.12 5.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.468 0.651 . . . . 0.0 110.342 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 t -118.08 2.02 12.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -87.12 66.04 9.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.119 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.64 70.18 4.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 109.849 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.4 mtt -114.24 113.68 46.03 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.288 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.3 110.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.732 2.288 . . . . 0.0 111.401 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.7 125.64 12.97 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.023 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -77.54 57.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.038 -178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 47.92 -114.97 0.64 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.128 0.571 . . . . 0.0 111.88 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 -113.28 117.79 32.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.891 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG11 HG21 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.576 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.602 HG13 HG23 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.539 ' O ' HG21 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.536 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.736 HG22 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.611 HD11 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.636 HD11 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.84 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.524 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.84 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.7 HG12 HG22 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.597 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB1' HD13 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.83 HG12 HD12 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.7 HG22 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo -73.32 154.81 51.37 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.84 49.35 2.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.038 2.492 . . . . 0.0 111.697 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.73 -28.79 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.035 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.618 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 68.6 p -85.12 178.1 2.56 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.205 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.618 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.4 Cg_exo -56.12 -26.34 59.58 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.353 2.036 . . . . 0.0 112.514 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.14 31.58 0.12 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.255 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 64' ' ' PRO . 3.2 t -63.12 -23.42 67.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -168.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.16 -13.99 61.7 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.509 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.736 ' HB2' HG22 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.416 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.439 HG21 HG11 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.891 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.616 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.59 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.47 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.611 ' HG3' HD11 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.508 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.579 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.579 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.462 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 -137.7 167.51 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.04 -84.3 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.413 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.11 -44.35 28.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.777 2.985 . . . . 0.0 113.427 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -94.21 -26.18 16.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.328 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 47.84 36.46 5.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.758 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 108.95 17.08 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.798 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.508 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m -97.3 121.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.504 HD12 HG21 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.576 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.442 HG21 HG23 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.488 ' O ' HG11 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.845 ' HA3' ' C5 ' ' B' ' 4' ' ' ' G' . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.572 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.573 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.521 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.496 ' HA2' HD12 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.724 HG23 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.521 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.792 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.687 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 67.4 ttt180 -77.15 76.47 3.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 51.55 44.21 29.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.322 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.564 ' OE1' ' HA ' ' A' ' 141' ' ' PRO . 4.4 pt20 -115.25 -11.57 11.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.679 ' H ' ' HD3' ' A' ' 146' ' ' PRO . 69.5 p -133.29 -16.92 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.679 ' HD3' ' H ' ' A' ' 145' ' ' THR . 25.8 Cg_exo -56.87 125.03 17.68 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 121.647 1.565 . . . . 0.0 113.393 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.792 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.421 HG23 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.539 ' H ' ' HB2' ' A' ' 162' ' ' ALA . 41.0 m170 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.724 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.48 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.573 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.619 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.619 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 67.14 30.71 7.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 121.67 -143.47 15.88 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.621 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -117.52 -178.14 3.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.2 p 51.67 35.83 15.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.584 0.754 . . . . 0.0 112.114 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.0 -35.71 5.23 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -77.42 -21.35 53.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 110.159 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 189' ' ' LEU . 2.7 mm? -96.71 105.13 17.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.197 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -96.44 75.68 2.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.613 0.721 . . . . 0.0 110.752 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.676 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C1'-C2' 107.548 0.82 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.448 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 104.633 3.481 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.779 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.938 0 C4'-C3'-C2' 105.691 2.991 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.946 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 O4'-C1'-C2' 108.487 1.491 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.946 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.696 0 P-O3'-C3' 123.766 3.388 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.452 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 104.304 -0.854 . 0.67 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.854 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.91 0 N19-C1'-C2' 115.149 1.093 . 0.178 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.58 34.3 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.346 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.9 tpp -70.46 126.77 30.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.745 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 10' ' ' GLY . . . 160.11 -66.45 0.27 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.435 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 57.03 4.61 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.866 2.378 . . . . 0.0 111.391 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -65.07 -63.09 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.796 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.3 m -149.92 -55.34 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.784 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.412 ' O ' ' HB3' ' A' ' 9' ' ' SER . 17.0 m -121.02 32.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.229 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 44.2 t 74.99 130.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.171 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.437 ' O ' ' HA2' ' A' ' 4' ' ' GLY . . . -158.35 171.2 35.16 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.841 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.688 ' HA ' ' HD2' ' A' ' 14' ' ' PHE . . . 63.49 48.07 3.61 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.921 0.489 . . . . 0.0 111.713 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.564 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -86.59 -50.6 0.47 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.954 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 5.1 Cg_exo -75.94 5.8 4.21 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 0.0 112.898 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.688 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 76.3 m-85 -105.26 102.75 12.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t 62.55 58.74 1.6 Allowed 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.686 0.616 . . . . 0.0 109.906 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 m -69.86 79.89 0.46 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.673 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 59.3 77.53 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.338 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 65.0 mtt -120.51 128.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.068 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 7.3 Cg_exo -74.55 118.87 5.5 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.813 2.342 . . . . 0.0 111.614 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.03 167.93 23.37 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.678 2.252 . . . . 0.0 112.394 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 8.6 pt-20 -49.37 -55.8 11.73 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.88 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.836 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -150.22 140.3 22.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.564 HG11 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.438 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG22 HD21 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.641 ' HA ' HG13 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.85 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.534 ' CB ' ' HG2' ' A' ' 94' ' ' GLU . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.542 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.614 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.674 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' CD1' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.471 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.448 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.559 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.613 HG23 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.674 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.17 140.77 66.45 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.524 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 57.0 Cg_endo -73.54 71.59 3.85 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.877 2.384 . . . . 0.0 111.653 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.02 -34.91 50.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.342 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 42.3 p -82.58 177.05 3.25 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.204 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.561 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 31.2 Cg_exo -60.95 -5.99 5.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.852 2.368 . . . . 0.0 112.556 176.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.93 17.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.009 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.524 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 32.4 t -66.34 -3.23 5.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.9 0.48 . . . . 0.0 112.029 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -72.62 -20.47 61.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.641 HG13 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.85 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.564 HG22 HG11 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.72 HG22 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.406 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.72 ' HG2' HG22 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.497 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.612 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.776 HD11 HD23 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.645 ' HZ2' ' HB3' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.612 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.534 ' HG2' ' CB ' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.47 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 -116.43 150.03 38.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.09 -79.55 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.942 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 -54.17 4.43 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.956 2.437 . . . . 0.0 113.115 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -26.89 9.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -115.49 168.42 10.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.505 0.669 . . . . 0.0 112.049 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -145.15 168.95 19.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m -66.21 120.62 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.118 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.776 HD23 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.422 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.478 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.555 HH11 HD13 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.428 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.706 ' HB2' HG23 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.914 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.702 HG12 HG13 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.538 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.527 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.483 ' HE2' ' OP1' ' B' ' 3' ' ' ' G' . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.671 ' HA3' ' OP1' ' B' ' 4' ' ' ' G' . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.538 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.527 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.463 ' HG1' ' HA ' ' A' ' 120' ' ' ILE . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.402 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.922 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.909 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.922 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.607 HG12 HG11 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.645 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 29.4 ttp180 -77.02 72.62 3.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.466 ' HA ' ' H22' ' B' ' 4' ' ' ' G' . 22.9 t70 -171.03 153.38 3.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.13 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -84.38 79.26 9.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.675 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 3.3 t -133.0 60.87 52.62 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.016 -175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 145' ' ' THR . 36.6 Cg_exo -59.14 143.84 99.62 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.958 2.439 . . . . 0.0 112.448 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.423 ' CG ' ' H ' ' A' ' 148' ' ' GLU . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.423 ' H ' ' CG ' ' A' ' 147' ' ' ASP . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 42.2 m-80 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.706 HG23 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.555 HD13 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.702 HG13 HG12 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.511 HD12 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.922 ' H ' ' HB1' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.922 ' HB1' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.77 ' HB3' HG23 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.634 ' HA ' HD23 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.488 ' HE3' HD12 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.511 HD13 HD12 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.617 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.617 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.701 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.516 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.914 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.423 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -123.05 40.97 3.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.38 159.15 17.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.599 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -104.85 141.28 36.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.6 m -89.89 106.43 18.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.799 0.333 . . . . 0.0 111.231 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.56 -50.92 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -102.75 75.71 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.85 117.57 9.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 67.29 72.54 0.34 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.876 0.735 . . . . 0.0 110.278 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.987 179.141 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 O4'-C1'-C2' 107.63 0.879 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.509 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C3'-C2'-C1' 104.096 2.885 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.509 ' OP1' " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 P-O3'-C3' 124.402 3.919 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.88 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C4'-C3' 102.054 -2.462 OUTLIER-EPSILON 0.016 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.88 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.749 0 P-O3'-C3' 122.862 2.635 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.572 " O2'" " H5'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.684 0.917 . 0.306 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.572 " H5'" " O2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C3'-C2'-C1' 100.289 -1.345 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.72 -75.18 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 0.239 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm 179.23 150.78 0.32 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.51 138.79 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.86 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.89 4.69 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.933 2.422 . . . . 0.0 111.908 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -86.59 32.64 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.08 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -68.31 -22.23 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.487 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 m -93.47 5.17 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.02 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -120.17 86.98 2.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.021 0.439 . . . . 0.0 110.382 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.77 131.17 6.06 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.047 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.5 66.42 8.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.55 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.71 131.78 48.48 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.542 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.84 -7.67 21.56 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.871 2.381 . . . . 0.0 112.429 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.481 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 86.0 t80 -147.23 104.08 3.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.218 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -94.55 -71.79 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.579 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -168.73 81.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.76 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.481 ' HE2' ' HA ' ' A' ' 14' ' ' PHE . 88.2 m-85 -84.57 62.78 7.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 110.478 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.3 mtp -118.47 96.04 49.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.431 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.604 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 74.5 Cg_exo -50.05 -44.2 38.67 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.009 2.472 . . . . 0.0 113.245 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.985 ' HA ' HG23 ' A' ' 74' ' ' THR . 33.9 Cg_exo -65.41 80.45 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.775 1.65 . . . . 0.0 112.636 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 9.03 39.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.894 0.854 . . . . 0.0 109.476 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -140.32 -170.1 2.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.962 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.19 136.03 42.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.701 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.75 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.455 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.572 ' HB3' ' HB3' ' A' ' 65' ' ' ASP . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.955 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.512 HD12 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.707 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.707 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.447 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.732 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.447 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.746 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.608 ' HB1' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.681 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.604 ' HE3' ' HG2' ' A' ' 19' ' ' PRO . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HB2' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo -61.15 138.4 77.58 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 36.5 Cg_endo -65.79 88.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.364 2.709 . . . . 0.0 111.749 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.872 ' HB3' ' HD2' ' A' ' 64' ' ' PRO . 12.8 tt0 -91.44 -47.55 7.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.795 HG22 ' HD3' ' A' ' 64' ' ' PRO . 0.6 OUTLIER 162.82 -38.13 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -154.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.872 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 31.4 Cg_exo -44.8 7.86 0.0 OUTLIER 'Trans proline' 0 C--O 1.201 -1.361 1 C-N-CA 125.737 4.292 . . . . 0.0 117.091 165.508 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.623 ' HA ' HG12 ' A' ' 68' ' ' VAL . 3.3 p30 -60.57 31.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.73 1.605 . . . . 0.0 115.116 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.552 ' H ' ' C ' ' A' ' 64' ' ' PRO . 33.5 t -144.43 -45.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 161.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' O ' ' HB3' ' A' ' 64' ' ' PRO . 39.1 mtmm -72.84 44.08 0.12 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 111.819 -2.446 . . . . 0.0 112.48 167.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.623 HG12 ' HA ' ' A' ' 65' ' ' ASP . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.715 ' HB2' HG23 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.448 HG12 HG22 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.985 HG23 ' HA ' ' A' ' 20' ' ' PRO . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.608 ' HB1' ' HB1' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.746 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.416 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.615 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.615 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.955 ' HG2' ' HB3' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.983 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 58.2 m-85 -126.94 96.05 4.51 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.9 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.1 -21.84 35.99 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.583 2.189 . . . . 0.0 110.994 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -109.26 23.58 14.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.723 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.983 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 11.1 tt0 -61.4 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 110.6 3.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 164.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m -82.22 121.68 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.704 HD23 HD11 ' A' ' 91' ' ' LEU . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.75 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.551 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.471 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.643 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.459 ' CG ' HG22 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.557 ' HA ' ' HG1' ' A' ' 126' ' ' THR . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.963 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.963 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.557 ' HG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.458 HD11 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.815 HG23 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.487 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.443 HG23 HD13 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.472 HG11 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.681 ' HG3' ' H21' ' B' ' 4' ' ' ' G' . 63.9 ttt180 -74.48 102.8 4.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 56.68 42.41 26.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.417 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 27.7 tp60 -62.88 -74.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.127 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.493 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 9.8 t -151.3 39.75 0.18 Allowed Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.679 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 20.7 Cg_endo -68.92 125.39 12.52 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 120.997 1.131 . . . . 0.0 112.295 169.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.526 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.526 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.514 ' HB3' HE21 ' A' ' 151' ' ' GLN . 15.2 m-80 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.514 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.477 HG11 ' HB3' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.472 HG12 HG11 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.599 HD12 ' HB3' ' A' ' 166' ' ' ALA . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.688 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.815 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.416 ' HA ' HG22 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.599 ' HB3' HD12 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.41 ' CD1' HD13 ' A' ' 156' ' ' ILE . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.444 HD12 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.6 HG21 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.429 ' HE3' HD21 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.4 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.59 -52.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 138.81 -155.94 24.0 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.466 ' C ' ' H ' ' A' ' 187' ' ' GLY . 13.7 mm100 -86.09 87.65 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.8 t 73.79 -26.59 0.19 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.574 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 185' ' ' GLN . . . 126.56 -48.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -153.5 102.23 2.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.19 79.19 9.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 110.844 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -72.54 118.49 15.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.116 0.484 . . . . 0.0 111.369 -179.146 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.435 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-N19 110.114 1.914 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.508 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C5'-C4'-O4' 106.772 -1.735 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.898 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -1.017 1 P-O3'-C3' 124.575 4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.94 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 108.2 1.286 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.94 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.72 0 P-O3'-C3' 123.938 3.532 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.495 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 O4'-C1'-C2' 107.953 1.109 . 0.345 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.744 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.428 -0.769 0 N19-C1'-C2' 114.852 0.908 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.83 76.18 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.246 0.545 . . . . 0.0 111.549 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.2 tpt -146.14 -37.6 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 -66.13 2.76 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.661 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 3.89 5.99 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.482 2.121 . . . . 0.0 113.189 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 p 40.13 48.72 2.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.526 0.73 . . . . 0.0 112.856 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m -86.75 -19.8 28.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.9 t 68.22 -73.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.304 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -90.14 -67.56 0.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.52 124.96 0.86 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.629 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.87 -0.56 2.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.735 -0.274 . . . . 0.0 111.609 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.1 90.77 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 123.925 0.766 . . . . 0.0 110.904 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.45 80.2 0.59 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.131 2.554 . . . . 0.0 112.601 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -93.34 4.58 53.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.311 0.577 . . . . 0.0 110.242 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.33 53.68 1.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -96.07 71.7 2.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.394 0.616 . . . . 0.0 109.693 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.49 ' HB3' HG21 ' A' ' 56' ' ' ILE . 83.8 m-85 -99.8 36.33 1.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.909 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.634 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 16.9 tpt 63.58 89.08 0.11 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.019 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 18' ' ' MET . 9.9 Cg_endo -50.75 112.21 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.632 2.888 . . . . 0.0 113.052 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.619 ' HB2' HG22 ' A' ' 74' ' ' THR . 84.1 Cg_endo -92.58 132.98 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.285 2.657 . . . . 0.0 113.386 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' OE1' ' HG3' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -133.69 12.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.165 0.507 . . . . 0.0 110.38 172.652 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.44 ' HG3' ' OE1' ' A' ' 21' ' ' GLU . 44.8 mt-30 -121.17 -156.39 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.894 -170.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.05 127.68 32.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.317 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.679 HG23 ' HG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.541 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.414 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.618 HG11 HG23 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.75 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.569 ' HA ' HG13 ' A' ' 68' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.879 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.679 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.743 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.679 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.743 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.627 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.862 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.891 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB3' ' HB2' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.903 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.976 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.976 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.63 151.79 73.51 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.64 96.4 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.28 2.653 . . . . 0.0 112.566 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.19 -51.24 3.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.038 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.506 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 41.4 p -84.15 174.61 5.63 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.514 -173.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 63' ' ' THR . 33.8 Cg_exo -62.29 -3.19 3.8 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.252 2.635 . . . . 0.0 112.967 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.93 31.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.824 0.45 . . . . 0.0 110.306 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.45 ' H ' ' C ' ' A' ' 64' ' ' PRO . 13.8 t -69.2 4.34 1.7 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.226 -172.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.25 -30.73 58.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.569 HG13 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.879 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.604 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.902 ' HA ' HG23 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.758 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.632 HD11 ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.903 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.403 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.59 ' HB2' ' HB3' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.605 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB2' HD13 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.605 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.607 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.441 ' O ' HD21 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.5 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.75 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.82 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.692 ' HD2' ' HA2' ' A' ' 98' ' ' GLY . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.82 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.703 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.666 ' HB2' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -130.46 60.97 1.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.692 ' HA2' ' HD2' ' A' ' 92' ' ' LYS . . . -103.1 -86.95 1.98 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.041 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 22.6 Cg_exo -66.5 -37.58 22.25 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.378 . . . . 0.0 113.1 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.72 -26.43 13.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -166.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -137.66 155.25 49.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.346 -166.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.41 137.01 32.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.69 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m -73.83 131.46 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.728 ' HZ3' ' HA2' ' A' ' 158' ' ' GLY . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.59 HD13 HD23 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.512 ' CG2' HG13 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.51 ' HD3' HD13 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.612 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.688 ' HB3' HG22 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.531 ' O ' HG23 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HD3' HG21 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.495 HG11 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.845 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.845 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.429 HG23 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.534 HG23 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.429 ' HB ' HG23 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.894 HG11 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.894 ' HD2' HG11 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -140.15 159.78 41.42 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.86 ' HB2' ' N3 ' ' B' ' 4' ' ' ' G' . 5.4 p-10 -63.95 90.7 0.06 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.832 0.825 . . . . 0.0 111.696 -173.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 57.74 62.71 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.871 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.5 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -113.13 114.96 48.27 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.276 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.676 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo -93.88 153.93 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.739 2.959 . . . . 0.0 114.202 -173.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.455 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.676 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.768 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.552 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.728 ' HA2' ' HZ3' ' A' ' 104' ' ' LYS . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.432 ' CD2' HG21 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.534 ' HA ' HG23 ' A' ' 134' ' ' THR . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.461 ' HB2' HD11 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.529 HD11 HD12 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.412 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.56 ' O ' HG22 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.412 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.29 107.1 18.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -155.58 -94.61 0.1 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.654 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -130.86 118.0 20.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.2 t -98.44 -51.3 4.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 172.02 167.15 31.74 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.163 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.92 106.3 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.853 0.358 . . . . 0.0 110.143 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.51 89.08 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -130.83 38.62 3.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.074 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.614 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.664 ' O2 ' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.691 1.991 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.584 " H3'" " O5'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C3'-C2'-C1' 103.373 2.081 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.884 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.982 1 P-O3'-C3' 124.539 4.033 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.921 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.429 -0.678 0 O4'-C4'-C3' 103.142 -1.684 OUTLIER-EPSILON 0.013 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.921 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 P-O3'-C3' 123.542 3.202 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.5 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 O4'-C1'-C2' 107.538 0.813 . 0.51 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.744 0 C3'-C2'-C1' 100.612 -0.986 . 0.0 OUTLIER '7D dist 5z' 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.25 57.6 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.988 0.423 . . . . 0.0 109.966 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt 59.11 60.92 2.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.466 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.95 169.73 13.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.31 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.93 -28.3 35.92 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.036 2.491 . . . . 0.0 112.075 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -85.01 56.37 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.383 0.611 . . . . 0.0 110.305 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -72.39 97.63 2.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.489 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.94 78.99 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.701 0.762 . . . . 0.0 109.232 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -88.82 88.36 7.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.402 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.7 128.29 3.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.979 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.48 104.53 11.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 84.77 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.76 -20.81 22.33 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 112.537 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 63.68 37.08 10.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.988 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -89.57 74.52 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.269 0.557 . . . . 0.0 110.999 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.7 m -93.18 161.28 14.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -84.32 48.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.433 0.635 . . . . 0.0 110.623 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 27.1 ttt -175.47 108.93 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.765 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 3.2 Cg_exo -81.36 108.28 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.296 2.664 . . . . 0.0 112.231 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -80.19 133.01 9.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.13 2.553 . . . . 0.0 112.032 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.486 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -92.52 37.02 1.0 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 46.33 -123.45 1.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.825 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -96.07 123.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.738 HG12 HG21 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 48.4 m170 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.651 HG11 HG23 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.604 HD11 ' HB3' ' A' ' 33' ' ' ALA . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.604 ' HB3' HD11 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.54 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.549 HG23 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.806 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.957 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG21 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.638 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.557 HG21 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.655 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.652 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 57.3 Cg_endo -92.89 -165.71 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 60' ' ' PRO . 81.8 Cg_exo -49.56 -16.54 1.38 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.349 2.033 . . . . 0.0 112.798 171.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.618 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 28.2 tt0 -51.06 -37.15 43.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.414 0.686 . . . . 0.0 111.107 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.4 p -96.54 161.04 28.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.61 -9.44 23.98 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.033 2.489 . . . . 0.0 111.468 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.73 31.23 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.624 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 13.2 p -69.23 4.59 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -72.79 -23.7 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 HG21 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.806 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.598 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.651 HG23 HG11 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.569 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 21' ' ' GLU . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.444 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.638 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.407 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.545 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.631 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.506 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.521 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.701 ' HB3' ' CE2' ' A' ' 97' ' ' PHE . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.763 ' HD3' ' HA2' ' A' ' 98' ' ' GLY . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.701 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -146.59 84.65 1.62 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.763 ' HA2' ' HD3' ' A' ' 92' ' ' LYS . . . -102.12 -91.38 2.15 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.605 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -70.17 -37.25 8.43 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.821 2.348 . . . . 0.0 112.086 176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -76.44 -25.37 54.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.612 -170.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.22 143.17 23.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -80.56 140.77 35.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.653 HG13 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m -72.94 123.05 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.65 HD21 HD12 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.438 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.738 HG21 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.535 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.534 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.84 ' HD3' HG23 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.605 HG11 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.733 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.424 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.733 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 140' ' ' VAL . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 44.4 tpt85 -61.93 122.78 16.3 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.5 OUTLIER 74.38 115.36 0.06 Allowed 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 124.294 0.996 . . . . 0.0 109.741 -169.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -117.13 136.69 52.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.056 -165.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 10.0 t -125.95 125.21 24.8 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 167.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 3.3 Cg_exo -80.44 144.83 16.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.674 2.25 . . . . 0.0 112.99 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 149' ' ' ASN . 0.9 OUTLIER -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 22.8 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.669 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.413 ' H ' ' HB2' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.413 ' HB2' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.469 ' HB3' HD11 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.661 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.605 HG12 HG11 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.661 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.498 ' O ' HG21 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.84 HG23 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.642 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -163.04 91.43 0.72 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.642 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -94.49 -17.72 38.23 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.763 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -79.13 91.98 4.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.328 0.585 . . . . 0.0 110.406 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.2 m -73.63 85.3 1.6 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.547 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 178.22 101.73 0.15 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.802 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.28 86.64 7.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.297 0.57 . . . . 0.0 110.504 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.6 mt -85.6 78.46 9.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.354 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.06 -58.31 2.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.588 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -178.053 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.712 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C4'-C3'-C2' 105.992 3.292 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.503 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C3'-C2'-C1' 103.168 1.853 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.517 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.965 1 P-O3'-C3' 124.665 4.138 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.972 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 O4'-C4'-C3' 103.181 -1.657 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.972 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.79 0 P-O3'-C3' 123.83 3.441 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.439 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 108.134 1.238 . 0.112 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C3'-C2'-C1' 102.959 1.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.38 105.95 14.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.876 0.369 . . . . 0.0 110.646 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -107.81 96.2 6.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.132 0.491 . . . . 0.0 110.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.79 -176.76 19.07 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.851 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 110.34 1.36 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.942 2.428 . . . . 0.0 112.229 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -96.41 -56.25 2.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p 39.75 62.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.184 0.927 . . . . 0.0 112.897 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.9 76.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.477 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 73.99 2.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.668 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.84 -118.09 6.07 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.642 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.38 -61.26 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.944 0.402 . . . . 0.0 110.291 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.51 120.6 27.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.37 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.21 66.13 8.37 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.746 2.297 . . . . 0.0 112.541 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -74.06 83.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.092 0.472 . . . . 0.0 110.837 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -71.62 -62.32 1.46 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.4 m 46.3 42.97 11.04 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.754 0.659 . . . . 0.0 111.644 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -86.39 89.35 7.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -138.93 76.62 33.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 0.0 111.197 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.564 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 51.1 Cg_exo -57.62 -44.41 41.81 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.813 2.342 . . . . 0.0 114.232 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 19' ' ' PRO . 19.6 Cg_endo -58.48 153.93 45.02 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.334 2.022 . . . . 0.0 113.526 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -95.55 10.38 36.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.754 0.788 . . . . 0.0 110.298 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.92 147.22 25.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.427 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.42 140.73 39.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.526 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.8 HG11 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.514 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.434 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.62 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.6 HG23 HD11 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.6 HD11 HG23 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.418 ' H ' ' C ' ' A' ' 40' ' ' ASP . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.593 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.47 ' CG2' HG22 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.906 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.602 ' HB3' HG21 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.906 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.4 151.94 70.99 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.9 91.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.357 2.705 . . . . 0.0 112.279 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -64.14 -50.41 68.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -124.24 153.59 68.56 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.071 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.24 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.951 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.74 26.85 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.666 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m -59.34 113.51 2.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.392 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -73.68 -38.2 64.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.63 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.522 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.458 ' C ' ' HG1' ' A' ' 24' ' ' THR . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.526 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.733 ' HA ' HE21 ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 81' ' ' PHE . 29.7 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.528 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.635 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.528 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' A' ' 96' ' ' PHE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.42 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.62 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.673 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.607 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 93.9 m-85 -134.24 129.63 35.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.519 ' C ' ' H ' ' A' ' 100' ' ' LYS . . . -74.7 -41.75 33.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 160.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 85.6 Cg_exo -49.29 9.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 125.127 3.885 . . . . 0.0 115.586 161.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -70.1 22.15 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -162.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.87 -19.85 64.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.947 1.356 . . . . 0.0 107.488 160.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.536 ' HB2' ' CD2' ' A' ' 159' ' ' HIS . 10.2 pt-20 -151.59 145.71 25.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.447 -2.16 . . . . 0.0 109.118 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.482 HG13 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m -116.31 133.8 61.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.601 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.8 HG22 HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.683 HH11 ' HG3' ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.607 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.595 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.524 ' HB2' HG12 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.51 ' HB1' HG13 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.442 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.624 ' HG3' HG23 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.648 HG11 HG13 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.637 HD11 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.473 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.554 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.613 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.69 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.645 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.648 HG13 HG11 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.402 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 -57.59 119.33 6.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.66 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.18 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.862 ' HG2' ' HD3' ' A' ' 146' ' ' PRO . 42.9 tt0 -175.37 140.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.735 0.302 . . . . 0.0 110.518 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -163.74 56.79 0.56 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 121.857 0.836 . . . . 0.0 110.957 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.862 ' HD3' ' HG2' ' A' ' 144' ' ' GLN . 58.9 Cg_endo -71.62 161.88 43.91 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.385 2.723 . . . . 0.0 113.54 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.663 HG12 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.618 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.645 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.69 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.715 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 2.2 m80 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.715 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.463 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 60.7 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.489 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.494 ' HE2' HD12 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.466 ' HD2' HD12 ' A' ' 174' ' ' LEU . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.624 HG23 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.607 HD11 HG12 ' A' ' 111' ' ' VAL . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.537 ' HB ' ' HG2' ' A' ' 118' ' ' ARG . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.403 ' HB3' ' H42' ' B' ' 2' ' ' ' C' . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.431 ' HB3' ' HE2' ' A' ' 183' ' ' LYS . 2.2 tmmm? 49.63 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.71 -133.48 1.05 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.305 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 59.33 36.39 23.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 t -111.86 139.66 47.15 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 140.6 -129.31 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.043 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.15 36.8 0.98 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tt -84.79 88.04 7.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -116.16 99.77 7.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.139 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 178.198 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.743 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 103.575 2.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.435 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-C1' 104.815 3.684 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.795 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 C4'-C3'-C2' 105.854 3.154 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.922 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 O4'-C4'-C3' 103.295 -1.575 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.922 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 P-O3'-C3' 123.384 3.07 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.491 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 103.049 1.721 . 0.356 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 O4'-C1'-C2' 107.652 0.894 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.96 117.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.98 90.86 3.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 110.72 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.41 ' HA3' ' HD3' ' A' ' 5' ' ' PRO . . . 115.88 -98.22 0.82 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.088 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA3' ' A' ' 4' ' ' GLY . 49.3 Cg_exo -57.0 117.28 3.94 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.033 2.489 . . . . 0.0 112.301 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -85.33 54.87 3.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.136 0.493 . . . . 0.0 110.763 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -72.67 -42.5 64.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.164 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 m -122.8 140.76 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.312 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 p -102.85 36.9 2.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.32 0.581 . . . . 0.0 110.017 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.25 111.0 3.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.536 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.93 71.46 1.05 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.398 0.618 . . . . 0.0 109.592 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.18 113.66 10.54 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.421 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.38 66.96 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.009 2.473 . . . . 0.0 111.241 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -55.63 112.76 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.767 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -156.72 93.32 1.36 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.177 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.0 m -82.02 84.32 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -67.42 113.98 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.811 -174.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.4 ttt 59.62 76.73 0.42 Allowed Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.948 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 16.0 Cg_exo -66.92 137.65 45.61 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.667 2.245 . . . . 0.0 111.646 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 2.9 Cg_exo -73.21 86.62 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.503 2.135 . . . . 0.0 111.879 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.82 29.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -114.32 -174.21 2.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.618 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.622 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 -63.39 107.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.556 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.685 HG11 HG21 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.64 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 30.6 m170 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' HB ' HG21 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.514 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD11 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.584 HG23 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.441 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.487 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.87 168.33 23.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.98 91.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.836 2.357 . . . . 0.0 111.862 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -55.85 -43.26 76.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.627 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p -130.79 169.39 13.79 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.611 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.02 -9.7 22.65 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.285 1.99 . . . . 0.0 111.969 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.41 2.05 54.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.491 ' O ' ' HB2' ' A' ' 31' ' ' ALA . 14.7 m -75.85 101.62 5.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -90.74 -21.79 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.956 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.495 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.595 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.622 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.547 ' O ' HD23 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HD2' HD11 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.748 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.748 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.976 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -142.95 97.67 3.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.75 -88.2 0.33 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.769 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.35 -24.5 50.18 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.009 2.473 . . . . 0.0 113.156 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -104.43 -26.29 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.532 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.976 ' HG3' ' HB3' ' A' ' 97' ' ' PHE . 12.0 pt-20 -158.66 168.32 27.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.814 0.34 . . . . 0.0 110.1 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.405 ' OE2' ' HB3' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -101.99 150.53 23.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.688 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m -68.01 130.8 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.849 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.567 HD13 HD22 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.687 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.685 HG21 HG11 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.422 ' HB ' HD23 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.768 ' HG2' HD21 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.419 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.548 ' HB2' HG13 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.644 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.558 HD12 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.463 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.558 ' HA2' HD12 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.407 HD21 ' HA ' ' A' ' 132' ' ' ASN . 3.2 m120 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.402 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.972 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.57 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.548 HG13 ' HB2' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.644 ' HG3' ' H62' ' B' ' 5' ' ' ' A' . 0.4 OUTLIER -64.43 145.02 56.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.17 46.48 15.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.29 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.426 ' HG3' HG12 ' A' ' 152' ' ' VAL . 17.4 pm0 -84.48 176.49 8.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.333 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.8 p -132.14 110.0 14.04 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.066 0.46 . . . . 0.0 111.318 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.36 135.01 62.4 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 123.058 2.506 . . . . 0.0 112.416 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.426 HG12 ' HG3' ' A' ' 144' ' ' GLN . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.632 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.849 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.469 ' HD2' ' O ' ' A' ' 103' ' ' VAL . 24.0 m170 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' HB2' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.771 ' HB1' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.685 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.421 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.685 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.597 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.768 HD21 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.644 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.683 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.683 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt -135.51 91.3 2.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.08 -125.94 5.71 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 189' ' ' LEU . 42.4 mt-30 -95.08 68.11 3.12 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 172.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.4 p -93.75 -44.39 8.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.117 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.61 25.96 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.469 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -91.93 56.77 2.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.64 0.733 . . . . 0.0 110.039 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 48.4 tp -108.96 -51.36 2.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.288 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -134.11 83.29 2.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.051 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.791 -176.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.007 0 C4'-C3'-C2' 105.238 2.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.547 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O3'--C3' 1.432 0.676 0 C3'-C2'-C1' 103.519 2.244 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.606 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.893 1 P-O3'-C3' 125.127 4.523 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.918 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 O4'-C4'-C3' 103.427 -1.481 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.918 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 P-O3'-C3' 123.852 3.46 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C4'-C3' 104.06 -1.029 . 0.48 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C4'-C3'-C2' 103.717 1.017 . 0.118 1m . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -50.15 36.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.676 0.274 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mmt -140.51 74.34 1.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.12 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.42 148.96 25.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.903 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.56 -44.15 48.41 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.097 2.531 . . . . 0.0 112.384 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t 60.5 52.59 4.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.584 0.706 . . . . 0.0 109.835 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 t -101.14 84.72 2.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.417 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.41 45.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 122.505 1.145 . . . . 0.0 109.789 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -88.9 -2.97 58.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.97 -92.8 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.87 75.54 9.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.0 0.428 . . . . 0.0 110.673 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -88.53 134.33 34.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.118 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.2 Cg_exo -76.27 72.55 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.908 2.406 . . . . 0.0 111.754 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -57.94 118.46 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -114.19 129.13 56.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -80.39 152.58 28.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.58 137.26 54.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.336 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.9 ttp -107.28 107.46 60.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.648 0.261 . . . . 0.0 110.843 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.3 Cg_exo -69.96 140.47 42.0 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.746 2.297 . . . . 0.0 111.064 176.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 24.3 Cg_exo -65.86 78.17 0.29 Allowed 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.906 2.404 . . . . 0.0 113.48 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.33 1.66 47.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.088 0.947 . . . . 0.0 109.405 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -113.56 168.34 9.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.821 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.16 119.06 8.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.796 HG13 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.499 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.3 m80 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG12 HG23 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.42 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.536 ' O ' HG21 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.536 HG21 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.589 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.411 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.452 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.786 ' HB3' HG22 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.589 ' HB2' HG23 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.587 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.786 HG22 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.591 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.55 137.31 77.48 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.98 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.81 2.34 . . . . 0.0 111.723 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.96 -46.9 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.836 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.7 p -133.06 135.21 25.38 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.2 Cg_exo -67.74 -14.7 42.55 Favored 'Trans proline' 0 C--N 1.334 -0.196 0 C-N-CA 123.594 2.863 . . . . 0.0 112.808 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.2 -1.47 42.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.417 ' O ' ' HB1' ' A' ' 31' ' ' ALA . 47.7 t -61.47 147.36 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.358 0.599 . . . . 0.0 111.196 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -91.39 -25.7 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.005 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.499 ' C ' ' HB3' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.591 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.483 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.642 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.561 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.624 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 1.036 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.578 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.602 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 1.036 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 -113.22 -173.67 2.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . 166.66 -63.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.858 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 6.3 Cg_endo -48.97 -39.75 40.38 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.403 2.735 . . . . 0.0 113.734 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 4.5 mptp? -100.34 -11.42 20.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.783 0.325 . . . . 0.0 111.828 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.517 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 9.9 tp10 57.19 33.42 23.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.785 1.279 . . . . 0.0 108.588 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 5.0 tp10 -128.47 116.54 19.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.929 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.462 ' HB ' ' CE1' ' A' ' 97' ' ' PHE . 9.3 p -83.98 120.03 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.561 ' HD2' HG21 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.796 HG22 HG13 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.477 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.479 HG13 HD12 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.615 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.446 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.832 ' HG2' HG23 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 HG22 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.55 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.668 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.083 ' HG ' ' HB2' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.668 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.516 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 1.083 ' HB2' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.639 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.649 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.431 HG13 HG22 ' A' ' 154' ' ' VAL . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.44 ' HG3' ' N6 ' ' B' ' 5' ' ' ' A' . 33.9 mtm180 62.25 -176.63 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.01 83.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.68 0.612 . . . . 0.0 112.042 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -53.39 102.52 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.849 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.6 p -135.87 89.52 20.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo -63.01 141.74 85.07 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.583 2.855 . . . . 0.0 113.152 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.608 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 48.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.478 HG12 ' HB1' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.477 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG22 HG13 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.649 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.561 HG21 ' HD2' ' A' ' 104' ' ' LYS . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.458 ' CB ' HG11 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.515 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.781 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.736 ' HD3' HD13 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.445 ' O ' HG22 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.736 HD13 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.615 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp 57.64 57.37 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.22 164.36 29.57 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.01 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -97.23 47.67 1.04 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t 74.11 -55.84 0.66 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.674 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.5 -173.61 35.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.095 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.11 103.23 11.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 87.7 mt 57.98 58.2 3.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.835 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 65.77 38.53 5.17 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.843 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.745 0 O4'-C4'-C3' 104.442 -0.756 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.501 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 C3'-C2'-C1' 104.514 3.349 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.845 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 P-O3'-C3' 124.216 3.763 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.86 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C4'-C3' 102.954 -1.819 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.86 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 P-O3'-C3' 123.861 3.468 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.514 " H1'" HG11 ' A' ' 127' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 O4'-C4'-C3' 104.334 -0.833 . 0.542 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.781 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 N19-C1'-C2' 116.011 1.632 . 0.131 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 92.7 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.06 0.457 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -106.88 -31.84 8.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.649 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . 74.94 56.01 5.04 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.785 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 4' ' ' GLY . 23.5 Cg_exo -64.51 136.73 51.74 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.495 2.13 . . . . 0.0 111.863 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t 71.86 -44.81 0.6 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.916 0.76 . . . . 0.0 111.612 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.5 m -64.08 -41.98 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.689 0.28 . . . . 0.0 110.826 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -116.73 73.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 t -169.07 88.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.677 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.13 61.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.862 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.02 100.89 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -104.35 112.45 65.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.348 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.0 Cg_endo -82.19 134.35 7.98 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.147 2.565 . . . . 0.0 112.428 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 62.13 -177.36 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.4 m 70.17 118.97 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.443 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.4 p 68.47 -18.74 0.16 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.937 1.295 . . . . 0.0 113.516 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.18 9.83 13.98 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.87 -0.519 . . . . 0.0 111.471 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.452 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 34.3 tpp 177.9 120.12 0.18 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 100.95 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.971 2.448 . . . . 0.0 109.865 166.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 18' ' ' MET . 39.4 Cg_exo -59.92 141.24 96.15 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.013 2.476 . . . . 0.0 113.005 -170.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.08 47.57 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -99.63 106.45 18.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.98 147.9 32.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.438 HG21 ' HG1' ' A' ' 74' ' ' THR . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.899 HG13 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.664 HG13 HG21 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.722 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.623 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.778 HG21 ' HG3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB2' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.555 HG22 HD11 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.56 HD12 HD11 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 43' ' ' GLN . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.427 ' H ' ' C ' ' A' ' 41' ' ' ASP . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.726 HD12 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.893 HD21 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.702 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.415 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.62 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.86 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 1.016 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 1.016 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.687 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.586 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.3 121.0 8.19 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.778 ' HG3' HG21 ' A' ' 34' ' ' VAL . 10.3 Cg_endo -52.44 128.04 26.31 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 122.949 2.433 . . . . 0.0 111.047 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.32 -35.78 74.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.287 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.7 p -141.16 154.98 68.4 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.383 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.42 -3.61 12.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.504 2.136 . . . . 0.0 110.397 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.17 -10.22 53.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.274 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 m -69.48 153.94 42.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.496 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 7.3 mtpm? -97.52 -46.95 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.855 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.722 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.687 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.664 HG21 HG13 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.785 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD13 ' HD3' ' A' ' 57' ' ' LYS . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.86 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.62 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.585 ' HB3' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.609 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.412 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.642 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.513 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.497 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.708 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.841 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -162.15 133.77 5.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 102' ' ' GLU . . . -164.94 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.735 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.08 -55.2 4.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.436 2.757 . . . . 0.0 114.455 -172.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -101.98 -1.75 31.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.182 0.515 . . . . 0.0 111.328 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -174.3 106.25 0.11 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.532 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 50.5 mt-10 -61.79 171.64 1.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.571 0.545 . . . . 0.0 111.744 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.841 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m -57.09 129.24 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.133 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.571 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.697 HD13 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.872 HG22 HE21 ' A' ' 167' ' ' GLN . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.899 HG22 HG13 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.529 HG22 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.51 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.402 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.491 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.437 HG21 HD13 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.624 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.849 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.432 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.849 ' HB1' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.624 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.515 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.52 HG23 ' C2 ' ' B' ' 5' ' ' ' A' . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -67.72 99.92 0.86 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.58 55.95 4.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.443 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.414 HE21 ' HB2' ' A' ' 144' ' ' GLN . 1.4 tt0 -74.04 143.33 45.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.078 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 p -76.38 108.17 5.84 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.242 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.44 149.76 89.46 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.637 2.891 . . . . 0.0 112.92 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.462 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.462 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.402 HG11 ' HB1' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.515 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.666 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 28.1 m170 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.609 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.872 HE21 HG22 ' A' ' 107' ' ' THR . 89.8 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.578 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.578 ' HG ' ' O ' ' A' ' 170' ' ' ILE . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.51 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.64 ' HE2' ' HA ' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.454 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . 0.962 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -167.31 52.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.962 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -80.77 150.29 30.88 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.803 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . 0.483 ' C ' ' HG ' ' A' ' 186' ' ' SER . 2.3 mp0 -81.46 87.23 6.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.483 ' HG ' ' C ' ' A' ' 185' ' ' GLN . 20.7 p 53.62 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.096 0.958 . . . . 0.0 111.527 -171.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -100.27 -112.62 3.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -96.13 -66.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 58.53 89.22 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.883 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -85.85 -29.07 24.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.687 178.735 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.483 " H4'" " O5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 103.842 2.602 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.544 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 122.506 2.338 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.694 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 P-O3'-C3' 124.443 3.952 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.906 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C4'-C3' 103.457 -1.459 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.906 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 P-O3'-C3' 123.374 3.062 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.42 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C4'-C3' 103.635 -1.332 . 0.499 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . 0.436 ' O4 ' HG11 ' A' ' 139' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 P-O3'-C3' 120.663 0.803 . 0.048 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.85 -93.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 ttm 62.91 101.17 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.48 0.657 . . . . 0.0 110.169 -171.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.75 110.19 3.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.24 -52.97 7.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.396 2.731 . . . . 0.0 113.162 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -87.68 92.99 9.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.7 t -133.52 -160.82 1.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.478 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -73.25 -52.71 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.967 0.413 . . . . 0.0 110.398 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.4 m 68.6 -3.25 1.42 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.349 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.83 22.79 23.33 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.482 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.64 69.56 7.18 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 69.12 126.17 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 124.03 0.831 . . . . 0.0 111.325 -179.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_exo -63.04 -18.37 64.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.053 2.502 . . . . 0.0 111.747 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 t80 49.27 54.54 10.78 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.754 0.659 . . . . 0.0 110.562 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 m -79.67 69.38 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.713 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -99.15 20.31 13.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.441 0.639 . . . . 0.0 109.542 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.84 102.2 1.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.6 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.467 ' HE1' ' HB2' ' A' ' 149' ' ' ASN . 25.0 ptt? -96.07 134.81 23.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 177.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -66.64 117.31 4.64 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.821 2.348 . . . . 0.0 112.241 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.62 71.06 4.83 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.952 2.435 . . . . 0.0 111.482 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' O ' HG21 ' A' ' 74' ' ' THR . 13.6 pt-20 -83.61 66.12 8.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.979 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 57.85 -146.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.46 119.62 30.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.681 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.418 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.416 HG21 HD21 ' A' ' 105' ' ' LEU . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HG2' ' HB2' ' A' ' 33' ' ' ALA . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.424 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.436 ' HB1' HD12 ' A' ' 91' ' ' LEU . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.567 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.566 HG13 HG12 ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.56 HD11 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.567 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.581 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.581 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 9.8 t-80 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.665 HG12 HG23 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.47 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.712 ' HB3' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.403 ' HB3' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.7 HG21 HG11 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.529 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo -78.1 170.54 18.58 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -39.85 -40.81 2.62 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.87 3.047 . . . . 0.0 114.762 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.51 -35.92 61.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 59' ' ' ALA . 74.6 p -70.38 156.12 92.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 112.117 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' C ' ' H ' ' A' ' 66' ' ' SER . 21.1 Cg_exo -66.72 -12.26 35.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.348 2.698 . . . . 0.0 111.564 176.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.35 33.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.914 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.542 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 13.9 t -62.58 -28.68 70.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.887 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.676 ' HZ3' ' HB3' ' A' ' 67' ' ' LYS . 6.7 ttpm? -74.78 -55.51 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.542 ' CZ ' ' HA ' ' A' ' 66' ' ' SER . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.485 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.7 HG11 HG21 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.681 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.419 HG21 ' O ' ' A' ' 21' ' ' GLU . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.413 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.543 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.44 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.566 HG12 HG13 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.503 ' CD1' HD11 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.651 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.743 ' HA ' ' CD1' ' A' ' 96' ' ' PHE . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.595 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PHE . . . . . 0.743 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.691 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.84 76.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.25 -83.93 1.71 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.482 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.884 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 32.1 Cg_exo -62.06 -41.62 34.96 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.345 2.697 . . . . 0.0 114.509 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.884 ' HD2' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -99.41 -8.91 24.12 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -168.275 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.31 158.19 29.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.915 -168.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.05 145.7 37.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.765 HG11 ' HD2' ' A' ' 159' ' ' HIS . 26.8 m -72.48 126.83 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.147 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.741 ' HG ' ' CD2' ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.418 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.581 ' HD2' HD12 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.548 ' HB1' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.823 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.559 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.424 ' HZ1' ' HB2' ' A' ' 122' ' ' LYS . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.522 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.572 ' HA3' " O2'" ' B' ' 5' ' ' ' A' . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.705 HG23 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.577 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.475 ' O ' ' HB1' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.475 ' HB1' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.747 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.512 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.705 ' HB ' HG23 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.475 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.28 140.91 58.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.44 ' HA ' ' H22' ' B' ' 4' ' ' ' G' . 7.7 m-20 65.27 11.01 6.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.537 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.544 ' C ' ' HD3' ' A' ' 146' ' ' PRO . 49.7 mt-30 66.55 100.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.627 0.58 . . . . 0.0 111.314 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.3 p -113.8 67.93 1.48 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.88 0.371 . . . . 0.0 110.702 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.544 ' HD3' ' C ' ' A' ' 144' ' ' GLN . 69.3 Cg_endo -93.5 165.59 2.33 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 113.136 -173.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' HG3' HD21 ' A' ' 149' ' ' ASN . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.467 ' HB2' ' HE1' ' A' ' 18' ' ' MET . 0.9 OUTLIER -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 141' ' ' PRO . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.523 HD12 HD11 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.512 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' HIS . . . . . 0.765 ' HD2' HG11 ' A' ' 103' ' ' VAL . 36.6 m80 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.543 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TYR . . . . . 0.448 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.747 ' HB3' ' HB1' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.775 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ILE . . . . . 0.559 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.581 HD12 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.823 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -101.51 33.91 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.85 19.8 3.48 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.185 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.51 115.59 28.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 110.717 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -108.52 -8.34 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.692 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 166.33 170.31 31.08 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.791 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -129.42 50.84 2.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.657 0.741 . . . . 0.0 109.132 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.0 84.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -113.72 107.74 16.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.099 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.187 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 103.866 2.629 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.511 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 103.414 2.127 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' G' . . . . . 0.83 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 P-O3'-C3' 124.256 3.796 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.961 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 O4'-C1'-C2' 108.258 1.327 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.961 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 P-O3'-C3' 123.866 3.472 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' C' . . . . . 0.477 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C4'-C3' 104.408 -0.78 . 0.543 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-N19 108.846 0.646 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' HG12 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.6 ' HB1' HD22 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.987 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.3 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.233 0.214 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HG23 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.987 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 44.2 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.686 ' HB2' HG11 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HD3' HG22 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.686 HG11 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HA ' HD11 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' HD11 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.8 ' HG2' HG21 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 HG13 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.96 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.762 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.96 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.641 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 114.26 0.831 . . . . 0.0 114.26 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 49.0 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.531 HG22 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 86.5 mm-40 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.509 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.573 HG22 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.801 HG13 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.545 HG12 HG21 ' A' ' 58' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.063 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 30' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HE ' HG13 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.811 ' HB ' HG13 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HG12 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.476 HD11 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.513 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' A' ' 103' ' ' VAL . 2.2 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.721 HG12 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG3' HD11 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.489 HG23 HG21 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.472 HH11 HD11 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD13 HG23 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.749 HG23 HD13 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.627 HG12 HG22 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.529 0.252 0 CA-C-O 121.05 0.354 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.472 HD11 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.799 HD11 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.88 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.88 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 168' ' ' ARG . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt . . . . . 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.867 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HG21 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.871 HG12 HD13 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.748 HG21 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HG3' HD13 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.571 HD13 HG22 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.422 HG23 HG21 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.599 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.583 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.536 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' THR . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.827 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 CA--C 1.533 0.433 0 N-CA-C 113.393 0.497 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.827 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 163' ' ' SER . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.583 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 3.8 m-70 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.751 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 156' ' ' ILE . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.572 HG22 HD22 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.685 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.885 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.751 HG21 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.751 ' HG2' HG21 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.825 HD11 HD21 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG23 HG23 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.912 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.941 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.936 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.941 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.167 0.403 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 15.3 m120 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.985 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.985 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.787 ' HB3' HG21 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.419 ' HE ' ' CG ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.498 HD13 HD11 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.624 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.912 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.775 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.898 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.71 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.771 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.465 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.771 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.774 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HG12 ' A' ' 45' ' ' ILE . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo . . . . . 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 mtmm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 29' ' ' ILE . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.463 HG12 HG23 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.406 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.607 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.898 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 58.2 m-85 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 157' ' ' ILE . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.972 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.972 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.683 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 20.7 Cg_endo . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.695 0.206 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.535 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.535 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.532 ' HB3' HE21 ' A' ' 151' ' ' GLN . 5.6 m120 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.477 HG22 ' HE3' ' A' ' 155' ' ' LYS . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.449 ' HA ' HG21 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 174' ' ' LEU . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HE3' HD22 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.03 0.443 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.74 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.902 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 33' ' ' ALA . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.643 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.898 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.909 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.012 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.929 HG22 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.902 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.929 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.787 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.638 ' CD1' ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.909 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD22 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.491 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.76 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.818 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.818 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.677 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.714 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HD3' HG22 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.843 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.843 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.938 HG12 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.938 ' HD2' HG12 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.706 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo . . . . . 0 N--CA 1.455 -0.736 0 N-CA-C 114.202 0.808 . . . . 0.0 114.202 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 149' ' ' ASN . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.691 HG21 ' HB2' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.769 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CD2' HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 156' ' ' ILE . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.3 m-70 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 69' ' ' ARG . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.832 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.967 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.967 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG22 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.832 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.61 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.632 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.793 HD11 HD21 ' A' ' 105' ' ' LEU . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.411 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.708 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.702 HG12 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.793 HD21 HD11 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.861 HG22 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.857 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.74 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.488 0 CA-C-O 121.522 0.551 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.499 ' H ' ' HB3' ' A' ' 147' ' ' ASP . 98.7 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 113' ' ' ALA . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 137' ' ' GLU . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.429 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.609 HG12 HG13 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.857 HG22 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB3' ' HE2' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 HD13 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.612 ' HB3' HG22 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.941 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.537 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 27' ' ' VAL . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 26' ' ' HIS . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 5.0 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.521 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 87' ' ' ILE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.676 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.485 ' CD2' HG12 ' A' ' 103' ' ' VAL . 93.9 m-85 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.827 HG22 HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.7 HH11 ' HG3' ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.634 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.651 ' HG3' HG22 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.64 HG12 HG11 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.642 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.642 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.666 ' HB3' HG13 ' A' ' 152' ' ' VAL . 58.9 Cg_endo . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 113.54 0.554 . . . . 0.0 113.54 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.798 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 3.1 m-70 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.798 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 23.2 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.651 HG22 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.634 HD13 ' HD2' ' A' ' 112' ' ' PRO . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.57 HG11 ' HB1' ' A' ' 115' ' ' ALA . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 183' ' ' LYS . 2.2 tmmm? . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.697 HG12 HG22 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.4 m-70 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD13 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.607 HG23 HG21 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.607 HG21 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.653 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.629 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' O ' HD22 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.609 ' HD2' HD13 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.757 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.847 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.717 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.697 HG22 HG12 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.476 ' HB ' HD21 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.811 ' HG2' HD22 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.648 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.581 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.581 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.964 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.964 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.526 ' HE ' ' HB3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.236 0.4 0 CA-C-O 120.848 0.27 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 113' ' ' ALA . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.847 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 5.3 m-70 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.648 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.0 m-70 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.575 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.81 ' HB3' HG21 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' HG22 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.597 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' C ' ' HB2' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.449 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.626 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 1.045 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 1.045 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 159' ' ' HIS . 9.3 p . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' HD2' HG22 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.795 HG22 HG12 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.517 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.807 ' HG2' HG21 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.415 ' HA3' ' OG1' ' A' ' 126' ' ' THR . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.082 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 1.082 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.658 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 142' ' ' ARG . 33.9 mtm180 . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.624 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.152 0.404 . . . . 0.0 113.152 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.624 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 56.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.517 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.658 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.473 ' HA ' HG13 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.612 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.757 ' HD3' HD12 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.757 HD12 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.807 HG21 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.748 HG12 HG22 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 HD13 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD23 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.877 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 7.3 mtpm? . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.702 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.748 HG22 HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.835 ' H ' ' HA ' ' A' ' 57' ' ' LYS . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.686 HD12 ' HB1' ' A' ' 83' ' ' ALA . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 77' ' ' PRO . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.65 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.85 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.85 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.582 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.61 HG23 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 173' ' ' ILE . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 121.311 0.463 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 107' ' ' THR . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 27.9 m-70 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.628 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 163' ' ' SER . 16.5 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.596 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD2' HD12 ' A' ' 174' ' ' LEU . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 118' ' ' ARG . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 111' ' ' VAL . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 177' ' ' VAL . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 87.4 m-70 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.609 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.57 HD13 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 40.9 t60 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG12 HD13 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 6.7 ttpm? . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.562 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.647 ' HA ' HD11 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.485 ' CD1' HD12 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 105' ' ' LEU . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PHE . . . . . 0.752 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.685 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 26.8 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 112' ' ' PRO . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.62 ' HD2' HD11 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 120' ' ' ILE . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.725 HG22 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.769 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 69.3 Cg_endo . . . . . 0 N--CA 1.452 -0.919 0 CA-C-O 121.182 0.409 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' HIS . . . . . 0.515 ' ND1' HG13 ' A' ' 103' ' ' VAL . 84.9 m-70 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.784 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.93 89.91 3.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -85.49 56.96 4.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.402 0.62 . . . . 0.0 111.424 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.45 113.26 3.8 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.519 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 -31.0 79.56 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.913 2.409 . . . . 0.0 112.504 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m 60.57 39.1 18.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.515 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.3 m -63.24 -28.06 69.77 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.187 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.99 123.21 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -125.19 89.02 2.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.231 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 159.76 36.48 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.751 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.54 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 111.243 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.8 42.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.584 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.87 79.8 2.22 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.982 2.455 . . . . 0.0 111.696 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -63.49 107.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -83.57 122.6 28.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.698 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -91.87 1.28 57.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.627 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -101.55 140.49 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.881 0.372 . . . . 0.0 110.566 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.479 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 mmt -124.85 129.98 24.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 2.3 Cg_endo -81.89 115.88 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.132 2.555 . . . . 0.0 111.851 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HB2' HG21 ' A' ' 74' ' ' THR . 94.9 Cg_endo -82.45 68.61 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.377 2.051 . . . . 0.0 112.787 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -93.24 32.53 1.31 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 20' ' ' PRO . 25.7 mp0 -87.41 177.04 7.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.924 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.36 119.21 9.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' HG12 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.6 ' HB1' HD22 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.987 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.3 Cg_exo -73.52 179.02 5.95 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.73 59.91 2.8 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.134 1.89 . . . . 0.0 112.164 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE1' ' HD2' ' A' ' 60' ' ' PRO . 4.4 pt-20 -92.17 -52.2 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.359 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 41.3 p -84.36 145.63 45.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.839 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 53.0 Cg_exo -55.14 -22.18 30.87 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.914 3.076 . . . . 0.0 113.299 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -83.09 32.38 0.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.417 0.627 . . . . 0.0 109.73 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 t -69.58 10.14 0.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.354 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.88 -18.87 61.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HG23 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 20' ' ' PRO . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.987 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 44.2 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.686 ' HB2' HG11 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HD3' HG22 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 -141.46 59.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 92' ' ' LYS . . . -122.8 -54.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.117 -174.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.3 -41.57 3.49 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.359 2.039 . . . . 0.0 112.969 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -103.9 3.83 34.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.657 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.24 155.54 30.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -99.23 133.58 43.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.686 HG11 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m -67.01 122.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HA ' HD11 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' HD11 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.8 ' HG2' HG21 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 HG13 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.96 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.762 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.96 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -68.26 108.61 3.25 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 72.15 -70.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.45 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -164.95 -53.44 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.196 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.1 p 44.43 70.2 2.06 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-O 121.484 0.659 . . . . 0.0 110.891 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.641 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo -87.86 149.77 7.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.782 2.988 . . . . 0.0 114.26 -167.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 49.0 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.531 HG22 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 86.5 mm-40 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.509 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.82 71.3 6.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.66 -132.07 1.63 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.668 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.75 24.89 12.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.6 m 66.41 -74.91 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.477 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -177.92 34.15 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.39 153.13 51.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.511 0.196 . . . . 0.0 110.609 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.23 76.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -95.35 -41.05 9.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.666 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.682 0.916 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.531 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 103.19 1.878 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.857 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 P-O3'-C3' 124.307 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.859 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 O4'-C4'-C3' 102.587 -2.081 OUTLIER-EPSILON 0.015 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.859 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 P-O3'-C3' 123.371 3.059 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.573 " H2'" " O4'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.417 -1.203 . 0.755 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.573 " O4'" " H2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.841 0 C4'-C3'-C2' 103.849 1.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 109.2 8.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.461 0.172 . . . . 0.0 111.024 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 56.75 79.85 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.855 0.722 . . . . 0.0 111.66 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.9 110.44 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.085 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.14 -51.24 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.771 2.314 . . . . 0.0 111.52 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 7' ' ' SER . 9.2 t -168.04 75.88 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 6' ' ' SER . 38.2 t 73.82 149.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.861 -170.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.49 7.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.828 0.347 . . . . 0.0 111.355 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 m -87.02 2.43 49.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.69 -92.9 0.12 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.351 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.95 41.88 20.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.315 0.579 . . . . 0.0 110.195 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -112.89 138.4 22.17 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.626 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 19.5 Cg_exo -66.64 131.66 26.64 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.615 2.21 . . . . 0.0 111.269 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.08 139.88 50.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.326 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.3 t 70.4 23.81 4.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.806 0.691 . . . . 0.0 111.232 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.64 128.06 34.44 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -96.89 141.9 29.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.24 0.543 . . . . 0.0 111.865 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.2 tpt -158.35 100.95 1.71 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.785 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.49 111.96 3.35 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.878 2.385 . . . . 0.0 111.923 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 55' ' ' SER . 30.2 Cg_endo -91.02 97.89 0.23 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.808 2.339 . . . . 0.0 112.86 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -109.88 40.71 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -85.05 -129.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.564 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 -70.89 140.6 51.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.573 HG22 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.801 HG13 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.545 HG12 HG21 ' A' ' 58' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.063 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.649 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.41 148.8 92.44 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 58.5 Cg_endo -72.07 61.44 3.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.046 2.497 . . . . 0.0 112.178 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.14 -39.56 65.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 53.7 p -81.57 174.64 5.81 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.518 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 83.5 Cg_exo -50.23 -18.18 3.19 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.694 2.263 . . . . 0.0 113.432 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.15 31.33 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.865 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.803 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 9.4 m -71.08 -1.81 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -172.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.11 -17.71 54.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 61' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HE ' HG13 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.811 ' HB ' HG13 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HG12 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.476 HD11 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' A' ' 103' ' ' VAL . 2.2 m-85 -131.6 147.52 52.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 99' ' ' PRO . . . 178.95 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.686 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 25.4 Cg_exo -67.26 -48.0 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.149 2.566 . . . . 0.0 113.128 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -92.56 -27.04 17.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.91 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -130.16 139.13 50.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.159 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 41.6 tt0 -90.7 137.68 32.17 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.721 HG12 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m -66.19 121.09 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.53 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG3' HD11 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.489 HG23 HG21 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.472 HH11 HD11 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD13 HG23 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.46 ' HA ' H5'' ' B' ' 3' ' ' ' G' . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.749 HG23 HD13 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 0.7 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.627 HG12 HG22 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.712 ' HG2' ' H62' ' B' ' 5' ' ' ' A' . 0.2 OUTLIER -81.04 143.43 32.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 66.21 -169.75 0.2 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.792 0.683 . . . . 0.0 110.524 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -104.53 117.05 33.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.76 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.592 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 6.6 t -141.93 49.01 1.26 Allowed Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.743 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 145' ' ' THR . 32.0 Cg_exo -54.1 138.15 70.7 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.841 2.361 . . . . 0.0 112.811 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.472 HD11 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' N ' ' HD2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.799 HD11 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.88 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.88 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 168' ' ' ARG . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt 60.55 56.1 3.19 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.98 131.93 5.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.875 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -168.64 138.08 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.7 m 57.07 75.21 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.837 0.71 . . . . 0.0 111.296 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.04 176.36 39.01 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -129.58 -29.92 2.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.945 0.402 . . . . 0.0 110.076 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.8 54.14 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.655 0.74 . . . . 0.0 109.796 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -86.22 79.98 8.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.08 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 -179.709 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 100.278 -1.358 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.523 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 104.119 2.91 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.884 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 P-O3'-C3' 124.389 3.907 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.914 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.746 0 O4'-C1'-C2' 108.347 1.391 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.914 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.615 0.68 0 P-O3'-C3' 123.492 3.16 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.53 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 107.754 0.967 . 0.375 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 57.68 3.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.919 0.488 . . . . 0.0 111.142 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.17 139.33 31.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.122 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.35 -74.5 0.23 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 6' ' ' SER . 16.6 Cg_endo -59.12 159.91 20.6 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.652 2.234 . . . . 0.0 110.906 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 50.8 m 73.1 -52.31 0.71 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.599 0.562 . . . . 0.0 111.015 -175.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -65.12 -23.67 67.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -86.29 42.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 110.871 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 58.41 42.34 21.45 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.032 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 51.63 0.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.976 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.19 -174.63 4.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.66 78.78 0.36 Allowed Pre-proline 0 C--O 1.235 0.29 0 O-C-N 123.9 0.75 . . . . 0.0 111.674 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.75 111.02 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.593 2.196 . . . . 0.0 111.18 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -78.96 70.12 5.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.468 0.651 . . . . 0.0 110.342 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 t -118.08 2.02 12.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -87.12 66.04 9.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.119 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.64 70.18 4.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 109.849 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.4 mtt -114.24 113.68 46.03 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.288 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 9.3 Cg_exo -72.3 110.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.732 2.288 . . . . 0.0 111.401 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 14.8 Cg_exo -68.7 125.64 12.97 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.023 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 pm0 -77.54 57.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.038 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 47.92 -114.97 0.64 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.128 0.571 . . . . 0.0 111.88 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 -113.28 117.79 32.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.867 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HG21 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.871 HG12 HD13 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.748 HG21 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo -73.32 154.81 51.37 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.84 49.35 2.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.038 2.492 . . . . 0.0 111.697 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.73 -28.79 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.035 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 68.6 p -85.12 178.1 2.56 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.205 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.4 Cg_exo -56.12 -26.34 59.58 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.353 2.036 . . . . 0.0 112.514 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.14 31.58 0.12 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.255 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -63.12 -23.42 67.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.16 -13.99 61.7 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HG3' HD13 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 -137.7 167.51 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.04 -84.3 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.413 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.11 -44.35 28.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.777 2.985 . . . . 0.0 113.427 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -94.21 -26.18 16.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.328 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 47.84 36.46 5.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.758 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 108.95 17.08 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.798 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m -97.3 121.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.571 HD13 HG22 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.422 HG23 HG21 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.599 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.86 ' HA3' ' C5 ' ' B' ' 4' ' ' ' G' . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.583 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.536 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' THR . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.827 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.709 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 67.4 ttt180 -77.15 76.47 3.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 51.55 44.21 29.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.322 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.588 ' OE1' ' HA ' ' A' ' 141' ' ' PRO . 4.4 pt20 -115.25 -11.57 11.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.793 ' H ' ' HD3' ' A' ' 146' ' ' PRO . 69.5 p -133.29 -16.92 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.793 ' HD3' ' H ' ' A' ' 145' ' ' THR . 25.8 Cg_exo -56.87 125.03 17.68 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 121.647 1.565 . . . . 0.0 113.393 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.827 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 163' ' ' SER . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.583 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 41.0 m170 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.751 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 156' ' ' ILE . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 67.14 30.71 7.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 121.67 -143.47 15.88 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.621 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -117.52 -178.14 3.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.2 p 51.67 35.83 15.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.584 0.754 . . . . 0.0 112.114 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.0 -35.71 5.23 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -77.42 -21.35 53.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 110.159 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.7 mm? -96.71 105.13 17.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.197 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -96.44 75.68 2.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.613 0.721 . . . . 0.0 110.752 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.676 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C1'-C2' 107.548 0.82 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.448 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 104.633 3.481 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.835 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.938 0 C4'-C3'-C2' 105.691 2.991 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.921 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 O4'-C1'-C2' 108.487 1.491 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.921 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.696 0 P-O3'-C3' 123.766 3.388 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.441 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 104.304 -0.854 . 0.67 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.8 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.91 0 N19-C1'-C2' 115.149 1.093 . 0.178 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.58 34.3 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.346 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.9 tpp -70.46 126.77 30.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.745 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 10' ' ' GLY . . . 160.11 -66.45 0.27 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.435 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 57.03 4.61 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.866 2.378 . . . . 0.0 111.391 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -65.07 -63.09 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.796 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.3 m -149.92 -55.34 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.784 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 9' ' ' SER . 17.0 m -121.02 32.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.229 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 44.2 t 74.99 130.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.171 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 4' ' ' GLY . . . -158.35 171.2 35.16 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.841 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HA ' ' HD2' ' A' ' 14' ' ' PHE . . . 63.49 48.07 3.61 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.921 0.489 . . . . 0.0 111.713 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -86.59 -50.6 0.47 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.954 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 5.1 Cg_exo -75.94 5.8 4.21 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 0.0 112.898 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 76.3 m-85 -105.26 102.75 12.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t 62.55 58.74 1.6 Allowed 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.686 0.616 . . . . 0.0 109.906 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 m -69.86 79.89 0.46 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.673 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 59.3 77.53 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.338 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 65.0 mtt -120.51 128.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.068 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 7.3 Cg_exo -74.55 118.87 5.5 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.813 2.342 . . . . 0.0 111.614 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.03 167.93 23.37 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.678 2.252 . . . . 0.0 112.394 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 8.6 pt-20 -49.37 -55.8 11.73 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.88 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.836 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -150.22 140.3 22.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.572 HG22 HD22 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.685 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.17 140.77 66.45 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 57.0 Cg_endo -73.54 71.59 3.85 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.877 2.384 . . . . 0.0 111.653 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.02 -34.91 50.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.342 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 42.3 p -82.58 177.05 3.25 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.204 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 31.2 Cg_exo -60.95 -5.99 5.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.852 2.368 . . . . 0.0 112.556 176.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.93 17.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.009 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 32.4 t -66.34 -3.23 5.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.9 0.48 . . . . 0.0 112.029 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -72.62 -20.47 61.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.885 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.751 HG21 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.751 ' HG2' HG21 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.825 HD11 HD21 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' HB3' ' NZ ' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 -116.43 150.03 38.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.09 -79.55 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.942 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 -54.17 4.43 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.956 2.437 . . . . 0.0 113.115 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -26.89 9.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -115.49 168.42 10.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.505 0.669 . . . . 0.0 112.049 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -145.15 168.95 19.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m -66.21 120.62 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.118 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG23 HG23 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.912 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' OP1' ' B' ' 3' ' ' ' G' . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.681 ' HA3' ' OP1' ' B' ' 4' ' ' ' G' . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.941 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.936 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.941 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.668 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 29.4 ttp180 -77.02 72.62 3.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.461 ' HA ' ' N2 ' ' B' ' 4' ' ' ' G' . 22.9 t70 -171.03 153.38 3.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.13 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -84.38 79.26 9.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.675 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.478 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 3.3 t -133.0 60.87 52.62 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.016 -175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 145' ' ' THR . 36.6 Cg_exo -59.14 143.84 99.62 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.958 2.439 . . . . 0.0 112.448 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.41 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 15.3 m120 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.985 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.985 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.787 ' HB3' HG21 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.419 ' HE ' ' CG ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.498 HD13 HD11 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.624 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.912 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -123.05 40.97 3.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.38 159.15 17.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.599 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -104.85 141.28 36.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.6 m -89.89 106.43 18.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.799 0.333 . . . . 0.0 111.231 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.56 -50.92 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -102.75 75.71 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.85 117.57 9.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 67.29 72.54 0.34 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.876 0.735 . . . . 0.0 110.278 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.987 179.141 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 O4'-C1'-C2' 107.63 0.879 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.509 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C3'-C2'-C1' 104.096 2.885 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.509 ' OP1' " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 P-O3'-C3' 124.402 3.919 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.865 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C4'-C3' 102.054 -2.462 OUTLIER-EPSILON 0.016 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.865 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.749 0 P-O3'-C3' 122.862 2.635 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.574 " O2'" " H5'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.684 0.917 . 0.306 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.574 " H5'" " O2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C3'-C2'-C1' 100.289 -1.345 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.72 -75.18 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 0.239 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm 179.23 150.78 0.32 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.51 138.79 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.86 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.89 4.69 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.933 2.422 . . . . 0.0 111.908 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -86.59 32.64 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.08 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -68.31 -22.23 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.487 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 m -93.47 5.17 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.02 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -120.17 86.98 2.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.021 0.439 . . . . 0.0 110.382 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.77 131.17 6.06 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.047 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.5 66.42 8.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.55 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.71 131.78 48.48 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.542 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.84 -7.67 21.56 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.871 2.381 . . . . 0.0 112.429 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 86.0 t80 -147.23 104.08 3.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.218 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -94.55 -71.79 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.579 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -168.73 81.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.76 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HE2' ' HA ' ' A' ' 14' ' ' PHE . 88.2 m-85 -84.57 62.78 7.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 110.478 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.3 mtp -118.47 96.04 49.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.431 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 74.5 Cg_exo -50.05 -44.2 38.67 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.009 2.472 . . . . 0.0 113.245 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.992 ' HA ' HG21 ' A' ' 74' ' ' THR . 33.9 Cg_exo -65.41 80.45 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.775 1.65 . . . . 0.0 112.636 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 9.03 39.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.894 0.854 . . . . 0.0 109.476 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -140.32 -170.1 2.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.962 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.19 136.03 42.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.775 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' CA ' ' A' ' 65' ' ' ASP . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.898 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.71 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.771 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.465 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.771 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.774 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HE3' ' HG2' ' A' ' 19' ' ' PRO . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HG12 ' A' ' 45' ' ' ILE . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo -61.15 138.4 77.58 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 36.5 Cg_endo -65.79 88.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.364 2.709 . . . . 0.0 111.749 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.906 ' HB3' ' HD2' ' A' ' 64' ' ' PRO . 12.8 tt0 -91.44 -47.55 7.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.769 HG22 ' HD3' ' A' ' 64' ' ' PRO . 0.6 OUTLIER 162.82 -38.13 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -154.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.906 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 31.4 Cg_exo -44.8 7.86 0.0 OUTLIER 'Trans proline' 0 C--O 1.201 -1.361 1 C-N-CA 125.737 4.292 . . . . 0.0 117.091 165.508 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.663 ' HA ' HG12 ' A' ' 68' ' ' VAL . 3.3 p30 -60.57 31.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.73 1.605 . . . . 0.0 115.116 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 64' ' ' PRO . 33.5 t -144.43 -45.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 161.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 64' ' ' PRO . 39.1 mtmm -72.84 44.08 0.12 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 111.819 -2.446 . . . . 0.0 112.48 167.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 65' ' ' ASP . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.463 HG12 HG23 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.992 HG21 ' HA ' ' A' ' 20' ' ' PRO . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.607 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.898 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 1.017 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 58.2 m-85 -126.94 96.05 4.51 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.9 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.1 -21.84 35.99 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.583 2.189 . . . . 0.0 110.994 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -109.26 23.58 14.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.723 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 1.017 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 11.1 tt0 -61.4 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 110.6 3.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 164.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m -82.22 121.68 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 157' ' ' ILE . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.663 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.972 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.972 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.705 ' HG3' ' H21' ' B' ' 4' ' ' ' G' . 63.9 ttt180 -74.48 102.8 4.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 56.68 42.41 26.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.417 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 27.7 tp60 -62.88 -74.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.493 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 9.8 t -151.3 39.75 0.18 Allowed Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.683 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 20.7 Cg_endo -68.92 125.39 12.52 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 120.997 1.131 . . . . 0.0 112.295 169.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.535 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.535 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.532 ' HB3' HE21 ' A' ' 151' ' ' GLN . 5.6 m120 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.477 HG22 ' HE3' ' A' ' 155' ' ' LYS . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.449 ' HA ' HG21 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 174' ' ' LEU . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HE3' HD22 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.425 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.59 -52.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 138.81 -155.94 24.0 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 187' ' ' GLY . 13.7 mm100 -86.09 87.65 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.8 t 73.79 -26.59 0.19 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.574 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 185' ' ' GLN . . . 126.56 -48.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -153.5 102.23 2.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.19 79.19 9.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 110.844 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -72.54 118.49 15.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.116 0.484 . . . . 0.0 111.369 -179.146 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.435 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-N19 110.114 1.914 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.51 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C5'-C4'-O4' 106.772 -1.735 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.888 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -1.017 1 P-O3'-C3' 124.575 4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.911 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 108.2 1.286 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.911 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.72 0 P-O3'-C3' 123.938 3.532 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.485 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 O4'-C1'-C2' 107.953 1.109 . 0.345 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.685 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.428 -0.769 0 N19-C1'-C2' 114.852 0.908 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.83 76.18 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.246 0.545 . . . . 0.0 111.549 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.2 tpt -146.14 -37.6 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 -66.13 2.76 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.661 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 3.89 5.99 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.482 2.121 . . . . 0.0 113.189 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 p 40.13 48.72 2.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.526 0.73 . . . . 0.0 112.856 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m -86.75 -19.8 28.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.9 t 68.22 -73.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.304 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -90.14 -67.56 0.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.52 124.96 0.86 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.629 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.87 -0.56 2.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.735 -0.274 . . . . 0.0 111.609 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.1 90.77 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 123.925 0.766 . . . . 0.0 110.904 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.45 80.2 0.59 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.131 2.554 . . . . 0.0 112.601 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -93.34 4.58 53.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.311 0.577 . . . . 0.0 110.242 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.33 53.68 1.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -96.07 71.7 2.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.394 0.616 . . . . 0.0 109.693 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 56' ' ' ILE . 83.8 m-85 -99.8 36.33 1.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.909 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 16.9 tpt 63.58 89.08 0.11 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.019 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 18' ' ' MET . 9.9 Cg_endo -50.75 112.21 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.632 2.888 . . . . 0.0 113.052 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 74' ' ' THR . 84.1 Cg_endo -92.58 132.98 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.285 2.657 . . . . 0.0 113.386 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' OE1' ' HG3' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -133.69 12.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.165 0.507 . . . . 0.0 110.38 172.652 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG3' ' OE1' ' A' ' 21' ' ' GLU . 44.8 mt-30 -121.17 -156.39 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.894 -170.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.05 127.68 32.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.317 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.74 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.902 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 33' ' ' ALA . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.643 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.898 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.909 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.012 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.929 HG22 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.63 151.79 73.51 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.64 96.4 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.28 2.653 . . . . 0.0 112.566 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.19 -51.24 3.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.038 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 41.4 p -84.15 174.61 5.63 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.514 -173.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 33.8 Cg_exo -62.29 -3.19 3.8 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.252 2.635 . . . . 0.0 112.967 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.93 31.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.824 0.45 . . . . 0.0 110.306 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 64' ' ' PRO . 13.8 t -69.2 4.34 1.7 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.226 -172.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.25 -30.73 58.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.902 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.929 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.787 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.638 ' CD1' ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.909 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD22 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.491 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.76 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.818 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.704 ' HD2' ' HA2' ' A' ' 98' ' ' GLY . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.818 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.677 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.714 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -130.46 60.97 1.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.704 ' HA2' ' HD2' ' A' ' 92' ' ' LYS . . . -103.1 -86.95 1.98 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.041 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.5 -37.58 22.25 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.378 . . . . 0.0 113.1 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.72 -26.43 13.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -166.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -137.66 155.25 49.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.346 -166.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.41 137.01 32.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.69 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m -73.83 131.46 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HD3' HG22 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.843 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.843 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.938 HG12 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.938 ' HD2' HG12 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -140.15 159.78 41.42 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.877 ' HB2' ' N3 ' ' B' ' 4' ' ' ' G' . 5.4 p-10 -63.95 90.7 0.06 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.832 0.825 . . . . 0.0 111.696 -173.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 57.74 62.71 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.871 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.504 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -113.13 114.96 48.27 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.276 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.706 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo -93.88 153.93 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.739 2.959 . . . . 0.0 114.202 -173.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 149' ' ' ASN . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.691 HG21 ' HB2' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.769 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CD2' HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 156' ' ' ILE . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.29 107.1 18.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -155.58 -94.61 0.1 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.654 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -130.86 118.0 20.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.2 t -98.44 -51.3 4.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 172.02 167.15 31.74 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.163 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.92 106.3 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.853 0.358 . . . . 0.0 110.143 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.51 89.08 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -130.83 38.62 3.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.074 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.614 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.667 ' O2 ' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.691 1.991 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.596 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C3'-C2'-C1' 103.373 2.081 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.913 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.982 1 P-O3'-C3' 124.539 4.033 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.913 ' N7 ' " H1'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.678 0 O4'-C4'-C3' 103.142 -1.684 OUTLIER-EPSILON 0.013 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.904 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 P-O3'-C3' 123.542 3.202 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.49 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 O4'-C1'-C2' 107.538 0.813 . 0.51 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.744 0 C3'-C2'-C1' 100.612 -0.986 . 0.0 OUTLIER '7D dist 5z' 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.25 57.6 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.988 0.423 . . . . 0.0 109.966 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt 59.11 60.92 2.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.466 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.95 169.73 13.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.31 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.93 -28.3 35.92 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.036 2.491 . . . . 0.0 112.075 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -85.01 56.37 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.383 0.611 . . . . 0.0 110.305 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -72.39 97.63 2.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.489 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.94 78.99 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.701 0.762 . . . . 0.0 109.232 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -88.82 88.36 7.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.402 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.7 128.29 3.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.979 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.48 104.53 11.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 84.77 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.76 -20.81 22.33 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 112.537 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 63.68 37.08 10.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.988 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -89.57 74.52 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.269 0.557 . . . . 0.0 110.999 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.7 m -93.18 161.28 14.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -84.32 48.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.433 0.635 . . . . 0.0 110.623 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 27.1 ttt -175.47 108.93 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.765 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 3.2 Cg_exo -81.36 108.28 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.296 2.664 . . . . 0.0 112.231 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 4.3 Cg_exo -80.19 133.01 9.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.13 2.553 . . . . 0.0 112.032 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -92.52 37.02 1.0 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 46.33 -123.45 1.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.825 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -96.07 123.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.3 m-70 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 69' ' ' ARG . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.832 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.967 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.967 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG22 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 57.3 Cg_endo -92.89 -165.71 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HA ' ' HB3' ' A' ' 66' ' ' SER . 81.8 Cg_exo -49.56 -16.54 1.38 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.349 2.033 . . . . 0.0 112.798 171.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 28.2 tt0 -51.06 -37.15 43.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.414 0.686 . . . . 0.0 111.107 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.4 p -96.54 161.04 28.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.61 -9.44 23.98 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.033 2.489 . . . . 0.0 111.468 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.73 31.23 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 13.2 p -69.23 4.59 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -72.79 -23.7 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.832 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.61 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 21' ' ' GLU . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' HA ' ' NE ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.632 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.793 HD11 HD21 ' A' ' 105' ' ' LEU . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.797 ' HD3' ' HA2' ' A' ' 98' ' ' GLY . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.411 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.708 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -146.59 84.65 1.62 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.797 ' HA2' ' HD3' ' A' ' 92' ' ' LYS . . . -102.12 -91.38 2.15 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.605 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 18.0 Cg_exo -70.17 -37.25 8.43 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.821 2.348 . . . . 0.0 112.086 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -76.44 -25.37 54.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.612 -170.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.22 143.17 23.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -80.56 140.77 35.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.702 HG12 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m -72.94 123.05 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.793 HD21 HD11 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.861 HG22 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.857 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.74 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 44.4 tpt85 -61.93 122.78 16.3 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.5 OUTLIER 74.38 115.36 0.06 Allowed 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 124.294 0.996 . . . . 0.0 109.741 -169.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' HG11 ' A' ' 152' ' ' VAL . 24.1 tt0 -117.13 136.69 52.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.056 -165.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 10.0 t -125.95 125.21 24.8 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 167.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 3.3 Cg_exo -80.44 144.83 16.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.674 2.25 . . . . 0.0 112.99 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.499 ' H ' ' HB3' ' A' ' 147' ' ' ASP . 98.7 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 144' ' ' GLN . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 137' ' ' GLU . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.531 ' HE2' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.429 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.609 HG12 HG13 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.857 HG22 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HB3' ' HE2' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.647 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -163.04 91.43 0.72 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -94.49 -17.72 38.23 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.763 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -79.13 91.98 4.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.328 0.585 . . . . 0.0 110.406 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.2 m -73.63 85.3 1.6 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.547 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 178.22 101.73 0.15 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.802 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.28 86.64 7.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.297 0.57 . . . . 0.0 110.504 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.6 mt -85.6 78.46 9.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.354 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.06 -58.31 2.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.588 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -178.053 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.628 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C4'-C3'-C2' 105.992 3.292 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.506 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C3'-C2'-C1' 103.168 1.853 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.554 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.965 1 P-O3'-C3' 124.665 4.138 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.955 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 O4'-C4'-C3' 103.181 -1.657 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.955 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.79 0 P-O3'-C3' 123.83 3.441 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.557 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 108.134 1.238 . 0.112 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C3'-C2'-C1' 102.959 1.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.38 105.95 14.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.876 0.369 . . . . 0.0 110.646 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -107.81 96.2 6.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.132 0.491 . . . . 0.0 110.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.79 -176.76 19.07 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.851 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 110.34 1.36 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.942 2.428 . . . . 0.0 112.229 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -96.41 -56.25 2.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p 39.75 62.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.184 0.927 . . . . 0.0 112.897 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.9 76.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.477 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 73.99 2.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.668 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.84 -118.09 6.07 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.642 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.38 -61.26 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.944 0.402 . . . . 0.0 110.291 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.51 120.6 27.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.37 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.21 66.13 8.37 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.746 2.297 . . . . 0.0 112.541 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -74.06 83.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.092 0.472 . . . . 0.0 110.837 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -71.62 -62.32 1.46 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.4 m 46.3 42.97 11.04 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.754 0.659 . . . . 0.0 111.644 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -86.39 89.35 7.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -138.93 76.62 33.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 0.0 111.197 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 51.1 Cg_exo -57.62 -44.41 41.81 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.813 2.342 . . . . 0.0 114.232 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 19' ' ' PRO . 19.6 Cg_endo -58.48 153.93 45.02 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.334 2.022 . . . . 0.0 113.526 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -95.55 10.38 36.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.754 0.788 . . . . 0.0 110.298 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.92 147.22 25.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.427 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.42 140.73 39.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 HD13 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.612 ' HB3' HG22 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.941 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.4 151.94 70.99 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.9 91.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.357 2.705 . . . . 0.0 112.279 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -64.14 -50.41 68.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -124.24 153.59 68.56 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.071 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.24 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.951 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.74 26.85 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.666 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m -59.34 113.51 2.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.392 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -73.68 -38.2 64.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.63 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.537 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 27' ' ' VAL . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 26' ' ' HIS . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.512 ' HA ' ' HG2' ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 5.0 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.521 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 87' ' ' ILE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.676 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.61 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 93.9 m-85 -134.24 129.63 35.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 100' ' ' LYS . . . -74.7 -41.75 33.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 160.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 85.6 Cg_exo -49.29 9.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 125.127 3.885 . . . . 0.0 115.586 161.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -70.1 22.15 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -162.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.87 -19.85 64.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.947 1.356 . . . . 0.0 107.488 160.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.548 ' HB2' ' CD2' ' A' ' 159' ' ' HIS . 10.2 pt-20 -151.59 145.71 25.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.447 -2.16 . . . . 0.0 109.118 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m -116.31 133.8 61.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.827 HG22 HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.7 HH11 ' HG3' ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.634 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.461 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.651 ' HG3' HG22 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.64 HG12 HG11 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.642 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.642 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 -57.59 119.33 6.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.66 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.18 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.922 ' HG2' ' HD3' ' A' ' 146' ' ' PRO . 42.9 tt0 -175.37 140.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.735 0.302 . . . . 0.0 110.518 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -163.74 56.79 0.56 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 121.857 0.836 . . . . 0.0 110.957 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.922 ' HD3' ' HG2' ' A' ' 144' ' ' GLN . 58.9 Cg_endo -71.62 161.88 43.91 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.385 2.723 . . . . 0.0 113.54 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.798 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 2.2 m80 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.798 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 23.2 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.651 HG22 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.634 HD13 ' HD2' ' A' ' 112' ' ' PRO . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.57 HG11 ' HB1' ' A' ' 115' ' ' ALA . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.436 ' HB3' ' H41' ' B' ' 2' ' ' ' C' . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.42 ' HB3' ' HE2' ' A' ' 183' ' ' LYS . 2.2 tmmm? 49.63 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.71 -133.48 1.05 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.305 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 59.33 36.39 23.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 t -111.86 139.66 47.15 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 140.6 -129.31 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.043 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.15 36.8 0.98 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tt -84.79 88.04 7.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -116.16 99.77 7.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.139 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 178.198 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.659 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 103.575 2.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.441 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-C1' 104.815 3.684 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.806 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 C4'-C3'-C2' 105.854 3.154 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.906 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 O4'-C4'-C3' 103.295 -1.575 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.906 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 P-O3'-C3' 123.384 3.07 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.548 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 103.049 1.721 . 0.356 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 O4'-C1'-C2' 107.652 0.894 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.96 117.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.98 90.86 3.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 110.72 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 5' ' ' PRO . . . 115.88 -98.22 0.82 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.088 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 4' ' ' GLY . 49.3 Cg_exo -57.0 117.28 3.94 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.033 2.489 . . . . 0.0 112.301 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -85.33 54.87 3.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.136 0.493 . . . . 0.0 110.763 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -72.67 -42.5 64.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.164 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 m -122.8 140.76 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.312 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 p -102.85 36.9 2.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.32 0.581 . . . . 0.0 110.017 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.25 111.0 3.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.536 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.93 71.46 1.05 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.398 0.618 . . . . 0.0 109.592 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.18 113.66 10.54 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.421 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.38 66.96 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.009 2.473 . . . . 0.0 111.241 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -55.63 112.76 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.767 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -156.72 93.32 1.36 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.177 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.0 m -82.02 84.32 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -67.42 113.98 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.811 -174.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.4 ttt 59.62 76.73 0.42 Allowed Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.948 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 16.0 Cg_exo -66.92 137.65 45.61 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.667 2.245 . . . . 0.0 111.646 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 2.9 Cg_exo -73.21 86.62 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.503 2.135 . . . . 0.0 111.879 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.82 29.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -114.32 -174.21 2.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.618 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 -63.39 107.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.556 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG12 HG22 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.4 m-70 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' HB ' HG22 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD13 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.607 HG23 HG21 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.607 HG21 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.653 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.87 168.33 23.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.98 91.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.836 2.357 . . . . 0.0 111.862 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -55.85 -43.26 76.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.627 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p -130.79 169.39 13.79 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.611 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.02 -9.7 22.65 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.285 1.99 . . . . 0.0 111.969 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.41 2.05 54.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.7 m -75.85 101.62 5.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -90.74 -21.79 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.956 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.629 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' O ' HD22 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.609 ' HD2' HD13 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.757 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.989 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -142.95 97.67 3.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.75 -88.2 0.33 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.769 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.35 -24.5 50.18 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.009 2.473 . . . . 0.0 113.156 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -104.43 -26.29 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.532 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.989 ' HG3' ' HB3' ' A' ' 97' ' ' PHE . 12.0 pt-20 -158.66 168.32 27.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.814 0.34 . . . . 0.0 110.1 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.482 ' HB3' ' CE1' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -101.99 150.53 23.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.204 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m -68.01 130.8 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.847 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.717 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.697 HG22 HG12 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.476 ' HB ' HD21 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.811 ' HG2' HD22 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.648 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.581 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.581 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.964 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 62.3 m-20 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.964 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.663 ' HG3' ' H62' ' B' ' 5' ' ' ' A' . 0.4 OUTLIER -64.43 145.02 56.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.17 46.48 15.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.29 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 152' ' ' VAL . 17.4 pm0 -84.48 176.49 8.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.333 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.8 p -132.14 110.0 14.04 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.066 0.46 . . . . 0.0 111.318 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.36 135.01 62.4 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 123.058 2.506 . . . . 0.0 112.416 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 113' ' ' ALA . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.847 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 5.3 m-70 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.648 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt -135.51 91.3 2.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.08 -125.94 5.71 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 189' ' ' LEU . 42.4 mt-30 -95.08 68.11 3.12 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 172.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.4 p -93.75 -44.39 8.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.117 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.61 25.96 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.469 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -91.93 56.77 2.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.64 0.733 . . . . 0.0 110.039 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 48.4 tp -108.96 -51.36 2.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.288 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -134.11 83.29 2.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.051 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.791 -176.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.007 0 C4'-C3'-C2' 105.238 2.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.547 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O3'--C3' 1.432 0.676 0 C3'-C2'-C1' 103.519 2.244 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.634 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.893 1 P-O3'-C3' 125.127 4.523 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.896 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 O4'-C4'-C3' 103.427 -1.481 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.896 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 P-O3'-C3' 123.852 3.46 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C4'-C3' 104.06 -1.029 . 0.48 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C4'-C3'-C2' 103.717 1.017 . 0.118 1m . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -50.15 36.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.676 0.274 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mmt -140.51 74.34 1.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.12 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.42 148.96 25.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.903 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.56 -44.15 48.41 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.097 2.531 . . . . 0.0 112.384 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t 60.5 52.59 4.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.584 0.706 . . . . 0.0 109.835 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 t -101.14 84.72 2.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.417 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.41 45.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 122.505 1.145 . . . . 0.0 109.789 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -88.9 -2.97 58.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.97 -92.8 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.87 75.54 9.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.0 0.428 . . . . 0.0 110.673 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -88.53 134.33 34.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.118 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.2 Cg_exo -76.27 72.55 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.908 2.406 . . . . 0.0 111.754 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -57.94 118.46 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -114.19 129.13 56.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -80.39 152.58 28.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.58 137.26 54.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.336 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.9 ttp -107.28 107.46 60.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.648 0.261 . . . . 0.0 110.843 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.3 Cg_exo -69.96 140.47 42.0 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.746 2.297 . . . . 0.0 111.064 176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 24.3 Cg_exo -65.86 78.17 0.29 Allowed 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.906 2.404 . . . . 0.0 113.48 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.33 1.66 47.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.088 0.947 . . . . 0.0 109.405 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -113.56 168.34 9.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.821 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.16 119.06 8.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 54.0 m-70 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.575 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.81 ' HB3' HG21 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' HG22 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.597 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.55 137.31 77.48 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.98 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.81 2.34 . . . . 0.0 111.723 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.96 -46.9 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.836 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.7 p -133.06 135.21 25.38 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.2 Cg_exo -67.74 -14.7 42.55 Favored 'Trans proline' 0 C--N 1.334 -0.196 0 C-N-CA 123.594 2.863 . . . . 0.0 112.808 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.2 -1.47 42.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 47.7 t -61.47 147.36 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.358 0.599 . . . . 0.0 111.196 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -91.39 -25.7 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.005 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' C ' ' HB2' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.449 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.481 ' HD3' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.626 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 1.045 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 1.045 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 -113.22 -173.67 2.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . 166.66 -63.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.858 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 6.3 Cg_endo -48.97 -39.75 40.38 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.403 2.735 . . . . 0.0 113.734 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 4.5 mptp? -100.34 -11.42 20.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.783 0.325 . . . . 0.0 111.828 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.503 ' O ' ' HG3' ' A' ' 101' ' ' GLU . 9.9 tp10 57.19 33.42 23.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.785 1.279 . . . . 0.0 108.588 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 5.0 tp10 -128.47 116.54 19.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.929 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 159' ' ' HIS . 9.3 p -83.98 120.03 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' HD2' HG22 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.795 HG22 HG12 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.517 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.807 ' HG2' HG21 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.415 ' HA3' ' OG1' ' A' ' 126' ' ' THR . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.082 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 1.082 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.658 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.448 ' HG3' ' N6 ' ' B' ' 5' ' ' ' A' . 33.9 mtm180 62.25 -176.63 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.01 83.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.68 0.612 . . . . 0.0 112.042 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -53.39 102.52 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.849 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.6 p -135.87 89.52 20.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.624 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo -63.01 141.74 85.07 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.583 2.855 . . . . 0.0 113.152 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.624 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 56.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.517 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.658 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.473 ' HA ' HG13 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.612 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.757 ' HD3' HD12 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.757 HD12 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.807 HG21 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp 57.64 57.37 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.22 164.36 29.57 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.01 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -97.23 47.67 1.04 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t 74.11 -55.84 0.66 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.674 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.5 -173.61 35.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.095 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.11 103.23 11.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 87.7 mt 57.98 58.2 3.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.835 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 65.77 38.53 5.17 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.843 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.745 0 O4'-C4'-C3' 104.442 -0.756 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.501 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 C3'-C2'-C1' 104.514 3.349 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.86 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 P-O3'-C3' 124.216 3.763 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.86 ' N7 ' " H1'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C4'-C3' 102.954 -1.819 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.836 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 P-O3'-C3' 123.861 3.468 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.477 " H1'" HG11 ' A' ' 127' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 O4'-C4'-C3' 104.334 -0.833 . 0.542 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.669 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 N19-C1'-C2' 116.011 1.632 . 0.131 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 92.7 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.06 0.457 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -106.88 -31.84 8.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.649 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . 74.94 56.01 5.04 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.785 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 4' ' ' GLY . 23.5 Cg_exo -64.51 136.73 51.74 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.495 2.13 . . . . 0.0 111.863 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t 71.86 -44.81 0.6 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.916 0.76 . . . . 0.0 111.612 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.5 m -64.08 -41.98 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.689 0.28 . . . . 0.0 110.826 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -116.73 73.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 t -169.07 88.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.677 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.13 61.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.862 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.02 100.89 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -104.35 112.45 65.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.348 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.0 Cg_endo -82.19 134.35 7.98 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.147 2.565 . . . . 0.0 112.428 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 62.13 -177.36 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.4 m 70.17 118.97 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.443 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.4 p 68.47 -18.74 0.16 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.937 1.295 . . . . 0.0 113.516 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.18 9.83 13.98 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.87 -0.519 . . . . 0.0 111.471 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 34.3 tpp 177.9 120.12 0.18 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 100.95 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.971 2.448 . . . . 0.0 109.865 166.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 18' ' ' MET . 39.4 Cg_exo -59.92 141.24 96.15 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.013 2.476 . . . . 0.0 113.005 -170.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.08 47.57 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -99.63 106.45 18.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.98 147.9 32.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.748 HG12 HG22 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG21 ' HG3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 HD13 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD23 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.877 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 9.6 Cg_endo -52.3 121.0 8.19 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.811 ' HG3' HG21 ' A' ' 34' ' ' VAL . 10.3 Cg_endo -52.44 128.04 26.31 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 122.949 2.433 . . . . 0.0 111.047 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.32 -35.78 74.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.287 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.7 p -141.16 154.98 68.4 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.383 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.42 -3.61 12.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.504 2.136 . . . . 0.0 110.397 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.17 -10.22 53.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.274 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 m -69.48 153.94 42.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 7.3 mtpm? -97.52 -46.95 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.855 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.702 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.748 HG22 HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.835 ' H ' ' HA ' ' A' ' 57' ' ' LYS . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.686 HD12 ' HB1' ' A' ' 83' ' ' ALA . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 77' ' ' PRO . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.65 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.85 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -162.15 133.77 5.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 102' ' ' GLU . . . -164.94 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.735 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.08 -55.2 4.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.436 2.757 . . . . 0.0 114.455 -172.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -101.98 -1.75 31.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.182 0.515 . . . . 0.0 111.328 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -174.3 106.25 0.11 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 50.5 mt-10 -61.79 171.64 1.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.571 0.545 . . . . 0.0 111.744 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.85 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m -57.09 129.24 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.133 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.582 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.458 ' HB ' ' HB ' ' A' ' 156' ' ' ILE . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.61 HG23 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 173' ' ' ILE . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.53 HG22 ' C2 ' ' B' ' 5' ' ' ' A' . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -67.72 99.92 0.86 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.58 55.95 4.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.443 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 144' ' ' GLN . 1.4 tt0 -74.04 143.33 45.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.078 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 p -76.38 108.17 5.84 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.242 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.44 149.76 89.46 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.637 2.891 . . . . 0.0 112.92 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 107' ' ' THR . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 28.1 m170 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.628 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 163' ' ' SER . 16.5 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.596 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD2' HD12 ' A' ' 174' ' ' LEU . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 118' ' ' ARG . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 111' ' ' VAL . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.649 ' HE2' ' HA ' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLN . . . . . 0.975 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -167.31 52.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.975 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -80.77 150.29 30.88 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.803 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.46 87.23 6.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.7 p 53.62 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.096 0.958 . . . . 0.0 111.527 -171.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -100.27 -112.62 3.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -96.13 -66.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 58.53 89.22 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.883 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -85.85 -29.07 24.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.687 178.735 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.444 " H4'" " O5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 103.842 2.602 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.561 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 122.506 2.338 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.695 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 P-O3'-C3' 124.443 3.952 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.871 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C4'-C3' 103.457 -1.459 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.871 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 P-O3'-C3' 123.374 3.062 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.499 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C4'-C3' 103.635 -1.332 . 0.499 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . 0.441 ' O4 ' HG11 ' A' ' 139' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 P-O3'-C3' 120.663 0.803 . 0.048 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.85 -93.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 ttm 62.91 101.17 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.48 0.657 . . . . 0.0 110.169 -171.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.75 110.19 3.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.24 -52.97 7.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.396 2.731 . . . . 0.0 113.162 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -87.68 92.99 9.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.7 t -133.52 -160.82 1.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.478 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 10' ' ' GLY . 41.5 t -73.25 -52.71 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.967 0.413 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.4 m 68.6 -3.25 1.42 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.349 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.83 22.79 23.33 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.482 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.64 69.56 7.18 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . 69.12 126.17 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 124.03 0.831 . . . . 0.0 111.325 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 29.1 Cg_exo -63.04 -18.37 64.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.053 2.502 . . . . 0.0 111.747 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 t80 49.27 54.54 10.78 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.754 0.659 . . . . 0.0 110.562 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 m -79.67 69.38 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.713 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -99.15 20.31 13.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.441 0.639 . . . . 0.0 109.542 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.84 102.2 1.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.6 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.07 134.81 23.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 35.4 Cg_endo -66.64 117.31 4.64 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.821 2.348 . . . . 0.0 112.241 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 6.7 Cg_exo -74.62 71.06 4.83 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.952 2.435 . . . . 0.0 111.482 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 74' ' ' THR . 13.6 pt-20 -83.61 66.12 8.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.979 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 57.85 -146.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.46 119.62 30.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 87.4 m-70 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.609 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' HA ' ' OE1' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.57 HD13 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 40.9 t60 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG12 HD13 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo -78.1 170.54 18.58 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -39.85 -40.81 2.62 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.87 3.047 . . . . 0.0 114.762 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.51 -35.92 61.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.431 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 74.6 p -70.38 156.12 92.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 112.117 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.72 -12.26 35.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.348 2.698 . . . . 0.0 111.564 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.35 33.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.914 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 13.9 t -62.58 -28.68 70.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.887 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 6.7 ttpm? -74.78 -55.51 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 66' ' ' SER . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 21' ' ' GLU . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.562 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.647 ' HA ' HD11 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.485 ' CD1' HD12 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 105' ' ' LEU . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PHE . . . . . 0.752 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.84 76.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.25 -83.93 1.71 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.482 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.899 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 32.1 Cg_exo -62.06 -41.62 34.96 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.345 2.697 . . . . 0.0 114.509 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.899 ' HD2' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -99.41 -8.91 24.12 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -168.275 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.31 158.19 29.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.915 -168.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.05 145.7 37.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 159' ' ' HIS . 26.8 m -72.48 126.83 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.147 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 112' ' ' PRO . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.62 ' HD2' HD11 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.537 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.585 ' HA3' " O2'" ' B' ' 5' ' ' ' A' . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.725 HG22 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.769 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.28 140.91 58.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.46 ' HA ' ' H22' ' B' ' 4' ' ' ' G' . 7.7 m-20 65.27 11.01 6.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.537 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.56 ' C ' ' HD3' ' A' ' 146' ' ' PRO . 49.7 mt-30 66.55 100.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.627 0.58 . . . . 0.0 111.314 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.3 p -113.8 67.93 1.48 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.88 0.371 . . . . 0.0 110.702 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 69.3 Cg_endo -93.5 165.59 2.33 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 113.136 -173.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' HIS . . . . . 0.776 ' HD2' HG13 ' A' ' 103' ' ' VAL . 36.6 m80 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.784 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -101.51 33.91 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.85 19.8 3.48 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.185 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.51 115.59 28.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 110.717 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -108.52 -8.34 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.692 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 166.33 170.31 31.08 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.791 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -129.42 50.84 2.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.657 0.741 . . . . 0.0 109.132 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.0 84.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -113.72 107.74 16.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.099 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.187 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 103.866 2.629 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.531 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 103.414 2.127 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' G' . . . . . 0.853 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 P-O3'-C3' 124.256 3.796 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.958 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 O4'-C1'-C2' 108.258 1.327 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.958 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 P-O3'-C3' 123.866 3.472 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' C' . . . . . 0.468 ' H6 ' " O5'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C4'-C3' 104.408 -0.78 . 0.543 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-N19 108.846 0.646 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' HG12 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.6 ' HB1' HD22 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.51 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.987 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.3 Cg_exo . . . . . 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.233 0.214 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HG23 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' A' ' 55' ' ' SER . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.987 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 7.4 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.686 ' HB2' HG11 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HD3' HG22 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 . . . . . 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.686 HG11 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.446 -0.631 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HA ' HD11 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' HD11 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.8 ' HG2' HG21 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 HG13 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.96 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.762 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.96 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.641 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo . . . . . 0 N--CA 1.452 -0.947 0 N-CA-C 114.26 0.831 . . . . 0.0 114.26 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 42.8 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.531 HG22 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.408 ' C ' HE21 ' A' ' 167' ' ' GLN . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 16.2 mm100 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 163' ' ' SER . 8.6 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.509 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 . . . . . 0 CA--C 1.521 -0.136 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.573 HG22 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.801 HG13 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.545 HG12 HG21 ' A' ' 58' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.063 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 30' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HE ' HG13 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.811 ' HB ' HG13 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HG12 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.476 HD11 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.513 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' A' ' 103' ' ' VAL . 2.2 m-85 . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.721 HG12 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m . . . . . 0 C--O 1.232 0.17 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG3' HD11 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.489 HG23 HG21 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.472 HH11 HD11 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.749 HD13 HG23 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.749 HG23 HD13 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.627 HG12 HG22 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 142' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 CA--C 1.529 0.252 0 CA-C-O 121.05 0.354 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.472 HD11 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.799 HD11 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.88 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.88 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 168' ' ' ARG . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt . . . . . 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.867 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HG21 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.871 HG12 HD13 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.748 HG21 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo . . . . . 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HG3' HD13 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.571 HD13 HG22 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.422 HG23 HG21 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.599 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.524 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.583 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.536 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' THR . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.827 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 CA--C 1.533 0.433 0 N-CA-C 113.393 0.497 . . . . 0.0 113.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.827 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 163' ' ' SER . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.583 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 41.0 m170 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.751 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 156' ' ' ILE . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm . . . . . 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.572 HG22 HD22 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.685 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.685 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo . . . . . 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--O 1.233 0.201 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.885 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.751 HG21 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.751 ' HG2' HG21 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.825 HD11 HD21 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 . . . . . 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG23 HG23 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.912 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.941 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.936 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.941 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 29.4 ttp180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo . . . . . 0 C--O 1.235 0.326 0 CA-C-O 121.167 0.403 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HG3' HD22 ' A' ' 149' ' ' ASN . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.442 HD22 ' HG3' ' A' ' 148' ' ' GLU . 42.2 m-80 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.985 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.985 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.787 ' HB3' HG21 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.419 ' HE ' ' CG ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.498 HD13 HD11 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.624 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.912 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp . . . . . 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.454 -0.246 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.775 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.898 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.71 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.771 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.465 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.771 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.774 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HG12 ' A' ' 45' ' ' ILE . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo . . . . . 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 mtmm . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' HB ' ' O ' ' A' ' 29' ' ' ILE . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.463 HG12 HG23 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.406 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.607 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.898 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 91' ' ' LEU . 58.2 m-85 . . . . . 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 157' ' ' ILE . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.972 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.972 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.683 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 20.7 Cg_endo . . . . . 0 C--O 1.236 0.392 0 CA-C-O 120.695 0.206 . . . . 0.0 112.295 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.535 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.535 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.532 ' HB3' HE21 ' A' ' 151' ' ' GLN . 15.2 m-80 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.477 HG22 ' HE3' ' A' ' 155' ' ' LYS . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.449 ' HA ' HG21 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 174' ' ' LEU . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HE3' HD22 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.03 0.443 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.74 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.902 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 33' ' ' ALA . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.643 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.898 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.909 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.012 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.929 HG22 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.902 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.929 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.787 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.638 ' CD1' ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.909 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD22 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.491 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.76 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.818 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.818 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.677 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.714 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m . . . . . 0 C--O 1.235 0.297 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HD3' HG22 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.843 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.843 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.408 HE21 ' HG3' ' A' ' 137' ' ' GLU . 35.5 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.938 HG12 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.938 ' HD2' HG12 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 . . . . . 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.706 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo . . . . . 0 N--CA 1.455 -0.736 0 N-CA-C 114.202 0.808 . . . . 0.0 114.202 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 149' ' ' ASN . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.691 HG21 ' HB2' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.769 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CD2' HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 156' ' ' ILE . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 . . . . . 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 48.4 m170 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 69' ' ' ARG . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.832 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.967 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.967 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG22 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 57.3 Cg_endo . . . . . 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt . . . . . 0 C--O 1.233 0.187 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.832 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.61 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.632 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.793 HD11 HD21 ' A' ' 105' ' ' LEU . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.411 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.708 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.702 HG12 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m . . . . . 0 N--CA 1.451 -0.421 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.793 HD21 HD11 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.441 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.861 HG22 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.857 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.74 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 44.4 tpt85 . . . . . 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo . . . . . 0 N--CA 1.46 -0.488 0 CA-C-O 121.522 0.551 . . . . 0.0 112.99 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.421 ' HG3' HD22 ' A' ' 149' ' ' ASN . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.421 HD22 ' HG3' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.499 ' H ' ' HB3' ' A' ' 147' ' ' ASP . 22.8 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 113' ' ' ALA . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 137' ' ' GLU . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.488 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.429 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.609 HG12 HG13 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.857 HG22 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp . . . . . 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 N--CA 1.449 -0.487 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 HD13 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.612 ' HB3' HG22 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.941 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.147 0.499 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.537 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 27' ' ' VAL . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 26' ' ' HIS . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.767 ' HA ' HE21 ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.767 HE21 ' HA ' ' A' ' 81' ' ' PHE . 29.7 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.521 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 87' ' ' ILE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.676 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.485 ' CD2' HG12 ' A' ' 103' ' ' VAL . 93.9 m-85 . . . . . 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.827 HG22 HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.7 ' HG3' HH11 ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.634 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.651 ' HG3' HG22 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.64 HG12 HG11 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.642 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.642 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 . . . . . 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.666 ' HB3' HG13 ' A' ' 152' ' ' VAL . 58.9 Cg_endo . . . . . 0 CA--C 1.52 -0.208 0 N-CA-C 113.54 0.554 . . . . 0.0 113.54 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.798 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 2.2 m80 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.798 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 60.7 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.651 HG22 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.634 HD13 ' HD2' ' A' ' 112' ' ' PRO . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.57 HG11 ' HB1' ' A' ' 115' ' ' ALA . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 183' ' ' LYS . 2.2 tmmm? . . . . . 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.697 HG12 HG22 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 30.6 m170 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.513 ' H ' HG22 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.609 HD13 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.607 HG23 HG21 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.607 HG21 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.653 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 121.029 0.442 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.629 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.579 ' O ' HD22 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.609 ' HD2' HD13 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.757 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.692 ' CD2' ' HA ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m . . . . . 0 CA--C 1.526 0.035 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.847 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.717 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.697 HG22 HG12 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.476 ' HB ' HD21 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.811 ' HG2' HD22 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.648 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.581 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.581 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.964 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 132' ' ' ASN . 3.2 m120 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.964 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.526 ' HE ' ' HB3' ' A' ' 142' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 C--O 1.236 0.4 0 CA-C-O 120.848 0.27 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 113' ' ' ALA . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.847 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 24.0 m170 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.648 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 . . . . . 0 N--CA 1.451 -0.407 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.3 m80 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.575 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.544 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.81 ' HB3' HG21 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' HG22 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.597 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt . . . . . 0 N--CA 1.451 -0.383 0 CA-C-O 120.6 0.238 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' C ' ' HB2' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.449 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.481 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.626 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 1.045 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 1.045 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 159' ' ' HIS . 9.3 p . . . . . 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.545 ' HD2' HG22 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.795 HG22 HG12 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.517 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.807 ' HG2' HG21 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.415 ' HA3' ' OG1' ' A' ' 126' ' ' THR . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.082 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 1.082 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.658 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 142' ' ' ARG . 33.9 mtm180 . . . . . 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.624 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo . . . . . 0 C--O 1.233 0.229 0 N-CA-C 113.152 0.404 . . . . 0.0 113.152 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.624 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 48.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.517 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.658 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.473 ' HA ' HG13 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.612 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.757 ' HD3' HD12 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.757 HD12 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.807 HG21 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.748 HG12 HG22 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.621 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 HG13 ' HG2' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 HD13 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.9 HD23 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.877 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo . . . . . 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 7.3 mtpm? . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.882 0.372 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.702 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.748 HG22 HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.835 ' H ' ' HA ' ' A' ' 57' ' ' LYS . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.686 HD12 ' HB1' ' A' ' 83' ' ' ALA . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 77' ' ' PRO . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.65 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.85 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.85 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m . . . . . 0 N--CA 1.453 -0.286 0 CA-C-O 121.128 0.489 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.582 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.904 HG21 HE21 ' A' ' 167' ' ' GLN . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.61 HG23 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 173' ' ' ILE . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 141' ' ' PRO . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo . . . . . 0 C--O 1.232 0.198 0 CA-C-O 121.311 0.463 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 107' ' ' THR . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 28.1 m170 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.628 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.904 HE21 HG21 ' A' ' 107' ' ' THR . 89.8 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.596 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD2' HD12 ' A' ' 174' ' ' LEU . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 118' ' ' ARG . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 111' ' ' VAL . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.649 ' HA ' ' HE2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 177' ' ' VAL . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 37.9 m80 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.609 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.57 HD13 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 9.8 t-80 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG12 HD13 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo . . . . . 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 6.7 ttpm? . . . . . 0 CA--C 1.528 0.108 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.562 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.647 ' HA ' HD11 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.485 ' CD1' HD12 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 105' ' ' LEU . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PHE . . . . . 0.752 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 159' ' ' HIS . 26.8 m . . . . . 0 N--CA 1.455 -0.219 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 112' ' ' PRO . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.62 ' HD2' HD11 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.49 ' O ' HG12 ' A' ' 120' ' ' ILE . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.492 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.725 HG22 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.769 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 69.3 Cg_endo . . . . . 0 N--CA 1.452 -0.919 0 CA-C-O 121.182 0.409 . . . . 0.0 113.136 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HD22 ' A' ' 149' ' ' ASN . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.441 HD22 ' HG3' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' HIS . . . . . 0.776 ' HD2' HG13 ' A' ' 103' ' ' VAL . 36.6 m80 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.784 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 112.553 -0.219 . . . . 0.0 112.553 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.93 89.91 3.2 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -85.49 56.96 4.19 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.402 0.62 . . . . 0.0 111.424 -174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.45 113.26 3.8 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.718 -0.754 . . . . 0.0 111.519 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.87 -31.0 79.56 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.913 2.409 . . . . 0.0 112.504 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m 60.57 39.1 18.35 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.515 177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.3 m -63.24 -28.06 69.77 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.187 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.99 123.21 25.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.238 0.542 . . . . 0.0 109.702 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.7 m -125.19 89.02 2.98 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.231 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.86 159.76 36.48 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.751 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.45 -14.54 62.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.36 . . . . 0.0 111.243 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -118.57 91.8 42.53 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.584 178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.87 79.8 2.22 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.982 2.455 . . . . 0.0 111.696 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -63.49 107.18 1.06 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.707 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.2 m -83.57 122.6 28.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.698 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.2 m -91.87 1.28 57.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.627 -174.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -101.55 140.49 35.78 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.881 0.372 . . . . 0.0 110.566 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.479 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 26.0 mmt -124.85 129.98 24.39 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.59 -178.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 2.3 Cg_endo -81.89 115.88 2.76 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.132 2.555 . . . . 0.0 111.851 178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.737 ' HB2' HG21 ' A' ' 74' ' ' THR . 94.9 Cg_endo -82.45 68.61 7.66 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.377 2.051 . . . . 0.0 112.787 -179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -93.24 32.53 1.31 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.515 0.674 . . . . 0.0 109.397 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.678 ' OE1' ' HA ' ' A' ' 20' ' ' PRO . 25.7 mp0 -87.41 177.04 7.23 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.924 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -63.36 119.21 9.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.246 0.546 . . . . 0.0 110.312 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.5 m -112.25 114.72 27.65 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.958 -172.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.515 HG23 ' HB ' ' A' ' 73' ' ' ILE . 4.5 m -106.93 149.7 10.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.18 173.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -119.07 112.88 20.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' HG22 ' A' ' 71' ' ' VAL . 7.4 p -125.58 141.27 45.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.564 ' CE2' ' HB3' ' A' ' 106' ' ' GLU . 18.8 p90 -117.06 143.54 45.65 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.137 -1.025 . . . . 0.0 113.281 -175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 HG13 HG22 ' A' ' 34' ' ' VAL . 21.8 pt -118.83 151.2 49.84 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.228 176.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HA ' HG12 ' A' ' 68' ' ' VAL . 47.8 Cg_exo -57.18 144.84 89.38 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.585 2.19 . . . . 0.0 111.045 176.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.6 -28.22 53.9 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.175 -174.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -71.02 -34.99 71.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.034 0.445 . . . . 0.0 110.523 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.6 ' HB1' HD22 ' A' ' 91' ' ' LEU . . . -76.21 -28.75 57.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.624 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.509 HG22 HG13 ' A' ' 29' ' ' ILE . 21.1 t -59.06 -35.25 56.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.811 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -63.48 -28.62 72.69 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.697 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -78.23 -37.61 44.93 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.42 -0.459 . . . . 0.0 110.925 178.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 37.9 mm -76.12 -47.96 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.064 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.507 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 11.4 mm -85.35 -28.06 6.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -176.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.53 -37.27 88.21 Favored Glycine 0 N--CA 1.453 -0.184 0 CA-C-N 115.821 -0.627 . . . . 0.0 114.641 -167.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.82 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 36.9 t70 -60.68 90.55 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 117.222 0.511 . . . . 0.0 111.24 -176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 20.7 t70 57.87 10.81 1.21 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.459 1.104 . . . . 0.0 111.859 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.507 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 66.04 20.05 68.49 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.177 -0.535 . . . . 0.0 112.858 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.513 ' HG2' ' HB3' ' A' ' 41' ' ' ASP . 20.0 pt20 -133.33 -8.52 2.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 3.3 t60 -64.45 -34.3 77.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.698 -175.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.558 HG12 ' CG2' ' A' ' 58' ' ' ILE . 7.0 tp -66.24 -34.68 71.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.05 0.452 . . . . 0.0 110.998 175.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -75.26 -23.87 57.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.412 0.625 . . . . 0.0 109.761 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -65.93 -30.68 71.3 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.573 174.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.46 HD23 HD12 ' A' ' 56' ' ' ILE . 11.5 tp -60.32 -29.32 68.79 Favored 'General case' 0 N--CA 1.461 0.078 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.064 177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.51 ' HA ' HG12 ' A' ' 56' ' ' ILE . 30.1 t -56.95 -54.34 47.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.623 -178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 tpp180 -76.85 -34.1 57.85 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.345 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -66.29 -53.01 41.63 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.39 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.987 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -84.32 -3.9 58.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.862 0.363 . . . . 0.0 110.835 -178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 26.1 m 63.55 49.46 3.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.865 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.568 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -143.03 165.14 28.19 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.558 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.57 ' HB3' ' HB ' ' A' ' 74' ' ' THR . 22.9 t -89.5 102.34 15.01 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 173.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 49' ' ' SER . 7.4 mm -91.47 117.99 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.865 -175.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 58.2 mtmt -122.22 135.35 54.75 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HG12 ' A' ' 45' ' ' ILE . 3.3 pt -108.47 140.12 28.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -83.13 126.28 72.63 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-O 121.148 0.499 . . . . 0.0 111.616 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.3 Cg_exo -73.52 179.02 5.95 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 123.548 2.832 . . . . 0.0 110.108 170.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.73 59.91 2.8 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.134 1.89 . . . . 0.0 112.164 176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' OE1' ' HD2' ' A' ' 60' ' ' PRO . 4.4 pt-20 -92.17 -52.2 4.81 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.359 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 41.3 p -84.36 145.63 45.82 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.839 -176.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 53.0 Cg_exo -55.14 -22.18 30.87 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 123.914 3.076 . . . . 0.0 113.299 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -83.09 32.38 0.44 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.417 0.627 . . . . 0.0 109.73 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.6 t -69.58 10.14 0.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.354 -174.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -72.88 -18.87 61.39 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 HG12 ' HA ' ' A' ' 30' ' ' PRO . 29.8 m -130.71 172.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.097 172.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 28.6 mmt85 -129.46 130.39 45.81 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 23.1 ptp -85.01 128.66 34.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.988 0.423 . . . . 0.0 110.291 178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 27' ' ' VAL . 12.0 m -98.71 134.49 37.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.145 0.498 . . . . 0.0 109.802 175.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 22.9 t -97.25 95.85 4.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.731 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.515 ' HB ' HG23 ' A' ' 25' ' ' VAL . 50.3 mm -91.76 97.17 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.737 HG21 ' HB2' ' A' ' 20' ' ' PRO . 24.6 m -100.46 106.44 18.0 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.399 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.27 179.57 48.27 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.169 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.603 ' HG2' ' HB3' ' A' ' 78' ' ' GLU . 65.6 Cg_endo -72.38 179.23 5.25 Favored 'Trans proline' 0 CA--C 1.532 0.393 0 C-N-CA 122.415 2.076 . . . . 0.0 111.822 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.43 -26.95 46.85 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.235 1.957 . . . . 0.0 111.359 176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 76' ' ' PRO . 16.3 tp10 -51.46 -49.92 60.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.564 172.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.568 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -77.14 -39.13 50.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.771 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -56.04 -51.38 68.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.371 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -67.03 -45.42 77.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.267 -178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.987 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 39.3 ttmt -72.75 -54.09 9.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.956 -172.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.5 85.44 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 111.693 0.257 . . . . 0.0 111.693 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.493 ' O ' ' HB2' ' A' ' 88' ' ' TYR . 7.4 tt0 -62.27 -47.89 82.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.882 0.373 . . . . 0.0 110.153 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -69.86 -31.72 70.05 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.463 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.572 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -66.22 -48.32 70.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 -178.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 48.2 pt -72.36 -32.9 44.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.721 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.29 -46.69 82.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.025 0.441 . . . . 0.0 110.108 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.9 -28.72 72.82 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.645 176.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.652 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 7.8 tmtm? -65.14 -38.9 92.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.151 0.501 . . . . 0.0 110.321 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.686 ' HB2' HG11 ' A' ' 103' ' ' VAL . 12.6 mt -61.37 -29.89 70.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.061 0.458 . . . . 0.0 110.704 176.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.49 ' HD3' HG22 ' A' ' 103' ' ' VAL . 27.0 mmmt -75.75 -50.06 16.37 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.506 -179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.652 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 8.1 pt-20 -62.37 -29.53 70.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.446 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.47 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 7.7 tp10 -79.66 7.62 8.09 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.716 0.293 . . . . 0.0 111.27 -174.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 45.12 30.86 0.66 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.105 0.962 . . . . 0.0 112.994 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.547 ' HB3' ' CD2' ' A' ' 97' ' ' PHE . 11.0 m-85 -73.16 -66.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.796 0.808 . . . . 0.0 109.72 172.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.547 ' CD2' ' HB3' ' A' ' 96' ' ' PHE . 1.4 p90 -141.46 59.49 1.5 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.26 -1.337 . . . . 0.0 108.639 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.425 ' HA2' ' HD2' ' A' ' 92' ' ' LYS . . . -122.8 -54.0 0.2 Allowed Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 114.984 -1.007 . . . . 0.0 113.117 -174.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -70.3 -41.57 3.49 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.359 2.039 . . . . 0.0 112.969 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -103.9 3.83 34.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.728 0.299 . . . . 0.0 111.657 -175.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -157.24 155.54 30.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -99.23 133.58 43.32 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.686 HG11 ' HB2' ' A' ' 91' ' ' LEU . 19.3 m -67.01 122.83 18.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-O 121.204 0.526 . . . . 0.0 110.098 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.531 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.3 mmmm -123.78 98.15 5.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.128 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.721 ' HG ' ' CE1' ' A' ' 88' ' ' TYR . 34.2 mt -101.09 161.88 13.29 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.135 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.564 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 36.3 tt0 -115.07 107.44 15.35 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.874 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.6 m -90.67 124.02 34.75 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.279 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.445 ' HB3' ' CG2' ' A' ' 153' ' ' ILE . 47.9 m170 -96.98 120.64 37.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.845 176.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.5 pt -117.01 155.01 18.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.95 0.405 . . . . 0.0 110.515 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -83.62 119.8 25.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.393 -174.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.578 ' HA ' HD11 ' A' ' 174' ' ' LEU . 63.6 t -129.91 138.76 33.81 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.657 ' HD2' HD11 ' A' ' 174' ' ' LEU . 38.0 Cg_endo -67.0 137.9 46.08 Favored 'Trans proline' 0 C--N 1.327 -0.576 0 C-N-CA 122.975 2.45 . . . . 0.0 111.152 174.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.641 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -60.53 -27.91 68.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.82 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.4 m -74.64 -9.51 58.64 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.632 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.29 16.12 8.35 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.558 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -61.97 -48.05 82.12 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.298 0.57 . . . . 0.0 110.891 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.431 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -77.02 -1.61 74.36 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.599 178.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.8 ' HG2' HG21 ' A' ' 177' ' ' VAL . 12.3 tpt180 -92.55 -40.67 10.67 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.682 0.277 . . . . 0.0 110.648 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.509 ' HB ' HG23 ' A' ' 170' ' ' ILE . 31.3 m -71.78 -19.64 20.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 121.174 0.512 . . . . 0.0 110.958 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 HG13 ' A' ' 140' ' ' VAL . 8.5 tp -82.51 1.53 3.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.598 0.713 . . . . 0.0 110.119 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 82.26 -172.0 52.23 Favored Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.555 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -78.81 68.28 4.73 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.347 0.594 . . . . 0.0 110.194 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 88.65 61.92 1.42 Allowed Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.707 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.561 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 66.56 31.76 79.61 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.134 -0.555 . . . . 0.0 113.008 176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -80.64 -38.45 29.14 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 122.62 -0.341 . . . . 0.0 111.183 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 30.7 p -65.39 -31.09 72.01 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.74 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 16.3 t -59.45 -49.9 81.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.287 0 CA-C-O 121.054 0.454 . . . . 0.0 109.827 176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -64.08 -46.83 82.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.023 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.47 -51.18 66.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.654 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 97.4 mt -77.97 -35.88 49.66 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.766 -171.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.96 ' HG3' ' HG2' ' A' ' 137' ' ' GLU . 56.8 tt0 -68.41 -49.08 62.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.867 0.365 . . . . 0.0 110.529 -178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -72.0 -45.55 60.5 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.815 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 96.6 mt -90.71 -41.57 11.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.2 m -100.42 -16.13 17.7 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -173.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.04 31.52 3.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 123.04 0.536 . . . . 0.0 110.711 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.762 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -113.97 106.32 14.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.424 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.96 ' HG2' ' HG3' ' A' ' 131' ' ' GLN . 22.2 mt-10 -88.71 111.36 21.88 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.014 -177.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 59.1 t -103.42 128.22 56.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.81 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 18.0 t -129.32 137.14 57.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.463 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.632 HG13 HD13 ' A' ' 120' ' ' ILE . 28.8 m -110.92 169.31 6.44 Favored Pre-proline 0 C--N 1.329 -0.325 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.554 176.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 20.9 Cg_exo -66.08 162.7 34.4 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.285 1.99 . . . . 0.0 111.207 173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -68.26 108.61 3.25 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 72.15 -70.3 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.45 -176.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -164.95 -53.44 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.196 177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 25.1 p 44.43 70.2 2.06 Favored Pre-proline 0 N--CA 1.466 0.373 0 CA-C-O 121.484 0.659 . . . . 0.0 110.891 -173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.641 ' HB3' ' CB ' ' A' ' 113' ' ' ALA . 10.1 Cg_endo -87.86 149.77 7.17 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.782 2.988 . . . . 0.0 114.26 -167.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 151' ' ' GLN . 17.1 t70 -73.95 163.2 28.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.769 168.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -60.5 -30.27 69.61 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.152 0.433 . . . . 0.0 111.093 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -83.29 22.95 0.94 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.275 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 44.85 52.62 7.94 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.391 1.077 . . . . 0.0 111.203 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 147' ' ' ASP . 42.8 mt-30 -109.09 131.34 55.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.41 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.539 HG21 ' HB2' ' A' ' 116' ' ' ALA . 31.9 m -129.98 159.36 42.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 172.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.445 ' CG2' ' HB3' ' A' ' 108' ' ' HIS . 42.2 mm -117.31 131.5 69.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.922 0.392 . . . . 0.0 110.754 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.417 ' CG1' HG12 ' A' ' 140' ' ' VAL . 6.1 m -115.41 140.55 36.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 177.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HB3' ' HG3' ' A' ' 106' ' ' GLU . 15.2 mmtp -104.48 144.2 31.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.831 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 57.7 mt -119.05 112.11 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.924 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.531 HG22 ' HE2' ' A' ' 104' ' ' LYS . 4.5 mm -111.56 111.16 34.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -174.59 -119.28 0.54 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.386 -179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 -144.84 161.85 38.27 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 164' ' ' GLN . 23.0 t80 -47.99 -50.03 28.86 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -172.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -64.56 -41.94 95.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.398 0.618 . . . . 0.0 110.14 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.762 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -69.12 -47.09 66.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.425 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.408 ' C ' HE21 ' A' ' 167' ' ' GLN . 48.2 m -59.86 -43.16 94.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.307 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 16.2 mm100 -63.43 -47.73 80.69 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.627 0.251 . . . . 0.0 110.884 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 64.3 mtt -59.28 -45.45 91.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.817 176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.407 ' O ' HG13 ' A' ' 170' ' ' ILE . . . -62.35 -54.77 35.68 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.692 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.408 HE21 ' C ' ' A' ' 163' ' ' SER . 8.6 pt20 -60.86 -33.01 72.41 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.48 0.181 . . . . 0.0 111.305 -178.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 168' ' ' ARG . 42.8 ttp180 -67.32 -49.96 62.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.543 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -61.56 -40.89 96.33 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 112.083 0.401 . . . . 0.0 112.083 178.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.509 HG23 ' HB ' ' A' ' 119' ' ' VAL . 82.7 mt -59.89 -53.92 41.84 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.995 0.184 . . . . 0.0 110.587 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -65.57 -27.12 68.2 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.114 -0.234 . . . . 0.0 111.346 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.72 -57.17 10.81 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 mt -59.81 -50.13 81.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.766 174.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.657 HD11 ' HD2' ' A' ' 112' ' ' PRO . 4.6 tt -50.24 -55.42 15.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.385 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.502 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -59.78 -45.04 93.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.057 -176.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -66.95 -25.44 66.34 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.024 -178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.8 HG21 ' HG2' ' A' ' 118' ' ' ARG . 88.0 t -65.64 -51.87 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.074 0 CA-C-O 120.621 0.248 . . . . 0.0 110.709 173.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -60.34 -37.36 80.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.873 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 48.8 mt-30 -62.6 -48.65 78.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.684 175.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.53 -35.63 74.57 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.116 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -62.54 -51.91 65.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.395 176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -68.85 -56.31 8.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.378 -177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -90.82 71.3 6.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.316 0.579 . . . . 0.0 110.682 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -177.66 -132.07 1.63 Allowed Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.668 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -109.75 24.89 12.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.696 0.284 . . . . 0.0 110.509 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 53.6 m 66.41 -74.91 0.06 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.477 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -177.92 34.15 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -132.39 153.13 51.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.511 0.196 . . . . 0.0 110.609 -177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.1 tp -103.23 76.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 175.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -95.35 -41.05 9.21 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.033 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.666 -179.725 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.837 0 O4'-C1'-C2' 107.682 0.916 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.531 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 103.19 1.878 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.857 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.894 0 P-O3'-C3' 124.307 3.839 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.859 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.899 0 O4'-C4'-C3' 102.587 -2.081 OUTLIER-EPSILON 0.015 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.859 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 P-O3'-C3' 123.371 3.059 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.573 " H2'" " O4'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C3'-C2'-C1' 100.417 -1.203 . 0.755 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.573 " O4'" " H2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.841 0 C4'-C3'-C2' 103.849 1.149 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.057 -0.417 . . . . 0.0 112.057 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.37 109.2 8.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.461 0.172 . . . . 0.0 111.024 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 mpt? 56.75 79.85 0.17 Allowed 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.855 0.722 . . . . 0.0 111.66 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.9 110.44 0.43 Allowed Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.085 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -67.14 -51.24 0.82 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.771 2.314 . . . . 0.0 111.52 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 7' ' ' SER . 9.2 t -168.04 75.88 0.13 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 6' ' ' SER . 38.2 t 73.82 149.77 0.1 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.861 -170.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.8 m -100.49 7.86 8.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.828 0.347 . . . . 0.0 111.355 -176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.5 m -87.02 2.43 49.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.146 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.69 -92.9 0.12 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.351 179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 58.95 41.88 20.36 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.315 0.579 . . . . 0.0 110.195 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -112.89 138.4 22.17 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.626 -178.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 19.5 Cg_exo -66.64 131.66 26.64 Favored 'Trans proline' 0 N--CA 1.462 -0.374 0 C-N-CA 122.615 2.21 . . . . 0.0 111.269 175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.08 139.88 50.51 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.326 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 40.3 t 70.4 23.81 4.84 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 123.806 0.691 . . . . 0.0 111.232 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.3 t -72.64 128.06 34.44 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -96.89 141.9 29.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.24 0.543 . . . . 0.0 111.865 -174.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 14.2 tpt -158.35 100.95 1.71 Allowed Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.785 175.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.49 111.96 3.35 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.878 2.385 . . . . 0.0 111.923 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.649 ' HG2' ' HB2' ' A' ' 55' ' ' SER . 30.2 Cg_endo -91.02 97.89 0.23 Allowed 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 122.808 2.339 . . . . 0.0 112.86 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -109.88 40.71 1.85 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 173.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -85.05 -129.28 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.564 -173.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' O ' ' HA ' ' A' ' 74' ' ' THR . 6.9 mm-40 -70.89 140.6 51.11 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.6 m -123.39 117.25 24.76 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.765 0.317 . . . . 0.0 111.607 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.811 HG13 ' HB ' ' A' ' 73' ' ' ILE . 0.9 OUTLIER -119.31 140.84 41.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 173.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 19.0 m-70 -104.45 111.21 23.77 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 71' ' ' VAL . 6.8 t -88.91 112.39 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.242 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 106' ' ' GLU . 6.9 m-85 -90.06 105.41 17.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.346 0.593 . . . . 0.0 110.47 178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.573 HG22 HD22 ' A' ' 105' ' ' LEU . 46.2 pt -113.89 147.81 38.52 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.166 177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' HA ' HG12 ' A' ' 68' ' ' VAL . 39.5 Cg_exo -61.7 138.75 76.83 Favored 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 122.265 1.977 . . . . 0.0 111.049 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.579 ' HA ' HG23 ' A' ' 34' ' ' VAL . . . -58.17 -22.98 53.71 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.054 0.454 . . . . 0.0 111.505 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -69.66 -30.71 68.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.357 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.77 -14.3 34.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.157 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.801 HG13 ' HE ' ' A' ' 69' ' ' ARG . 52.8 t -61.47 -38.66 80.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.69 -33.15 71.35 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.592 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.427 ' O ' ' HE2' ' A' ' 90' ' ' LYS . . . -75.75 -45.06 38.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.07 0.462 . . . . 0.0 110.668 179.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.467 HD12 HG22 ' A' ' 87' ' ' ILE . 38.1 mm -64.76 -41.89 93.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.144 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' VAL . 29.7 mm -75.87 -51.61 19.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.067 179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -60.73 -15.12 39.75 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.547 -0.751 . . . . 0.0 113.814 -174.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.613 ' HB3' ' HB3' ' A' ' 44' ' ' HIS . 2.2 t70 -42.15 -36.78 1.26 Allowed 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.594 0.758 . . . . 0.0 111.259 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 27.4 t70 -156.1 13.13 0.31 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 170.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 74.12 -46.14 1.5 Allowed Glycine 0 CA--C 1.517 0.167 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.048 -169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.626 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 31.9 tt0 -117.18 13.86 14.76 Favored 'General case' 0 C--N 1.323 -0.568 0 O-C-N 122.52 -0.4 . . . . 0.0 110.319 178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 2.1 t-160 -65.57 -36.62 84.31 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.695 0.283 . . . . 0.0 110.264 -178.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.545 HG12 HG21 ' A' ' 58' ' ' ILE . 4.6 tp -56.81 -33.98 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.509 173.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.626 ' HB2' ' HG2' ' A' ' 43' ' ' GLN . 57.3 mttp -80.94 -32.47 34.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.329 . . . . 0.0 110.303 177.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' A' ' 44' ' ' HIS . 93.3 mt-30 -64.95 -30.15 71.12 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 172.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.445 ' HB3' HD12 ' A' ' 56' ' ' ILE . 13.9 tp -55.37 -30.12 59.73 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.532 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.0 m -54.37 -50.73 66.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.919 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -71.19 -39.97 71.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.906 0.384 . . . . 0.0 109.98 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -59.8 -46.9 87.79 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.92 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.063 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -78.38 -23.2 46.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.057 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 37.9 m 75.3 45.2 0.14 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 124.421 1.076 . . . . 0.0 109.979 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.518 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -141.66 175.58 9.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.302 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.649 ' HB2' ' HG2' ' A' ' 20' ' ' PRO . 34.8 t -102.91 101.34 11.37 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 173.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 48' ' ' LEU . 48.0 mt -97.68 119.27 45.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.32 0.581 . . . . 0.0 110.852 -176.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 28.9 mttm -118.91 127.95 53.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.621 -176.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 58' ' ' ILE . 7.6 pt -100.36 110.94 28.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.739 -0.785 . . . . 0.0 110.209 176.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 69' ' ' ARG . . . -91.9 113.18 58.1 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.741 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.41 148.8 92.44 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.067 2.512 . . . . 0.0 113.004 -172.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.803 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 58.5 Cg_endo -72.07 61.44 3.2 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.046 2.497 . . . . 0.0 112.178 178.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.14 -39.56 65.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.61 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.647 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 53.7 p -81.57 174.64 5.81 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.518 -174.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.647 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 83.5 Cg_exo -50.23 -18.18 3.19 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.694 2.263 . . . . 0.0 113.432 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -75.15 31.33 0.1 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.865 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.803 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 9.4 m -71.08 -1.81 13.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -172.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -79.11 -17.71 54.62 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.952 0.406 . . . . 0.0 110.408 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HB3' ' A' ' 61' ' ' PRO . 22.9 m -136.89 167.76 23.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.653 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.801 ' HE ' HG13 ' A' ' 34' ' ' VAL . 62.0 ttp85 -131.88 138.69 48.53 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 59' ' ' ALA . 24.2 ptp -96.16 132.1 41.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.544 0.688 . . . . 0.0 111.552 -177.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HH12 ' A' ' 69' ' ' ARG . 13.1 t -99.76 114.38 37.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.72 175.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.534 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 26.1 t -85.36 96.08 4.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.811 ' HB ' HG13 ' A' ' 25' ' ' VAL . 42.9 mm -92.17 101.21 12.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.851 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 17.1 m -109.49 109.76 20.67 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.568 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 178.2 -160.7 27.05 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.176 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 95.8 Cg_endo -84.75 159.95 12.17 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.632 2.222 . . . . 0.0 112.238 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -45.69 -39.0 17.83 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.877 2.385 . . . . 0.0 112.881 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -51.6 -49.86 61.34 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.829 178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.518 ' CB ' ' HB2' ' A' ' 54' ' ' ALA . . . -72.9 -33.78 66.22 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.314 -176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.445 ' NE2' HG12 ' A' ' 25' ' ' VAL . 6.9 mm100 -57.18 -49.17 76.8 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.506 0.504 . . . . 0.0 109.839 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -77.46 -32.93 54.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.319 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 1.063 ' HD2' ' HA ' ' A' ' 52' ' ' ALA . 33.3 ttmt -67.14 -54.05 24.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.0 111.229 -177.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.33 -42.15 88.59 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.403 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -64.75 -41.77 95.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 0.0 110.436 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.27 -31.03 76.19 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.576 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.462 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 2.0 tmt_? -65.47 -46.37 80.05 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.476 HD11 HG11 ' A' ' 27' ' ' VAL . 26.1 pt -71.01 -31.62 45.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.834 -0.346 . . . . 0.0 111.05 -179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -59.26 -50.32 74.47 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.883 0.373 . . . . 0.0 110.345 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -61.31 -32.05 79.4 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.152 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.576 ' O ' ' HG3' ' A' ' 93' ' ' GLU . 2.2 tmtm? -66.3 -42.33 88.48 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.882 HD11 HD21 ' A' ' 105' ' ' LEU . 25.3 mt -54.23 -44.87 72.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.233 0.54 . . . . 0.0 110.649 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -64.77 -50.22 67.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.252 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.576 ' HG3' ' O ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -67.55 -29.51 68.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.183 -176.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.513 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 5.8 tp10 -78.37 -9.64 59.35 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.53 0.681 . . . . 0.0 109.758 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 66.67 30.05 8.42 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.94 174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.513 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 11.1 m-85 -72.02 -38.8 69.52 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 110.167 175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.721 ' CD2' HG12 ' A' ' 103' ' ' VAL . 2.2 m-85 -131.6 147.52 52.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.855 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 99' ' ' PRO . . . 178.95 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.686 176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 25.4 Cg_exo -67.26 -48.0 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 123.149 2.566 . . . . 0.0 113.128 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -92.56 -27.04 17.62 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.91 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -130.16 139.13 50.91 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.159 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 104' ' ' LYS . 41.6 tt0 -90.7 137.68 32.17 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 169.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.721 HG12 ' CD2' ' A' ' 97' ' ' PHE . 13.7 m -66.19 121.09 14.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 119.356 -0.937 . . . . 0.0 108.53 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.587 ' HE3' HG22 ' A' ' 157' ' ' ILE . 27.4 mmmt -130.61 102.68 6.23 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.909 -174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.882 HD21 HD11 ' A' ' 91' ' ' LEU . 46.9 mt -103.89 160.81 14.49 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.906 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.799 ' HG3' HD11 ' A' ' 157' ' ' ILE . 36.6 tt0 -118.45 105.83 12.08 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.404 0.621 . . . . 0.0 110.891 -175.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.489 HG23 HG21 ' A' ' 25' ' ' VAL . 23.7 m -90.2 117.95 29.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.087 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.582 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 12.6 m170 -102.19 120.51 40.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.511 177.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.464 HD12 HD12 ' A' ' 170' ' ' ILE . 7.9 pt -121.01 149.66 23.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.476 175.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.472 HH11 HD11 ' A' ' 153' ' ' ILE . 18.0 mmm180 -90.58 118.44 30.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.941 178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 170' ' ' ILE . 6.4 m -134.74 156.57 78.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 174' ' ' LEU . 21.9 Cg_endo -61.85 132.23 38.83 Favored 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 122.304 2.003 . . . . 0.0 111.271 176.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.553 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -60.98 -26.19 67.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.398 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.1 m -71.71 -10.51 59.88 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.812 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -111.11 0.36 16.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.201 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.785 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.73 -36.57 82.77 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 121.263 0.554 . . . . 0.0 110.488 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.84 -5.42 87.97 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.615 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 16.8 tpt180 -92.8 -33.3 14.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.85 -0.175 . . . . 0.0 111.101 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG12 ' O ' ' A' ' 116' ' ' ALA . 7.6 p -59.05 -34.39 53.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 CA-C-O 121.19 0.519 . . . . 0.0 110.638 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.749 HD13 HG23 ' A' ' 127' ' ' VAL . 3.7 tp -78.44 -36.69 20.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.574 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 100.81 -164.49 18.64 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.833 178.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.46 ' HA ' H5'' ' B' ' 3' ' ' ' G' . 85.0 tttt -82.45 72.85 9.51 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.439 0.637 . . . . 0.0 109.576 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' ILE . . . 113.02 -178.36 18.68 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.245 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.682 ' HA2' HD11 ' A' ' 120' ' ' ILE . . . -71.9 75.75 0.73 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.395 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -98.46 -79.27 0.48 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 23.2 p -55.86 -45.98 78.34 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -171.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.749 HG23 HD13 ' A' ' 120' ' ' ILE . 62.0 t -58.17 -40.57 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.607 0.242 . . . . 0.0 110.744 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -74.54 -49.67 21.03 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.82 0.343 . . . . 0.0 110.943 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.5 -44.37 94.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.483 -176.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.445 ' O ' ' HB ' ' A' ' 134' ' ' THR . 95.8 mt -76.06 -32.29 59.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.628 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.65 ' HG2' ' HG3' ' A' ' 137' ' ' GLU . 1.0 OUTLIER -75.03 -51.4 13.67 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.379 -178.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.19 -37.36 72.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.977 -171.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -99.44 -45.93 5.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.709 0.29 . . . . 0.0 111.36 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 130' ' ' LEU . 23.7 m -92.75 -13.44 29.27 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -172.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.58 35.67 4.02 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.104 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.58 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -127.08 114.82 18.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.546 177.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.65 ' HG3' ' HG2' ' A' ' 131' ' ' GLN . 2.0 mp0 -88.19 124.27 33.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.498 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 127' ' ' VAL . 60.5 t -102.8 118.97 50.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.65 176.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.8 t -121.21 133.69 66.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 120.743 0.306 . . . . 0.0 110.88 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.627 HG12 HG22 ' A' ' 154' ' ' VAL . 29.8 m -128.94 163.94 42.2 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.617 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 41.3 Cg_endo -68.61 137.57 39.39 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.031 1.821 . . . . 0.0 112.078 178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.712 ' HG2' ' H62' ' B' ' 5' ' ' ' A' . 0.2 OUTLIER -81.04 143.43 32.49 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.938 177.54 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 66.21 -169.75 0.2 Allowed 'General case' 0 N--CA 1.464 0.275 0 O-C-N 123.792 0.683 . . . . 0.0 110.524 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -104.53 117.05 33.2 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.235 0.541 . . . . 0.0 111.76 -176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.592 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 6.6 t -141.93 49.01 1.26 Allowed Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.743 172.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 145' ' ' THR . 32.0 Cg_exo -54.1 138.15 70.7 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.841 2.361 . . . . 0.0 112.811 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.436 ' OD2' ' HG2' ' A' ' 148' ' ' GLU . 35.8 t70 -67.27 179.93 1.13 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.277 175.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HG2' ' OD2' ' A' ' 147' ' ' ASP . 12.1 pt-20 -52.16 -42.23 63.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 120.913 0.387 . . . . 0.0 111.85 -178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -93.96 24.93 3.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.605 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 49.77 51.73 15.95 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.243 1.017 . . . . 0.0 110.777 -173.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -107.97 156.95 18.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.946 177.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 116' ' ' ALA . 7.7 m -140.64 173.61 9.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 174.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.472 HD11 HH11 ' A' ' 110' ' ' ARG . 39.8 mm -109.41 122.29 63.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.978 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.627 HG22 HG12 ' A' ' 140' ' ' VAL . 91.9 t -106.59 130.01 59.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.48 ' HD2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -109.4 123.84 50.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.55 -174.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 60.8 mt -112.72 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.488 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.799 HD11 ' HG3' ' A' ' 106' ' ' GLU . 1.8 mp -112.25 110.71 33.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -155.11 -162.74 11.48 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 119.558 -1.306 . . . . 0.0 112.94 -175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.88 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -99.18 -173.18 2.43 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -60.08 -52.96 63.11 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -173.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.474 ' O ' ' HG2' ' A' ' 165' ' ' MET . 87.3 m-85 -79.42 -29.87 42.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.236 0.541 . . . . 0.0 111.081 176.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.88 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -65.55 -47.24 76.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.11 -173.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 35.1 p -64.87 -49.48 70.34 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.006 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -59.9 -35.61 75.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.645 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.474 ' HG2' ' O ' ' A' ' 161' ' ' TYR . 22.6 mmt -65.91 -47.04 76.07 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.618 0.246 . . . . 0.0 110.843 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.25 -41.93 97.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.267 176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 163' ' ' SER . 52.9 mt-30 -59.42 -37.14 77.31 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.139 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.403 ' HD2' HH11 ' A' ' 168' ' ' ARG . 62.8 mtt85 -67.74 -35.64 79.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.49 176.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' LYS . 27.6 mmtm -68.41 -52.69 30.1 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.749 176.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.677 HD11 HG11 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -55.28 -43.21 70.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 O-C-N 123.124 0.265 . . . . 0.0 111.125 -175.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 15.5 ptt180 -65.81 -44.99 84.01 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.578 0.228 . . . . 0.0 111.052 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.598 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 45.0 m-20 -62.58 -51.31 67.85 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.415 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.54 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.4 mt -54.92 -45.2 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.34 178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.596 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.8 tt -57.77 -50.66 72.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.231 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -57.01 -42.23 79.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.974 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.598 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.2 mt-30 -57.82 -36.25 72.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.166 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 16.7 t -61.23 -51.51 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-O 121.093 0.473 . . . . 0.0 110.227 177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 182' ' ' GLN . 98.9 mttt -58.83 -40.83 85.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.73 177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 89.3 mt-30 -61.43 -55.7 28.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.541 178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -62.19 -26.33 68.29 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.689 0.28 . . . . 0.0 111.424 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -73.97 -52.74 11.85 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.702 -0.226 . . . . 0.0 111.383 176.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 86.6 mt-30 -69.53 -48.61 59.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.794 -0.184 . . . . 0.0 111.311 -176.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt 60.55 56.1 3.19 Favored 'General case' 0 C--O 1.235 0.304 0 O-C-N 123.385 0.428 . . . . 0.0 110.68 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.98 131.93 5.8 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.875 178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -168.64 138.08 2.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.552 -0.166 . . . . 0.0 110.552 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 49.7 m 57.07 75.21 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 123.837 0.71 . . . . 0.0 111.296 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -92.04 176.36 39.01 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.074 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -129.58 -29.92 2.14 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.945 0.402 . . . . 0.0 110.076 177.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.8 54.14 1.78 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.655 0.74 . . . . 0.0 109.796 177.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -86.22 79.98 8.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.08 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.805 -179.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 100.278 -1.358 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.523 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.922 0 C3'-C2'-C1' 104.119 2.91 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.884 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.917 0 P-O3'-C3' 124.389 3.907 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.914 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.746 0 O4'-C1'-C2' 108.347 1.391 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.914 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.615 0.68 0 P-O3'-C3' 123.492 3.16 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.53 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.871 0 O4'-C1'-C2' 107.754 0.967 . 0.375 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C1'-C2' 107.589 0.849 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.83 57.68 3.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.919 0.488 . . . . 0.0 111.142 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -86.17 139.33 31.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.122 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 156.35 -74.5 0.23 Allowed Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 110.764 -0.935 . . . . 0.0 110.764 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' ' HB2' ' A' ' 6' ' ' SER . 16.6 Cg_endo -59.12 159.91 20.6 Favored 'Trans proline' 0 C--O 1.235 0.374 0 C-N-CA 122.652 2.234 . . . . 0.0 110.906 172.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 5' ' ' PRO . 50.8 m 73.1 -52.31 0.71 Allowed 'General case' 0 N--CA 1.467 0.379 0 O-C-N 123.599 0.562 . . . . 0.0 111.015 -175.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m -65.12 -23.67 67.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -86.29 42.58 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.342 0 CA-C-O 121.058 0.456 . . . . 0.0 110.871 176.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m 58.41 42.34 21.45 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.032 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.08 51.63 0.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.049 -0.596 . . . . 0.0 111.976 -178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -162.19 -174.63 4.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 56.66 78.78 0.36 Allowed Pre-proline 0 C--O 1.235 0.29 0 O-C-N 123.9 0.75 . . . . 0.0 111.674 176.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.75 111.02 2.48 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.593 2.196 . . . . 0.0 111.18 177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -78.96 70.12 5.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.468 0.651 . . . . 0.0 110.342 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 t -118.08 2.02 12.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.044 179.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.7 m -87.12 66.04 9.15 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.119 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -78.64 70.18 4.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.442 0.639 . . . . 0.0 109.849 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 54.4 mtt -114.24 113.68 46.03 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.288 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 9.3 Cg_exo -72.3 110.81 3.05 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.732 2.288 . . . . 0.0 111.401 175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 14.8 Cg_exo -68.7 125.64 12.97 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.931 2.42 . . . . 0.0 112.023 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 74' ' ' THR . 2.3 pm0 -77.54 57.17 1.53 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.038 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 47.92 -114.97 0.64 Allowed 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.128 0.571 . . . . 0.0 111.88 174.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 7.7 tp10 -113.28 117.79 32.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 173.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.8 m -134.35 132.42 39.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.579 0.704 . . . . 0.0 112.317 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.908 HG13 HG23 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -114.16 143.32 24.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.31 173.484 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.538 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 31.8 m-70 -112.74 111.82 22.88 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 71' ' ' VAL . 3.4 p -114.16 137.99 45.57 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 C-N-CA 120.244 -0.583 . . . . 0.0 111.425 -173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.599 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 48.0 m-85 -104.24 110.09 22.17 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.641 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.6 HG13 HG22 ' A' ' 34' ' ' VAL . 39.0 pt -107.85 152.14 41.48 Favored Pre-proline 0 C--N 1.319 -0.756 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.241 175.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HG23 ' A' ' 34' ' ' VAL . 24.3 Cg_exo -63.79 140.88 76.13 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 C-N-CA 122.469 2.113 . . . . 0.0 111.119 -176.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.58 -25.21 59.66 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.655 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' HG2' ' CE1' ' A' ' 96' ' ' PHE . 62.0 tt0 -72.35 -40.42 67.38 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.163 0.506 . . . . 0.0 110.134 175.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.542 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -72.48 -31.61 65.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 -178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 9.7 t -62.05 -34.0 61.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 175.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.81 -28.94 66.51 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.954 177.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.96 17.56 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.916 0.389 . . . . 0.0 110.9 175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.619 HD13 ' HG3' ' A' ' 90' ' ' LYS . 38.6 mm -61.75 -46.91 95.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.062 -176.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.634 HD12 HG21 ' A' ' 45' ' ' ILE . 4.3 mm -85.27 -12.3 11.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.316 0.579 . . . . 0.0 109.748 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -66.63 -41.69 93.81 Favored Glycine 0 N--CA 1.448 -0.543 0 CA-C-N 115.564 -0.743 . . . . 0.0 113.83 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.867 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 51.7 m-20 -60.37 86.02 0.01 OUTLIER 'General case' 0 C--O 1.239 0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 111.644 -175.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.1 t70 60.79 13.52 4.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.325 176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 61.0 19.11 56.28 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.953 -0.567 . . . . 0.0 113.146 -177.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -119.18 -26.77 5.83 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 122.424 -0.456 . . . . 0.0 111.482 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.867 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 8.2 t-160 -52.43 -46.62 66.48 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -169.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.748 HG12 HG21 ' A' ' 58' ' ' ILE . 6.7 tp -67.9 -41.7 85.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -179.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -73.91 -32.55 63.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.368 0.604 . . . . 0.0 109.717 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -67.78 -34.85 77.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.288 174.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 14.1 tp -56.03 -38.03 70.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.525 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' ' HB ' ' A' ' 56' ' ' ILE . 21.0 t -56.45 -51.8 67.05 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.26 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 8.4 mpt_? -73.85 -32.4 63.63 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.267 0.556 . . . . 0.0 109.903 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -60.44 -40.24 90.42 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.1 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -97.17 8.34 44.73 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.1 t 56.08 45.78 22.9 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 -172.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' HD11 ' A' ' 73' ' ' ILE . . . -121.76 174.87 6.57 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.324 -1.307 . . . . 0.0 111.038 -168.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.643 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 23.5 m -118.82 98.18 6.08 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 171.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.871 HG12 HD13 ' A' ' 73' ' ' ILE . 48.0 mt -105.09 118.82 53.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.234 0.54 . . . . 0.0 111.359 -176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.54 114.53 21.34 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.591 175.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.748 HG21 HG12 ' A' ' 45' ' ' ILE . 6.8 pt -90.97 135.97 25.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.159 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . . . -104.81 144.01 27.86 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-O 120.711 0.291 . . . . 0.0 110.683 -179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 9.4 Cg_exo -73.32 154.81 51.37 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 123.35 2.7 . . . . 0.0 111.769 176.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -77.84 49.35 2.92 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 123.038 2.492 . . . . 0.0 111.697 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -77.73 -28.79 50.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.035 -174.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.652 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 68.6 p -85.12 178.1 2.56 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.205 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.652 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.4 Cg_exo -56.12 -26.34 59.58 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.353 2.036 . . . . 0.0 112.514 177.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.14 31.58 0.12 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.255 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.2 t -63.12 -23.42 67.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -72.16 -13.99 61.7 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.375 0.607 . . . . 0.0 110.433 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 30' ' ' PRO . 27.2 m -128.4 176.75 7.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.222 173.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 72.0 mtt180 -138.55 129.08 26.17 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 120.802 0.334 . . . . 0.0 110.182 176.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.429 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 24.1 ptm -93.13 136.47 33.36 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.112 -177.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 27' ' ' VAL . 12.1 m -121.45 144.22 31.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.422 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.7 t -101.14 108.61 23.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.246 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.908 HG23 HG13 ' A' ' 25' ' ' VAL . 4.7 tp -109.38 113.4 44.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.567 0.699 . . . . 0.0 111.107 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.643 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.1 m -112.17 133.79 54.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.856 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 156.71 -167.65 33.68 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.51 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 43.9 Cg_endo -68.42 146.23 67.78 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.682 2.255 . . . . 0.0 111.069 176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 33.2 Cg_exo -58.73 -15.1 24.63 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.012 2.475 . . . . 0.0 112.921 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -74.11 -34.22 63.85 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.477 0.656 . . . . 0.0 109.441 177.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.605 ' HA ' ' HG2' ' A' ' 82' ' ' LYS . . . -77.38 -36.53 53.42 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.041 177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -59.78 -43.63 94.28 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 171.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -57.57 -54.41 47.12 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.295 0.372 . . . . 0.0 111.396 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.605 ' HG2' ' HA ' ' A' ' 79' ' ' ALA . 18.1 ptpt -70.01 -47.48 61.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.675 -176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.48 -42.86 93.05 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -63.59 -46.7 84.62 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.959 0.409 . . . . 0.0 110.243 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -63.1 -31.8 81.95 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.474 -0.87 . . . . 0.0 111.812 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.549 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.87 -47.66 65.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.526 -0.337 . . . . 0.0 110.32 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 29.8 pt -68.12 -39.16 80.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 C-N-CA 120.874 -0.33 . . . . 0.0 111.111 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.474 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 9.2 m-85 -62.32 -40.76 97.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.052 0.453 . . . . 0.0 110.847 175.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -65.6 -28.7 73.87 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.7 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.619 ' HG3' HD13 ' A' ' 37' ' ' ILE . 1.4 tmtt? -64.18 -48.97 73.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.941 -0.129 . . . . 0.0 110.792 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.509 HD23 ' HB ' ' A' ' 103' ' ' VAL . 0.2 OUTLIER -54.97 -30.88 60.1 Favored 'General case' 0 C--O 1.233 0.208 0 O-C-N 122.098 -0.376 . . . . 0.0 111.166 178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -55.07 7.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 120.926 0.393 . . . . 0.0 110.942 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.26 -31.87 72.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.719 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.594 ' HG2' ' CE2' ' A' ' 96' ' ' PHE . 39.1 tp10 -72.77 -18.64 61.48 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.6 -177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 69.25 36.43 2.35 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 114.733 -1.121 . . . . 0.0 111.648 177.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.594 ' CE2' ' HG2' ' A' ' 94' ' ' GLU . 25.3 m-85 -68.62 -21.87 64.46 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 171.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.471 ' HE2' ' HB3' ' A' ' 91' ' ' LEU . 16.5 m-85 -137.7 167.51 21.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.734 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -156.04 -84.3 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.413 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -48.11 -44.35 28.53 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.777 2.985 . . . . 0.0 113.427 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -94.21 -26.18 16.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.162 0.506 . . . . 0.0 110.328 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 47.84 36.46 5.95 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 114.774 -1.103 . . . . 0.0 110.758 -172.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 108.95 17.08 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.798 179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.509 ' HB ' HD23 ' A' ' 91' ' ' LEU . 30.4 m -97.3 121.35 47.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 172.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 11.2 mmmm -123.71 92.44 3.68 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-O 121.457 0.646 . . . . 0.0 111.318 -169.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.571 HD13 HG22 ' A' ' 29' ' ' ILE . 16.6 mt -111.61 162.04 15.58 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.868 175.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.599 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 9.9 pt-20 -118.72 106.84 12.98 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.471 0.653 . . . . 0.0 110.849 179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.422 HG23 HG21 ' A' ' 25' ' ' VAL . 7.8 m -89.94 118.45 29.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.979 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 25.0 m170 -98.64 120.83 39.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -112.33 153.19 14.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 -96.61 118.81 33.88 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.296 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.599 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 33.4 m -132.77 162.99 54.05 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.589 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.599 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 56.6 Cg_endo -71.45 132.14 20.12 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.338 2.026 . . . . 0.0 112.225 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.547 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -59.21 -28.75 66.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.456 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.7 m -65.95 -17.21 64.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.761 179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -123.02 24.13 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.499 ' O ' HG12 ' A' ' 119' ' ' VAL . . . -62.39 -43.51 98.64 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.239 0.542 . . . . 0.0 110.991 -179.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.86 ' HA3' ' C5 ' ' B' ' 4' ' ' ' G' . . . -85.42 -3.8 86.46 Favored Glycine 0 C--N 1.321 -0.3 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.257 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.583 ' CG ' HG21 ' A' ' 177' ' ' VAL . 10.9 tpt85 -94.06 -30.61 14.59 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.729 -0.277 . . . . 0.0 110.642 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 170' ' ' ILE . 13.0 p -66.54 -20.79 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-O 121.402 0.62 . . . . 0.0 110.682 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.536 ' HB ' HG11 ' A' ' 140' ' ' VAL . 13.2 tt -82.03 1.81 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 121.934 0.873 . . . . 0.0 109.64 177.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.522 ' HA2' HD13 ' A' ' 173' ' ' ILE . . . 92.41 -78.09 1.22 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.311 -0.858 . . . . 0.0 113.389 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -160.25 70.7 0.43 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 78.95 -148.61 31.87 Favored Glycine 0 N--CA 1.45 -0.398 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -78.48 45.6 2.66 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.474 -0.869 . . . . 0.0 112.058 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -79.48 -56.05 4.6 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -173.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 29.6 p -61.47 -32.13 72.12 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.749 0.309 . . . . 0.0 110.83 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 138' ' ' VAL . 11.3 t -60.82 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.169 177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -69.81 -50.19 45.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.445 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -49.78 68.66 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -175.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 126' ' ' THR . 4.1 mm? -70.39 -36.41 74.06 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.516 -175.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -77.08 -45.81 25.74 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.036 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -61.94 -49.31 76.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.775 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 8.6 tt -95.3 -47.89 6.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.724 0.297 . . . . 0.0 111.322 -173.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.751 HG22 ' HA ' ' A' ' 162' ' ' ALA . 2.5 m -92.21 -11.61 34.95 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -171.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.97 6.77 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 122.914 0.485 . . . . 0.0 111.302 -177.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.688 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -114.48 115.28 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 40.1 tt0 -88.67 113.69 24.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.134 -0.485 . . . . 0.0 109.87 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 127' ' ' VAL . 57.4 t -98.3 115.87 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.598 -178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 26.6 t -118.04 126.36 74.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.343 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.536 HG11 ' HB ' ' A' ' 120' ' ' ILE . 31.4 m -102.49 162.13 21.17 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.351 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.827 ' HG3' ' HB ' ' A' ' 152' ' ' VAL . 92.0 Cg_endo -82.24 106.23 1.54 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.403 2.069 . . . . 0.0 112.527 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.709 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 67.4 ttt180 -77.15 76.47 3.7 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.132 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 51.55 44.21 29.23 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.19 -0.914 . . . . 0.0 111.322 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.588 ' OE1' ' HA ' ' A' ' 141' ' ' PRO . 4.4 pt20 -115.25 -11.57 11.94 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -175.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.793 ' H ' ' HD3' ' A' ' 146' ' ' PRO . 69.5 p -133.29 -16.92 0.03 OUTLIER Pre-proline 0 CA--C 1.555 1.145 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -175.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.793 ' HD3' ' H ' ' A' ' 145' ' ' THR . 25.8 Cg_exo -56.87 125.03 17.68 Favored 'Trans proline' 0 C--N 1.361 1.228 0 C-N-CA 121.647 1.565 . . . . 0.0 113.393 -175.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -115.14 -165.23 1.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.552 177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -62.74 -27.86 69.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.254 0.549 . . . . 0.0 110.895 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -84.13 2.26 40.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.736 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 44.85 39.79 3.83 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.716 1.206 . . . . 0.0 112.202 -176.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -101.94 134.48 45.08 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.877 0.37 . . . . 0.0 110.059 175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.827 ' HB ' ' HG3' ' A' ' 141' ' ' PRO . 15.9 m -124.98 171.2 14.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.638 -178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.47 HG23 ' HB3' ' A' ' 108' ' ' HIS . 45.5 mm -112.69 114.1 46.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.253 -177.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.555 HG22 ' HD3' ' A' ' 141' ' ' PRO . 95.1 t -108.33 137.31 40.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.4 mptt -116.28 131.9 56.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.923 0.392 . . . . 0.0 111.531 -170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.435 HG21 ' HA ' ' A' ' 163' ' ' SER . 62.0 mt -112.21 117.98 56.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.093 174.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 6.1 mm -105.6 109.98 29.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 179.68 -162.75 29.58 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.127 -1.511 . . . . 0.0 113.596 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.583 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 41.0 m170 -94.34 -173.55 3.1 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.92 -51.85 65.32 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.974 -0.29 . . . . 0.0 111.451 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -73.84 -27.75 61.25 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.751 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -66.28 -53.49 36.02 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.534 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.435 ' HA ' HG21 ' A' ' 156' ' ' ILE . 63.7 m -65.84 -37.06 85.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.256 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -55.31 -55.69 28.59 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.79 0.329 . . . . 0.0 110.822 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 53.1 tpp -63.13 -43.84 97.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.295 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.32 56.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.829 -176.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HA ' HG12 ' A' ' 170' ' ' ILE . 9.4 pt20 -62.49 -36.23 81.85 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.468 0.175 . . . . 0.0 111.375 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.24 -42.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.283 175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 169' ' ' LYS . 10.8 mmmm -67.33 -44.78 78.26 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.576 ' HB ' ' CG2' ' A' ' 119' ' ' VAL . 39.4 pt -65.67 -41.67 91.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.223 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -68.88 -29.24 67.5 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.444 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.622 ' O ' ' HG2' ' A' ' 176' ' ' GLN . 25.1 t70 -61.46 -53.84 51.25 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 177' ' ' VAL . 62.2 mt -52.49 -49.59 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 O-C-N 123.647 0.592 . . . . 0.0 110.099 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.448 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.2 tt -52.54 -53.68 43.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.169 178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.87 -41.34 86.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.865 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 172' ' ' ASP . 17.8 mm-40 -61.41 -46.9 88.2 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.703 178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.6 t -59.74 -43.73 92.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 177.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -54.18 -45.88 72.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.609 175.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 75.5 mt-30 -65.65 -47.45 75.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.012 177.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -52.94 -55.52 22.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.552 177.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 -68.97 -47.22 66.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.99 -175.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -72.19 -23.71 61.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.884 0.373 . . . . 0.0 111.046 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 29.9 mtmm 67.14 30.71 7.18 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.937 177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 121.67 -143.47 15.88 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.621 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -117.52 -178.14 3.4 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 34.2 p 51.67 35.83 15.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.584 0.754 . . . . 0.0 112.114 178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -97.0 -35.71 5.23 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -77.42 -21.35 53.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.255 0.55 . . . . 0.0 110.159 176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 189' ' ' LEU . 2.7 mm? -96.71 105.13 17.19 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.197 -177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -96.44 75.68 2.89 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.613 0.721 . . . . 0.0 110.752 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.676 179.794 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C1'-C2' 107.548 0.82 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.448 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 104.633 3.481 OUTLIER-DELTA 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.835 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.938 0 C4'-C3'-C2' 105.691 2.991 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.921 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 O4'-C1'-C2' 108.487 1.491 OUTLIER-EPSILON 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.921 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.696 0 P-O3'-C3' 123.766 3.388 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.441 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 104.304 -0.854 . 0.67 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.8 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.91 0 N19-C1'-C2' 115.149 1.093 . 0.178 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.58 34.3 0.62 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.096 0.474 . . . . 0.0 110.346 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.9 tpp -70.46 126.77 30.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.745 176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' A' ' 10' ' ' GLY . . . 160.11 -66.45 0.27 Allowed Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.435 -176.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.28 57.03 4.61 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.866 2.378 . . . . 0.0 111.391 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.2 p -65.07 -63.09 1.19 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.796 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 63.3 m -149.92 -55.34 0.17 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.784 173.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' O ' ' HB3' ' A' ' 9' ' ' SER . 17.0 m -121.02 32.63 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.229 176.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 44.2 t 74.99 130.6 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.171 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' HA2' ' A' ' 4' ' ' GLY . . . -158.35 171.2 35.16 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.841 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.704 ' HA ' ' HD2' ' A' ' 14' ' ' PHE . . . 63.49 48.07 3.61 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.921 0.489 . . . . 0.0 111.713 177.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.566 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -86.59 -50.6 0.47 Allowed Pre-proline 0 CA--C 1.538 0.482 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.954 175.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 5.1 Cg_exo -75.94 5.8 4.21 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.449 2.099 . . . . 0.0 112.898 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.704 ' HD2' ' HA ' ' A' ' 11' ' ' ALA . 76.3 m-85 -105.26 102.75 12.21 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 t 62.55 58.74 1.6 Allowed 'General case' 0 C--O 1.236 0.364 0 O-C-N 123.686 0.616 . . . . 0.0 109.906 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.6 m -69.86 79.89 0.46 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.673 -172.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 59.3 77.53 0.31 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.338 172.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.443 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 65.0 mtt -120.51 128.22 25.91 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.068 178.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 18' ' ' MET . 7.3 Cg_exo -74.55 118.87 5.5 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.813 2.342 . . . . 0.0 111.614 176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -70.03 167.93 23.37 Favored 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 122.678 2.252 . . . . 0.0 112.394 -177.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' HA ' ' CG2' ' A' ' 74' ' ' THR . 8.6 pt-20 -49.37 -55.8 11.73 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 57.88 -80.64 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.836 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -150.22 140.3 22.06 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.8 m -108.82 129.17 55.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.692 -173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG13 ' HA ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -114.07 146.99 17.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 67.5 m170 -120.84 123.7 43.22 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.574 HG13 HG22 ' A' ' 71' ' ' VAL . 2.8 p -123.41 133.61 68.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.875 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.447 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 86.5 m-85 -99.67 115.81 30.31 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.098 -177.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.572 HG22 HD22 ' A' ' 105' ' ' LEU . 37.2 pt -115.31 146.08 35.66 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.249 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.653 ' HA ' HG12 ' A' ' 68' ' ' VAL . 50.7 Cg_exo -53.16 139.73 62.18 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.704 2.269 . . . . 0.0 111.752 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.43 -28.36 66.88 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.764 -174.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -75.94 -35.04 59.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.037 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' HA ' ' CE2' ' A' ' 96' ' ' PHE . . . -67.43 -30.73 70.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.408 178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.885 HG11 ' HD3' ' A' ' 69' ' ' ARG . 24.4 t -60.53 -38.4 78.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.873 176.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.13 -33.12 73.26 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.709 -0.757 . . . . 0.0 111.847 177.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.55 ' HB1' ' HE3' ' A' ' 90' ' ' LYS . . . -77.95 -50.22 12.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.81 0.338 . . . . 0.0 111.143 177.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 48.3 mm -60.84 -41.55 89.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.838 -176.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 34' ' ' VAL . 13.6 mm -85.36 -59.74 2.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.209 178.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -61.56 -26.42 66.57 Favored Glycine 0 C--N 1.33 0.213 0 CA-C-N 115.223 -0.899 . . . . 0.0 114.56 -167.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 13.7 t70 -42.4 -42.51 3.24 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.3 0.571 . . . . 0.0 111.287 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.642 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 17.6 t70 -134.99 -3.51 2.49 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.418 176.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 75.98 -49.81 2.56 Favored Glycine 0 C--O 1.228 -0.222 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.525 -168.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.409 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 26.5 mp0 -102.61 16.67 25.73 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.952 0.406 . . . . 0.0 110.001 176.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 73.2 t60 -61.26 -37.59 83.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.297 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.685 HG12 ' CG2' ' A' ' 58' ' ' ILE . 5.4 tp -64.43 -36.16 76.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.631 175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.86 -18.77 42.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.307 0.575 . . . . 0.0 110.254 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 84.1 mm-40 -72.23 -30.71 65.16 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.035 167.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 HD11 ' HB1' ' A' ' 83' ' ' ALA . 1.0 OUTLIER -63.17 -51.47 66.26 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.03 179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.475 ' HB3' HG13 ' A' ' 56' ' ' ILE . 3.8 p -62.64 -58.49 7.34 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.47 -176.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' HD2' ' HA ' ' A' ' 50' ' ' ARG . 21.7 tpt180 -60.01 -33.21 71.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.002 -174.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.24 95.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.873 -177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 53' ' ' SER . . . -91.44 3.61 54.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.527 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 52' ' ' ALA . 70.8 m 67.8 38.75 2.82 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.747 0.784 . . . . 0.0 109.634 -172.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.37 168.5 9.59 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.892 -174.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.601 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 53.8 m -122.01 119.7 32.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.625 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.63 HG21 HD11 ' A' ' 45' ' ' ILE . 63.6 mt -128.04 130.26 69.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.868 0.366 . . . . 0.0 110.62 -178.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.555 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 62.4 mttm -119.31 126.31 51.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 175.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.685 ' CG2' HG12 ' A' ' 45' ' ' ILE . 29.2 pt -91.12 97.26 7.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 122.332 1.063 . . . . 0.0 110.252 -178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.25 136.6 56.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.964 -172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.17 140.77 66.45 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.865 2.377 . . . . 0.0 112.265 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.54 ' HB2' ' HA ' ' A' ' 66' ' ' SER . 57.0 Cg_endo -73.54 71.59 3.85 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.877 2.384 . . . . 0.0 111.653 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -78.02 -34.91 50.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.342 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 42.3 p -82.58 177.05 3.25 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.204 -175.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 31.2 Cg_exo -60.95 -5.99 5.53 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.852 2.368 . . . . 0.0 112.556 176.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -80.93 17.72 1.15 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.009 176.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 32.4 t -66.34 -3.23 5.52 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 122.9 0.48 . . . . 0.0 112.029 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -72.62 -20.47 61.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.715 0.769 . . . . 0.0 109.587 172.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 30' ' ' PRO . 30.1 m -133.34 -179.39 3.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 114.746 -1.115 . . . . 0.0 108.48 175.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.885 ' HD3' HG11 ' A' ' 34' ' ' VAL . 76.8 ttt180 -138.95 133.79 32.29 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.95 139.37 33.07 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.204 0.526 . . . . 0.0 111.201 -177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.574 HG22 HG13 ' A' ' 27' ' ' VAL . 14.9 m -111.88 142.57 23.87 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.919 173.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 59.8 t -88.44 108.83 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 114.586 -1.188 . . . . 0.0 109.849 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.751 HG21 ' HG2' ' A' ' 80' ' ' GLN . 13.5 mm -91.72 126.24 44.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.494 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.601 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 91.0 m -130.67 123.87 30.34 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.622 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 133.84 -162.18 24.41 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 119.81 -1.186 . . . . 0.0 113.285 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.429 ' HB2' ' HG2' ' A' ' 78' ' ' GLU . 2.0 Cg_endo -81.62 130.42 6.87 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.634 2.889 . . . . 0.0 111.915 -176.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.54 -24.69 45.75 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 123.557 2.838 . . . . 0.0 114.221 -173.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.429 ' HG2' ' HB2' ' A' ' 76' ' ' PRO . 1.4 pm0 -52.64 -46.48 67.13 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.031 0.443 . . . . 0.0 111.159 177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -68.52 -31.65 71.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.793 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.751 ' HG2' HG21 ' A' ' 73' ' ' ILE . 1.6 mp0 -76.87 -27.42 55.04 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -178.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -64.93 -46.32 82.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.015 0.436 . . . . 0.0 110.215 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -73.49 -46.36 48.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.064 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.506 ' O ' ' HB3' ' A' ' 86' ' ' ARG . . . -58.84 -38.29 78.35 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.644 ' HB2' ' O ' ' A' ' 80' ' ' GLN . 7.5 tt0 -67.92 -46.81 70.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.745 0.307 . . . . 0.0 110.333 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -61.52 -34.09 87.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.395 -0.907 . . . . 0.0 111.033 175.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.506 ' HB3' ' O ' ' A' ' 83' ' ' ALA . 23.4 ttt85 -59.22 -52.84 63.95 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.033 -0.584 . . . . 0.0 111.033 176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 2.8 pp -75.52 -24.92 17.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.79 -177.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 2.2 m-85 -58.38 -48.48 80.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.148 0.499 . . . . 0.0 110.196 169.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.71 -29.49 75.39 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.983 179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.624 ' O ' ' HG2' ' A' ' 93' ' ' GLU . 7.6 tmtm? -63.54 -37.84 88.86 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.825 HD11 HD21 ' A' ' 105' ' ' LEU . 12.2 mt -55.3 -49.47 72.05 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 92' ' ' LYS . 1.9 mmmp? -60.58 -49.0 79.3 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.982 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 7.7 pt-20 -61.69 -26.04 67.78 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.102 0.477 . . . . 0.0 110.184 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 36' ' ' ALA . 7.6 tp10 -87.32 -14.16 41.58 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 121.594 0.712 . . . . 0.0 110.796 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 66.5 t30 58.05 40.91 24.89 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 114.325 -1.307 . . . . 0.0 111.812 172.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.506 ' CE2' ' HA ' ' A' ' 33' ' ' ALA . 10.0 m-85 -72.29 -35.69 68.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.186 0.517 . . . . 0.0 111.539 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.487 ' CZ ' ' HD2' ' A' ' 92' ' ' LYS . 24.3 p90 -116.43 150.03 38.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.733 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -170.09 -79.55 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.294 -0.955 . . . . 0.0 111.942 176.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.99 -54.17 4.43 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.956 2.437 . . . . 0.0 113.115 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -108.99 -26.89 9.96 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.071 0.767 . . . . 0.0 113.071 -171.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -115.49 168.42 10.01 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-O 121.505 0.669 . . . . 0.0 112.049 -170.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -145.15 168.95 19.13 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 106.63 -1.619 . . . . 0.0 106.63 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.427 ' HB ' HD12 ' A' ' 91' ' ' LEU . 19.3 m -66.21 120.62 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 C-N-CA 118.698 -1.201 . . . . 0.0 108.118 174.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -136.65 91.41 2.65 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.565 -175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.825 HD21 HD11 ' A' ' 91' ' ' LEU . 17.3 mt -113.55 161.35 17.5 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.273 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.447 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.3 pt-20 -139.92 108.13 5.78 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.576 0.703 . . . . 0.0 111.298 -179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.596 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.12 116.85 28.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.693 176.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.431 ' CD2' ' HB3' ' A' ' 155' ' ' LYS . 17.2 m170 -94.0 118.74 31.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 170' ' ' ILE . 2.6 mt -117.98 143.97 27.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 O-C-N 123.311 0.382 . . . . 0.0 110.273 -172.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.605 HH11 HD11 ' A' ' 153' ' ' ILE . 34.9 mmt180 -76.48 119.1 19.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.089 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG23 HG23 ' A' ' 152' ' ' VAL . 27.7 m -135.77 153.07 77.04 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.461 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 41.7 Cg_endo -69.92 135.74 30.82 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.567 2.178 . . . . 0.0 111.751 178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -60.65 -26.38 67.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.46 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.5 p -70.57 -13.37 62.07 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 177.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -116.85 8.7 13.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.815 178.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.759 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -66.09 -51.19 60.33 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.313 0.578 . . . . 0.0 110.954 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -75.6 -10.77 84.72 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.674 -0.775 . . . . 0.0 111.957 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.912 ' HG2' HG22 ' A' ' 177' ' ' VAL . 15.7 tpt180 -93.87 -29.29 15.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.62 0.247 . . . . 0.0 111.395 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 154' ' ' VAL . 6.9 p -68.0 -20.16 25.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.574 0.702 . . . . 0.0 110.013 -179.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.546 HG13 ' HA2' ' A' ' 124' ' ' GLY . 10.8 tp -87.21 2.85 5.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.442 175.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.553 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 85.02 -161.33 36.01 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.497 ' HE2' ' OP1' ' B' ' 3' ' ' ' G' . 36.6 ttmt -79.08 71.39 5.55 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.359 0.599 . . . . 0.0 109.633 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.681 ' HA3' ' OP1' ' B' ' 4' ' ' ' G' . . . 72.08 62.94 3.14 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 113.274 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.546 ' HA2' HG13 ' A' ' 120' ' ' ILE . . . 83.12 37.15 13.04 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.743 177.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.553 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 40.6 tttm -86.76 -38.7 16.65 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.826 0.346 . . . . 0.0 110.112 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 25.6 p -66.27 -45.42 80.54 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.227 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.58 -34.0 53.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.002 177.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 54.6 t-20 -67.17 -52.9 35.81 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.788 0.328 . . . . 0.0 110.868 -178.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 130' ' ' LEU . 9.4 pt-20 -82.12 -41.76 20.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.183 0.516 . . . . 0.0 111.759 -174.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.941 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 18.4 tp -74.91 -30.45 61.28 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.06 -171.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 35.1 tt0 -80.99 -41.28 23.0 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.148 177.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 56.9 t30 -68.25 -38.52 81.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.613 -177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.16 -49.77 5.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 0.0 111.84 -177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.936 HG22 ' HA ' ' A' ' 162' ' ' ALA . 3.3 m -100.43 -12.71 19.14 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.261 -0.427 . . . . 0.0 112.017 -171.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 67.91 34.62 4.15 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.194 0.598 . . . . 0.0 111.435 -177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.941 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -106.29 129.18 54.36 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.986 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.71 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 28.4 tt0 -100.7 111.62 23.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.302 -176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.38 121.9 47.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.556 -177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.7 t -126.93 128.36 70.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 120.93 0.395 . . . . 0.0 111.309 -177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.604 HG12 HG12 ' A' ' 154' ' ' VAL . 7.1 m -131.33 165.19 37.1 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.953 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 57.9 Cg_endo -74.69 108.56 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.134 1.889 . . . . 0.0 111.018 174.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.668 ' HB2' ' H62' ' B' ' 5' ' ' ' A' . 29.4 ttp180 -77.02 72.62 3.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.722 0.296 . . . . 0.0 110.941 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.461 ' HA ' ' N2 ' ' B' ' 4' ' ' ' G' . 22.9 t70 -171.03 153.38 3.77 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.13 175.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -84.38 79.26 9.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.675 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.478 ' N ' ' HD3' ' A' ' 146' ' ' PRO . 3.3 t -133.0 60.87 52.62 Favored Pre-proline 0 CA--C 1.547 0.857 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.016 -175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 145' ' ' THR . 36.6 Cg_exo -59.14 143.84 99.62 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.958 2.439 . . . . 0.0 112.448 174.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -85.69 178.08 7.47 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.107 176.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.442 ' HG3' HD22 ' A' ' 149' ' ' ASN . 10.2 pt-20 -48.14 -46.26 34.12 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.131 0.573 . . . . 0.0 112.426 -177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.442 HD22 ' HG3' ' A' ' 148' ' ' GLU . 42.2 m-80 -98.09 24.43 7.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.858 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 149' ' ' ASN . 16.3 pt-20 50.72 48.05 23.41 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 124.2 0.937 . . . . 0.0 110.527 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.45 128.14 52.28 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.312 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.759 HG21 ' HB2' ' A' ' 116' ' ' ALA . 17.3 m -126.21 166.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 174.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.605 HD11 HH11 ' A' ' 110' ' ' ARG . 32.9 mm -114.45 129.26 70.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.146 0.498 . . . . 0.0 111.3 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.724 HG11 HG11 ' A' ' 119' ' ' VAL . 24.8 m -118.32 139.59 44.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.235 -0.893 . . . . 0.0 108.729 173.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -127.14 134.53 50.18 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.518 -174.497 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.498 HD11 HD13 ' A' ' 170' ' ' ILE . 66.5 mt -107.74 118.89 56.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.029 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.71 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 10.9 mm -97.58 110.68 25.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -156.87 -153.08 6.52 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.091 -1.528 . . . . 0.0 113.888 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.985 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 15.6 m80 -133.98 -165.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -58.04 -52.5 65.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.81 0.338 . . . . 0.0 111.035 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -76.79 -44.63 32.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.92 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.985 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -55.41 -53.64 53.66 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.533 -0.758 . . . . 0.0 112.272 -174.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 70.5 m -69.17 -34.58 75.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.085 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -56.66 -54.99 39.74 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.225 0.536 . . . . 0.0 110.536 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.787 ' HB3' HG21 ' A' ' 134' ' ' THR . 45.3 tpp -69.46 -38.52 77.81 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.359 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.631 ' HA ' HD21 ' A' ' 130' ' ' LEU . . . -59.01 -51.49 69.86 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.732 0.301 . . . . 0.0 111.647 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -61.35 -35.75 78.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.201 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.419 ' HE ' ' CG ' ' A' ' 172' ' ' ASP . 0.0 OUTLIER -68.01 -46.14 72.08 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.518 0.199 . . . . 0.0 110.745 174.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.507 ' HE3' HD11 ' A' ' 173' ' ' ILE . 56.5 tptt -55.05 -54.7 39.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.821 0.343 . . . . 0.0 111.373 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.498 HD13 HD11 ' A' ' 156' ' ' ILE . 49.3 pt -64.41 -43.38 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.916 -174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.624 ' HG3' ' N ' ' A' ' 172' ' ' ASP . 11.6 ptt180 -64.06 -38.91 92.77 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 121.127 -0.229 . . . . 0.0 110.741 178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.624 ' N ' ' HG3' ' A' ' 171' ' ' ARG . 1.2 m-20 -63.85 -54.37 35.95 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 177' ' ' VAL . 59.0 mt -53.19 -43.72 50.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.362 175.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 5.3 tt -55.81 -47.17 77.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.162 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.528 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -60.45 -44.23 96.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.701 179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -62.59 -37.57 86.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.181 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.912 HG22 ' HG2' ' A' ' 118' ' ' ARG . 21.9 t -59.12 -49.41 83.43 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.192 0.52 . . . . 0.0 109.751 173.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 182' ' ' GLN . 30.4 mtpp -56.77 -37.65 71.38 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.218 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 42.7 mt-30 -65.59 -56.44 12.22 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.576 0.226 . . . . 0.0 110.836 177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.21 -34.88 74.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -71.9 -53.39 13.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.468 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 178' ' ' LYS . 2.5 tp60 -77.77 -35.51 51.53 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.806 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 25.1 mtpp -123.05 40.97 3.58 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.962 0.41 . . . . 0.0 110.715 -174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -103.38 159.15 17.13 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.451 -0.88 . . . . 0.0 113.599 -175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 52.1 tp60 -104.85 141.28 36.8 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 25.6 m -89.89 106.43 18.46 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.799 0.333 . . . . 0.0 111.231 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.56 -50.92 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 175.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -102.75 75.71 1.44 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.7 tp -67.85 117.57 9.91 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 67.29 72.54 0.34 Allowed 'General case' 0 C--O 1.233 0.189 0 O-C-N 123.876 0.735 . . . . 0.0 110.278 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.987 179.141 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.942 0 O4'-C1'-C2' 107.63 0.879 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.509 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.76 0 C3'-C2'-C1' 104.096 2.885 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.509 ' OP1' " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 P-O3'-C3' 124.402 3.919 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.865 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C4'-C3' 102.054 -2.462 OUTLIER-EPSILON 0.016 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.865 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.749 0 P-O3'-C3' 122.862 2.635 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.574 " O2'" " H5'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 O4'-C1'-C2' 107.684 0.917 . 0.306 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.574 " H5'" " O2'" ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C3'-C2'-C1' 100.289 -1.345 . 0.01 1b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 111.913 -0.475 . . . . 0.0 111.913 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.72 -75.18 0.22 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.677 0.239 . . . . 0.0 110.575 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.9 ptm 179.23 150.78 0.32 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.51 138.79 3.23 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.86 177.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -88.89 4.69 5.3 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.933 2.422 . . . . 0.0 111.908 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.9 m -86.59 32.64 0.65 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.842 -0.617 . . . . 0.0 112.08 -175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 m -68.31 -22.23 64.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.032 0.444 . . . . 0.0 110.487 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.5 m -93.47 5.17 7.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.02 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.2 t -120.17 86.98 2.66 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.021 0.439 . . . . 0.0 110.382 -177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -132.77 131.17 6.06 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.047 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.5 66.42 8.09 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.117 0.484 . . . . 0.0 110.55 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.71 131.78 48.48 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.542 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.84 -7.67 21.56 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.871 2.381 . . . . 0.0 112.429 -179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.489 ' HA ' ' HE2' ' A' ' 17' ' ' PHE . 86.0 t80 -147.23 104.08 3.63 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.218 177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 11.6 p -94.55 -71.79 0.65 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.579 174.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.3 t -168.73 81.22 0.14 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.362 -0.836 . . . . 0.0 108.76 173.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.489 ' HE2' ' HA ' ' A' ' 14' ' ' PHE . 88.2 m-85 -84.57 62.78 7.51 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.282 0.563 . . . . 0.0 110.478 -178.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 84.3 mtp -118.47 96.04 49.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.431 179.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HG2' ' HE3' ' A' ' 57' ' ' LYS . 74.5 Cg_exo -50.05 -44.2 38.67 Favored 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.009 2.472 . . . . 0.0 113.245 174.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.992 ' HA ' HG21 ' A' ' 74' ' ' THR . 33.9 Cg_exo -65.41 80.45 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.775 1.65 . . . . 0.0 112.636 173.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 9.03 39.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.894 0.854 . . . . 0.0 109.476 171.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -140.32 -170.1 2.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 113.997 -1.456 . . . . 0.0 108.962 176.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -74.19 136.03 42.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.86 0.362 . . . . 0.0 110.156 176.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 7.4 t -139.98 143.08 36.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.078 0.466 . . . . 0.0 111.373 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.0 m -106.46 145.0 14.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.343 175.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 23.8 m-70 -113.73 112.56 23.65 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.715 ' O ' ' HA ' ' A' ' 70' ' ' MET . 3.6 t -104.59 114.61 44.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.866 -0.333 . . . . 0.0 111.855 -173.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.775 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 20.0 m-85 -79.66 105.92 11.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 171.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 43.4 pt -114.69 148.96 41.5 Favored Pre-proline 0 N--CA 1.438 -1.073 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' HA ' HG11 ' A' ' 68' ' ' VAL . 88.0 Cg_exo -46.96 122.93 6.73 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.152 1.901 . . . . 0.0 110.162 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB3' ' CA ' ' A' ' 65' ' ' ASP . . . -60.94 -22.0 63.97 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.219 -175.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -69.28 -37.94 78.1 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.991 0.424 . . . . 0.0 110.021 171.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -73.12 -26.26 61.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG21 ' HB2' ' A' ' 69' ' ' ARG . 37.7 t -59.72 -42.01 87.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.327 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 174.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.91 -27.89 57.09 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.055 176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.898 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.68 -46.42 21.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.84 0.353 . . . . 0.0 111.198 177.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.455 HD13 ' HD2' ' A' ' 90' ' ' LYS . 37.5 mm -62.81 -39.77 86.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.489 0.662 . . . . 0.0 109.986 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.71 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 8.8 mm -85.28 -3.31 8.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.571 176.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -77.35 -44.12 14.15 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.721 -0.672 . . . . 0.0 113.133 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.771 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 36.5 m-20 -60.23 94.72 0.03 OUTLIER 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.78 0.29 . . . . 0.0 110.639 -177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.1 t70 68.02 -1.38 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 122.992 0.517 . . . . 0.0 111.337 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.71 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 68.14 8.63 55.03 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.307 -0.406 . . . . 0.0 112.536 -176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.465 ' HG2' ' HD3' ' A' ' 46' ' ' LYS . 24.5 mt-30 -135.12 6.87 3.37 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.581 0.229 . . . . 0.0 111.584 -177.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.771 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 19.1 t-160 -66.26 -39.27 89.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.747 0.308 . . . . 0.0 110.204 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.523 HG21 HD12 ' A' ' 38' ' ' ILE . 10.4 tp -63.86 -32.74 58.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.108 0.48 . . . . 0.0 110.523 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 43' ' ' GLN . 28.4 mtpp -74.19 -30.03 62.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.128 0.489 . . . . 0.0 109.915 178.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -69.97 -35.49 74.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.745 173.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.8 tp -53.98 -39.03 65.65 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.618 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.45 -60.56 2.88 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.21 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -78.87 -32.93 46.14 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 -175.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -62.56 -39.36 93.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.793 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.774 ' HA ' ' HD3' ' A' ' 82' ' ' LYS . . . -92.77 -7.05 47.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.768 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 65.29 43.64 3.48 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.344 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.607 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -132.23 153.34 50.71 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.066 0.46 . . . . 0.0 111.47 -176.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.7 m -82.89 126.48 32.52 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.691 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 13.8 tt -125.04 145.25 32.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.417 0.627 . . . . 0.0 112.311 -168.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.625 ' HE3' ' HG2' ' A' ' 19' ' ' PRO . 91.8 mttt -125.14 146.86 49.29 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 166.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.419 HG21 HG12 ' A' ' 45' ' ' ILE . 1.4 pt -121.64 145.11 28.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.212 177.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' A' ' 69' ' ' ARG . . . -102.77 118.91 57.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 59' ' ' ALA . 38.8 Cg_exo -61.15 138.4 77.58 Favored 'Trans proline' 0 N--CA 1.474 0.33 0 C-N-CA 123.276 2.651 . . . . 0.0 113.373 -174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 31' ' ' ALA . 36.5 Cg_endo -65.79 88.9 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.364 2.709 . . . . 0.0 111.749 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.906 ' HB3' ' HD2' ' A' ' 64' ' ' PRO . 12.8 tt0 -91.44 -47.55 7.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.769 HG22 ' HD3' ' A' ' 64' ' ' PRO . 0.6 OUTLIER 162.82 -38.13 0.0 OUTLIER Pre-proline 0 CA--C 1.546 0.805 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -154.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.906 ' HD2' ' HB3' ' A' ' 62' ' ' GLU . 31.4 Cg_exo -44.8 7.86 0.0 OUTLIER 'Trans proline' 0 C--O 1.201 -1.361 1 C-N-CA 125.737 4.292 . . . . 0.0 117.091 165.508 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.663 ' HA ' HG12 ' A' ' 68' ' ' VAL . 3.3 p30 -60.57 31.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 120.73 1.605 . . . . 0.0 115.116 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.515 ' H ' ' C ' ' A' ' 64' ' ' PRO . 33.5 t -144.43 -45.77 0.25 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 161.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 64' ' ' PRO . 39.1 mtmm -72.84 44.08 0.12 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 111.819 -2.446 . . . . 0.0 112.48 167.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 65' ' ' ASP . 27.3 m -88.7 -179.22 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-N 120.044 1.293 . . . . 0.0 113.844 -140.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' HB2' HG21 ' A' ' 34' ' ' VAL . 16.2 mmt180 -95.77 141.93 28.65 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 114.155 -1.384 . . . . 0.0 111.569 -153.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.715 ' HA ' ' O ' ' A' ' 27' ' ' VAL . 22.4 ptt? -102.58 147.63 26.54 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.717 -174.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 HG23 HG12 ' A' ' 73' ' ' ILE . 2.5 m -101.53 144.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 114.686 -1.143 . . . . 0.0 108.077 167.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 62.5 t -112.24 95.87 4.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.463 HG12 HG23 ' A' ' 71' ' ' VAL . 49.3 mm -100.44 94.55 3.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.473 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.992 HG21 ' HA ' ' A' ' 20' ' ' PRO . 43.5 m -97.59 122.84 41.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.085 176.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.34 -164.99 36.3 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.138 -1.03 . . . . 0.0 112.3 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.44 170.84 18.97 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.907 2.404 . . . . 0.0 111.678 178.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -49.4 -34.12 31.67 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.396 2.064 . . . . 0.0 112.034 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.428 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 20.9 mm-40 -53.94 -50.32 66.72 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.957 177.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.607 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -69.98 -36.05 74.88 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.238 -175.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -61.54 -48.63 80.13 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -67.28 -46.34 73.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.889 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.774 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 25.9 tttp -67.1 -54.0 25.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.541 -173.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.93 94.09 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -64.82 -44.04 91.16 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.965 0.412 . . . . 0.0 110.486 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -67.45 -32.25 78.68 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.782 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -65.27 -47.74 75.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.606 -0.297 . . . . 0.0 110.513 -178.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 32.4 pt -71.28 -35.11 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.516 -178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.41 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-85 -59.15 -49.74 76.73 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.188 0.518 . . . . 0.0 110.669 175.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -66.3 -30.37 76.58 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.137 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.642 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.1 tmtm? -65.4 -35.5 81.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.968 0.413 . . . . 0.0 109.968 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.705 HD12 ' HB ' ' A' ' 103' ' ' VAL . 28.0 mt -56.37 -42.39 77.77 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.034 0.445 . . . . 0.0 111.0 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -49.23 67.15 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.313 -179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.642 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 5.8 pt-20 -67.01 -25.69 66.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.329 -177.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.898 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 7.3 tp10 -86.93 2.79 48.16 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.317 0.58 . . . . 0.0 110.486 -176.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 65.8 t30 58.65 40.48 23.39 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.908 168.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -88.65 -10.6 47.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.774 0.797 . . . . 0.0 109.002 169.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 1.017 ' HB3' ' HA ' ' A' ' 101' ' ' GLU . 58.2 m-85 -126.94 96.05 4.51 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.243 -174.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -118.31 -79.9 0.69 Allowed Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 176.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.1 -21.84 35.99 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.583 2.189 . . . . 0.0 110.994 172.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -109.26 23.58 14.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.723 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 1.017 ' HA ' ' HB3' ' A' ' 97' ' ' PHE . 11.1 tt0 -61.4 82.93 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -172.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -154.39 110.6 3.25 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 164.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.705 ' HB ' HD12 ' A' ' 91' ' ' LEU . 24.4 m -82.22 121.68 35.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.533 0.683 . . . . 0.0 110.145 -175.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.6 mmmt -127.34 97.5 4.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.705 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 157' ' ' ILE . 50.5 mt -102.01 161.73 13.46 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.723 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.775 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 6.8 pt-20 -115.42 106.61 14.19 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.513 0.673 . . . . 0.0 110.923 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 27.4 m -89.46 108.92 19.92 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.308 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.06 121.16 36.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.034 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 21.9 pt -124.1 151.48 29.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 120.92 0.39 . . . . 0.0 110.623 176.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -87.79 119.27 27.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.582 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.555 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 21.8 m -128.96 157.52 75.49 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.555 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 36.1 Cg_endo -66.33 129.46 21.57 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.453 2.102 . . . . 0.0 111.036 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.683 ' HB1' ' HB3' ' A' ' 146' ' ' PRO . . . -63.3 -25.67 68.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.719 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -16.85 63.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.379 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.501 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -122.28 19.32 10.63 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.859 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.61 -53.46 57.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.01 0.433 . . . . 0.0 111.114 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.663 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -81.56 -5.95 89.52 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.392 -0.909 . . . . 0.0 111.579 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.469 ' CG ' HG21 ' A' ' 177' ' ' VAL . 32.8 tpt85 -83.0 -35.06 26.14 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 26.1 m -80.3 -20.34 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.902 0.382 . . . . 0.0 110.364 175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.495 HD11 HG13 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -82.7 -27.59 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 121.419 0.628 . . . . 0.0 109.388 175.324 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.972 ' HA3' ' HB3' ' A' ' 125' ' ' LYS . . . 87.69 155.02 28.02 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.705 175.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 11.5 ptpt -62.16 118.99 8.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.71 0.29 . . . . 0.0 111.217 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 74.88 24.21 72.67 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.861 176.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.07 60.29 3.15 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.55 -0.834 . . . . 0.0 112.19 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.972 ' HB3' ' HA3' ' A' ' 121' ' ' GLY . 21.1 tptt -68.87 -53.77 19.4 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 122.508 0.323 . . . . 0.0 111.217 -178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 120' ' ' ILE . 5.6 p -71.93 -39.03 69.73 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -173.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.495 HG13 HD11 ' A' ' 120' ' ' ILE . 4.0 m -61.8 -43.01 96.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.558 -0.457 . . . . 0.0 111.05 178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -68.05 -49.52 60.85 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.066 0.46 . . . . 0.0 110.712 -178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.12 -49.87 53.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.659 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.466 HD13 ' CB ' ' A' ' 166' ' ' ALA . 93.4 mt -77.62 -26.91 50.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -169.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -81.33 -47.62 13.05 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.362 -0.535 . . . . 0.0 110.584 179.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.27 -36.79 79.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.739 -176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 57.9 tp -98.4 -43.97 6.71 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.844 HG22 ' HA ' ' A' ' 162' ' ' ALA . 4.8 m -103.37 -17.02 15.45 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -171.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 69.55 44.37 0.91 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.491 0.716 . . . . 0.0 111.474 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.527 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -119.12 130.84 55.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.233 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 2.2 tp10 -88.55 129.38 35.49 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.46 HG21 HD12 ' A' ' 130' ' ' LEU . 49.9 t -120.16 109.39 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.2 t -121.29 123.52 69.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.427 -0.509 . . . . 0.0 112.012 -174.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG13 HG12 ' A' ' 154' ' ' VAL . 38.2 t -121.51 123.49 27.56 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.52 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 144' ' ' GLN . 18.0 Cg_exo -64.75 120.59 7.89 Favored 'Trans proline' 0 C--O 1.237 0.429 0 C-N-CA 122.613 2.208 . . . . 0.0 112.155 -176.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.705 ' HG3' ' H21' ' B' ' 4' ' ' ' G' . 63.9 ttt180 -74.48 102.8 4.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.826 -177.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 56.68 42.41 26.95 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.417 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.433 ' HB2' ' HB2' ' A' ' 141' ' ' PRO . 27.7 tp60 -62.88 -74.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.127 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.493 ' N ' ' CD ' ' A' ' 146' ' ' PRO . 9.8 t -151.3 39.75 0.18 Allowed Pre-proline 0 CA--C 1.552 1.043 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.683 ' HB3' ' HB1' ' A' ' 113' ' ' ALA . 20.7 Cg_endo -68.92 125.39 12.52 Favored 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 120.997 1.131 . . . . 0.0 112.295 169.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.535 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -164.58 -106.61 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.38 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.535 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 10.6 pt-20 -59.72 -46.24 89.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.532 ' HB3' HE21 ' A' ' 151' ' ' GLN . 15.2 m-80 -84.96 -2.04 57.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.705 -0.225 . . . . 0.0 111.376 -176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 44.04 35.62 1.22 Allowed 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.379 1.071 . . . . 0.0 113.11 177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.532 HE21 ' HB3' ' A' ' 149' ' ' ASN . 25.9 pt20 -136.42 145.23 45.04 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.13 0.491 . . . . 0.0 111.307 -177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.571 HG13 ' HB2' ' A' ' 113' ' ' ALA . 16.4 m -134.46 175.02 12.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.959 178.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.477 HG22 ' HE3' ' A' ' 155' ' ' LYS . 28.9 mm -107.65 117.6 53.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.031 178.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.498 HG12 HG13 ' A' ' 140' ' ' VAL . 16.8 m -106.42 138.78 30.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 171.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 107' ' ' THR . 0.6 OUTLIER -132.57 144.11 50.17 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 120.215 -0.594 . . . . 0.0 111.625 -170.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 54.2 mt -117.3 123.77 72.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.454 -178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.699 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 2.0 mp -114.49 114.21 45.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 123.525 0.516 . . . . 0.0 109.875 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -178.1 -149.64 8.15 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.332 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -98.56 -177.52 3.71 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -64.05 -49.8 70.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.96 0.345 . . . . 0.0 111.74 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -71.82 -30.79 65.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.965 0.412 . . . . 0.0 110.158 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.844 ' HA ' HG22 ' A' ' 134' ' ' THR . . . -63.27 -53.63 49.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.851 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.449 ' HA ' HG21 ' A' ' 156' ' ' ILE . 49.8 m -62.69 -47.28 84.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.933 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -56.47 -51.98 66.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.819 0.342 . . . . 0.0 111.41 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 49.3 ttm -60.03 -42.14 93.76 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.082 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.528 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -63.87 -47.18 81.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.675 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -57.09 -39.01 74.18 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.899 0.38 . . . . 0.0 110.64 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -62.41 -42.8 99.71 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.588 176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -61.71 -42.8 99.44 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 121.252 -0.179 . . . . 0.0 111.409 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.421 ' O ' ' HB2' ' A' ' 174' ' ' LEU . 89.2 mt -58.58 -54.68 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.018 -179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 12.0 ptm85 -65.72 -32.13 73.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.267 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -60.56 -56.05 26.0 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.611 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 mt -59.68 -48.72 86.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.509 176.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.486 HD11 ' HD2' ' A' ' 112' ' ' PRO . 1.4 tt -55.11 -50.82 68.26 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.444 -176.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.28 -44.33 88.41 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.898 0.38 . . . . 0.0 110.781 -177.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -65.86 -33.48 75.94 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.568 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 173' ' ' ILE . 58.0 t -67.48 -39.75 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.413 0.149 . . . . 0.0 111.125 173.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.422 ' HE3' HD22 ' A' ' 174' ' ' LEU . 95.4 mttt -57.05 -52.49 65.06 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 173.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 50.2 mt-30 -53.76 -52.39 60.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.157 176.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.425 ' HA ' ' HA2' ' A' ' 184' ' ' GLY . 36.1 tt0 -47.99 -51.01 25.55 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 123.944 0.898 . . . . 0.0 111.988 177.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -69.59 -40.85 76.44 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -178.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 178' ' ' LYS . 53.2 mt-30 -71.6 -38.6 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.66 0.267 . . . . 0.0 111.479 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -161.59 -52.77 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.227 0.537 . . . . 0.0 110.956 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 180' ' ' GLN . . . 138.81 -155.94 24.0 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.427 ' C ' ' H ' ' A' ' 187' ' ' GLY . 13.7 mm100 -86.09 87.65 7.46 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 178.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 29.8 t 73.79 -26.59 0.19 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.574 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 185' ' ' GLN . . . 126.56 -48.8 0.95 Allowed Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 110.774 -0.93 . . . . 0.0 110.774 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -153.5 102.23 2.56 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 173.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 44.4 tp -84.19 79.19 9.61 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.125 0.488 . . . . 0.0 110.844 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -72.54 118.49 15.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.45 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.52 0 CA-C-O 121.116 0.484 . . . . 0.0 111.369 -179.146 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.435 ' O2 ' " O4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-N19 110.114 1.914 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.51 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C5'-C4'-O4' 106.772 -1.735 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.888 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -1.017 1 P-O3'-C3' 124.575 4.062 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.911 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.427 -0.82 0 O4'-C1'-C2' 108.2 1.286 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.911 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.72 0 P-O3'-C3' 123.938 3.532 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.485 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.875 0 O4'-C1'-C2' 107.953 1.109 . 0.345 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.685 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.428 -0.769 0 N19-C1'-C2' 114.852 0.908 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.319 -0.313 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.83 76.18 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.246 0.545 . . . . 0.0 111.549 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.2 tpt -146.14 -37.6 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.761 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -62.59 -66.13 2.76 Favored Glycine 0 CA--C 1.522 0.479 0 CA-C-N 116.046 -0.525 . . . . 0.0 113.661 -175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 3.89 5.99 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.482 2.121 . . . . 0.0 113.189 -178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.1 p 40.13 48.72 2.27 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.526 0.73 . . . . 0.0 112.856 173.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m -86.75 -19.8 28.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 62.9 t 68.22 -73.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.304 -178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.8 p -90.14 -67.56 0.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.881 0.372 . . . . 0.0 110.74 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 176.52 124.96 0.86 Allowed Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.629 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.87 -0.56 2.55 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 122.735 -0.274 . . . . 0.0 111.609 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 65.1 90.77 0.08 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 O-C-N 123.925 0.766 . . . . 0.0 110.904 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -68.45 80.2 0.59 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.131 2.554 . . . . 0.0 112.601 -177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -93.34 4.58 53.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.311 0.577 . . . . 0.0 110.242 176.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.7 m -80.33 53.68 1.84 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.796 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 23.0 t -96.07 71.7 2.89 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.394 0.616 . . . . 0.0 109.693 178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.509 ' HB3' HG22 ' A' ' 56' ' ' ILE . 83.8 m-85 -99.8 36.33 1.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.909 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.643 ' HB3' ' HA ' ' A' ' 55' ' ' SER . 16.9 tpt 63.58 89.08 0.11 Allowed Pre-proline 0 N--CA 1.465 0.311 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.019 -175.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 18' ' ' MET . 9.9 Cg_endo -50.75 112.21 0.71 Allowed 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.632 2.888 . . . . 0.0 113.052 -175.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.664 ' HB2' HG21 ' A' ' 74' ' ' THR . 84.1 Cg_endo -92.58 132.98 1.09 Allowed 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.285 2.657 . . . . 0.0 113.386 -178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.454 ' OE1' ' HG3' ' A' ' 22' ' ' GLN . 0.4 OUTLIER -133.69 12.67 4.06 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.165 0.507 . . . . 0.0 110.38 172.652 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HG3' ' OE1' ' A' ' 21' ' ' GLU . 44.8 mt-30 -121.17 -156.39 0.68 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.894 -170.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.05 127.68 32.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.317 -176.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 74' ' ' THR . 26.6 m -120.67 113.79 20.74 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.166 -174.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 73' ' ' ILE . 35.1 m -110.34 140.49 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-O 121.457 0.646 . . . . 0.0 110.522 174.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 108' ' ' HIS . 44.2 m-70 -122.82 113.24 18.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.361 173.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.651 HG13 HG22 ' A' ' 71' ' ' VAL . 1.3 p -120.07 136.39 57.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.221 0.534 . . . . 0.0 110.598 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -96.87 122.71 40.13 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.196 -173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.74 HG13 HG22 ' A' ' 34' ' ' VAL . 32.3 pt -101.8 143.7 27.12 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.309 173.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.583 ' O ' HG23 ' A' ' 34' ' ' VAL . 22.0 Cg_exo -64.5 144.65 85.73 Favored 'Trans proline' 0 N--CA 1.463 -0.277 0 C-N-CA 122.741 2.294 . . . . 0.0 110.796 -178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.21 -26.18 37.73 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.383 0.427 . . . . 0.0 111.244 -177.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -65.91 -37.89 87.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.412 ' O ' HG12 ' A' ' 37' ' ' ILE . . . -87.07 -27.56 23.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.493 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.902 HG21 ' HD3' ' A' ' 69' ' ' ARG . 13.2 t -59.1 -41.32 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.184 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -31.04 63.32 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.58 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.15 -42.66 31.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.872 0.336 . . . . 0.0 110.887 178.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 33' ' ' ALA . 41.3 mm -60.97 -47.66 92.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.616 0.722 . . . . 0.0 109.904 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.682 ' O ' ' HA2' ' A' ' 42' ' ' GLY . 4.4 mm -86.1 2.38 4.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.969 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -75.4 -41.27 30.92 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.565 -0.743 . . . . 0.0 112.301 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.779 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 32.2 m-20 -63.15 100.59 0.23 Allowed 'General case' 0 C--O 1.238 0.48 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 66.45 -5.32 0.61 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.235 0.614 . . . . 0.0 112.551 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.682 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 59.47 21.81 55.07 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -169.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -139.11 -9.75 1.3 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.313 -0.444 . . . . 0.0 110.375 -172.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.779 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 9.7 t-160 -58.96 -43.85 91.4 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.232 -175.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.643 ' O ' HD11 ' A' ' 56' ' ' ILE . 9.2 tp -58.13 -41.02 79.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.419 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -64.16 -48.07 77.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.23 177.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -57.65 -29.61 64.74 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.855 ' HG ' ' HD2' ' A' ' 57' ' ' LYS . 4.6 tp -51.73 -27.38 11.8 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.283 -178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.898 ' HB2' HD13 ' A' ' 56' ' ' ILE . 22.4 t -58.9 -62.83 1.59 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.611 0.243 . . . . 0.0 110.992 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -74.87 -33.22 62.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.526 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.06 -44.62 64.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.84 -176.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -108.57 11.7 26.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.923 0.392 . . . . 0.0 111.331 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.1 m 53.64 55.98 7.84 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.318 -0.856 . . . . 0.0 111.008 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.631 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -141.2 169.11 18.24 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.492 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.909 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 19.9 m -79.81 145.81 32.6 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.012 HD12 ' HE3' ' A' ' 57' ' ' LYS . 8.5 tp -85.02 156.85 3.51 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.429 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -156.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.012 ' HE3' HD12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -95.53 -160.51 0.79 Allowed 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 130.752 3.621 . . . . 0.0 110.998 -170.191 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.929 HG22 ' HA ' ' A' ' 71' ' ' VAL . 2.8 pt -58.59 152.33 3.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 128.333 2.653 . . . . 0.0 117.364 -127.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.11 151.65 37.71 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 111.002 -2.817 . . . . 0.0 110.062 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.63 151.79 73.51 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 123.086 2.524 . . . . 0.0 112.397 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.64 96.4 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.28 2.653 . . . . 0.0 112.566 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -102.19 -51.24 3.42 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.038 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 41.4 p -84.15 174.61 5.63 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.514 -173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 33.8 Cg_exo -62.29 -3.19 3.8 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 123.252 2.635 . . . . 0.0 112.967 177.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -77.93 31.75 0.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.824 0.45 . . . . 0.0 110.306 177.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 64' ' ' PRO . 13.8 t -69.2 4.34 1.7 Allowed 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.02 -0.536 . . . . 0.0 112.226 -172.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -76.25 -30.73 58.0 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.343 0.592 . . . . 0.0 110.001 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.58 HG12 ' HA ' ' A' ' 30' ' ' PRO . 20.4 m -135.93 177.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.518 -176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.902 ' HD3' HG21 ' A' ' 34' ' ' VAL . 6.8 mpt_? -126.98 138.42 53.26 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 172.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 23.1 ptp -85.22 119.73 25.92 Favored 'General case' 0 C--O 1.248 0.985 0 C-N-CA 121.147 -0.221 . . . . 0.0 110.87 -176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.929 ' HA ' HG22 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -95.11 137.81 22.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.625 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.787 ' HB ' ' O ' ' A' ' 56' ' ' ILE . 11.6 t -110.99 110.21 31.33 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.98 -174.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.638 ' CD1' ' HD3' ' A' ' 57' ' ' LYS . 42.4 mm -117.61 105.02 17.24 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 O-C-N 123.348 0.405 . . . . 0.0 110.118 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.909 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 18.9 m -120.8 137.36 54.57 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.384 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 152.12 -154.73 25.71 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.059 -0.591 . . . . 0.0 111.68 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_exo -72.35 159.08 50.28 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.617 2.211 . . . . 0.0 111.131 176.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_exo -54.13 -22.16 24.56 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.745 2.297 . . . . 0.0 112.259 175.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -63.32 -41.67 98.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.617 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -78.27 -34.91 48.66 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.708 -176.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.622 ' O ' ' HB3' ' A' ' 84' ' ' GLN . 1.5 mp0 -64.43 -35.47 81.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.154 0.502 . . . . 0.0 109.718 171.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -64.27 -52.79 56.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.318 177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.61 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 62.7 mttp -72.73 -53.67 11.02 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.03 -175.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.04 -48.64 57.11 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -175.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.622 ' HB3' ' O ' ' A' ' 80' ' ' GLN . 48.6 tt0 -70.48 -33.28 71.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.118 0.485 . . . . 0.0 109.699 -178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.38 -31.47 68.55 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.759 173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -65.78 -46.2 79.61 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 122.475 0.31 . . . . 0.0 110.767 -177.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.449 ' O ' HD22 ' A' ' 91' ' ' LEU . 25.7 pt -64.51 -34.73 71.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.643 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.491 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 6.5 m-85 -63.48 -39.13 93.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.077 175.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -69.21 -31.67 72.01 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.669 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.76 ' O ' ' HG3' ' A' ' 94' ' ' GLU . 3.7 tmtm? -64.24 -49.24 72.7 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 176.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.818 ' HA ' ' OE2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -50.51 -25.57 4.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 173.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.704 ' HD2' ' HA2' ' A' ' 98' ' ' GLY . 39.2 tptt -76.17 -43.95 40.33 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.458 -0.776 . . . . 0.0 110.635 174.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.622 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 10.1 pt-20 -73.62 -34.75 65.15 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -174.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.818 ' OE2' ' HA ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -77.59 2.52 16.25 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.573 0.583 . . . . 0.0 112.573 -172.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 72.58 10.43 5.65 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.071 171.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.677 ' HD2' ' OE2' ' A' ' 94' ' ' GLU . 43.4 m-85 -77.35 -46.41 22.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 175.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.714 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -130.46 60.97 1.61 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 170.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.704 ' HA2' ' HD2' ' A' ' 92' ' ' LYS . . . -103.1 -86.95 1.98 Allowed Glycine 0 N--CA 1.44 -1.041 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.041 -175.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -66.5 -37.58 22.25 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.868 2.378 . . . . 0.0 113.1 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -101.72 -26.43 13.49 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -166.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -137.66 155.25 49.34 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.346 -166.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.41 137.01 32.9 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.69 174.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.714 HG12 ' HB2' ' A' ' 97' ' ' PHE . 10.3 m -73.83 131.46 34.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.018 0.437 . . . . 0.0 110.749 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -129.63 110.28 11.68 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.401 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.561 HD11 HD21 ' A' ' 91' ' ' LEU . 49.3 mt -115.19 162.14 17.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.142 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -106.54 105.12 15.0 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.538 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 8.9 m -90.26 129.35 36.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.627 0.251 . . . . 0.0 110.988 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 26' ' ' HIS . 18.4 m170 -114.08 121.66 44.5 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.023 178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.527 ' CG2' HG12 ' A' ' 25' ' ' VAL . 4.8 pt -122.47 141.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.348 171.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.529 ' HD3' HD11 ' A' ' 153' ' ' ILE . 18.8 mmm180 -83.54 119.13 24.32 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.285 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 28.7 m -131.57 160.97 64.99 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.287 -0.415 . . . . 0.0 109.949 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.534 ' HD2' ' HB ' ' A' ' 111' ' ' VAL . 58.1 Cg_endo -73.6 140.76 30.1 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.388 2.059 . . . . 0.0 111.909 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.601 ' CB ' ' HB3' ' A' ' 146' ' ' PRO . . . -58.95 -32.54 69.71 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.439 -178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.3 t -61.05 -28.76 69.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.484 178.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.48 -16.23 20.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.862 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.691 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -58.11 -28.07 64.3 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.824 0.345 . . . . 0.0 111.402 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.541 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -78.83 -35.15 32.27 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.738 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HD3' HG22 ' A' ' 177' ' ' VAL . 55.8 ttt180 -94.12 -15.51 24.64 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.536 0.668 . . . . 0.0 111.606 -178.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 116' ' ' ALA . 9.8 p -62.49 -22.91 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 121.701 0.763 . . . . 0.0 109.718 177.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.843 HG12 ' HA2' ' A' ' 124' ' ' GLY . 12.8 tt -92.48 2.8 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.073 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 80.57 -155.83 38.03 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.716 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.411 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 37.1 ttmt -85.91 63.07 7.83 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.431 0.634 . . . . 0.0 110.379 -179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.16 29.78 8.74 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.813 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.843 ' HA2' HG12 ' A' ' 120' ' ' ILE . . . 110.34 2.13 29.52 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.034 -1.079 . . . . 0.0 113.251 176.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -54.57 -44.83 73.3 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 48.7 p -65.92 -35.33 80.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.563 0.221 . . . . 0.0 111.105 -176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG22 ' HB ' ' A' ' 138' ' ' VAL . 39.3 t -61.83 -47.1 94.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -63.43 -47.05 83.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -59.11 -49.82 76.42 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 94.5 mt -76.48 -36.62 57.75 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.74 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.408 HE21 ' HG3' ' A' ' 137' ' ' GLU . 35.5 tt0 -71.9 -49.79 34.82 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.949 -178.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -68.53 -40.54 80.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.628 -173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 44.5 tp -97.62 -49.03 5.02 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.841 -175.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.526 HG22 ' HA ' ' A' ' 162' ' ' ALA . 20.2 m -91.24 -15.2 29.6 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.9 -173.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.67 29.85 3.17 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.453 0.701 . . . . 0.0 111.197 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -109.8 110.39 21.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.343 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.59 ' HB3' ' HB ' ' A' ' 157' ' ' ILE . 31.6 tt0 -88.38 111.86 22.24 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.097 -177.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.457 ' HB ' HG22 ' A' ' 127' ' ' VAL . 91.7 t -101.1 129.94 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.858 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 59.9 t -133.11 137.31 53.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.017 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.938 HG12 ' HD2' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -104.69 148.66 36.42 Favored Pre-proline 0 CA--C 1.535 0.399 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.091 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.938 ' HD2' HG12 ' A' ' 140' ' ' VAL . 27.0 Cg_endo -63.02 -65.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 121.577 1.518 . . . . 0.0 111.532 -174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -140.15 159.78 41.42 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 171.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.877 ' HB2' ' N3 ' ' B' ' 4' ' ' ' G' . 5.4 p-10 -63.95 90.7 0.06 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.832 0.825 . . . . 0.0 111.696 -173.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 57.74 62.71 2.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.871 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.504 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 0.6 OUTLIER -113.13 114.96 48.27 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 168.276 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.706 ' HB2' ' HA ' ' A' ' 150' ' ' GLU . 21.5 Cg_endo -93.88 153.93 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.739 2.959 . . . . 0.0 114.202 -173.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -79.5 -169.69 2.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.357 166.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 149' ' ' ASN . 9.0 pt-20 -51.45 -46.26 62.99 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.915 0.388 . . . . 0.0 112.03 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.471 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 5.0 m-80 -97.53 25.19 5.92 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.317 -178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 146' ' ' PRO . 7.6 pt-20 58.7 38.78 24.92 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.386 1.074 . . . . 0.0 110.869 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -97.17 139.08 33.69 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.139 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.691 HG21 ' HB2' ' A' ' 116' ' ' ALA . 18.0 m -136.02 171.87 16.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.002 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.769 ' O ' ' HD3' ' A' ' 141' ' ' PRO . 23.8 mm -116.52 125.6 73.59 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.539 178.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.11 138.13 37.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.613 171.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.542 ' HE2' HG22 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -108.6 139.46 43.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.643 -169.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.557 HD11 HD12 ' A' ' 170' ' ' ILE . 62.4 mt -125.29 118.4 52.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.415 176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 137' ' ' GLU . 5.4 mm -109.87 112.65 41.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.397 178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 177.32 -156.36 19.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 119.498 -1.334 . . . . 0.0 113.296 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.442 ' CD2' HG22 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -92.53 179.98 5.36 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -66.81 -47.56 71.67 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.097 0.408 . . . . 0.0 111.707 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -60.91 -47.25 87.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.166 0.508 . . . . 0.0 109.939 179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -56.41 -50.29 72.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.538 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 50.1 m -59.46 -49.22 78.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.192 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 -56.64 -55.17 37.34 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 120.916 0.389 . . . . 0.0 111.451 -179.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 22.7 mmt -55.14 -44.81 75.44 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.175 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.4 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -61.8 -51.08 69.75 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.06 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.412 ' HG3' HD12 ' A' ' 156' ' ' ILE . 42.9 mt-30 -56.74 -44.26 81.5 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.012 0.434 . . . . 0.0 111.127 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.526 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 71.8 mtt180 -70.4 -33.14 71.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.955 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.07 -43.93 90.59 Favored 'General case' 0 C--N 1.329 -0.283 0 O-C-N 121.628 -0.67 . . . . 0.0 110.584 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.557 HD12 HD11 ' A' ' 156' ' ' ILE . 71.6 mt -54.88 -54.08 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.178 178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' A' ' 168' ' ' ARG . 29.0 ptt180 -59.6 -35.39 74.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.173 -178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 7.6 m-20 -68.73 -56.12 9.12 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.766 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.583 ' O ' HG23 ' A' ' 177' ' ' VAL . 42.3 mt -56.27 -43.74 77.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.835 0.35 . . . . 0.0 110.238 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 3.8 tt -53.66 -55.17 28.34 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.343 177.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.83 -44.05 86.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.01 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 62.3 mt-30 -62.3 -33.2 74.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.602 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 173' ' ' ILE . 90.5 t -62.66 -52.06 64.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-O 120.864 0.364 . . . . 0.0 110.386 174.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 45.2 mtpt -59.26 -41.22 88.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.792 178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.71 -46.83 88.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.037 176.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -57.53 -46.77 83.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.2 0.524 . . . . 0.0 110.532 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -62.46 -32.71 73.63 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.072 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -81.25 -50.45 9.54 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -88.29 107.1 18.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.421 -175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -155.58 -94.61 0.1 Allowed Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.398 -0.906 . . . . 0.0 112.654 178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -130.86 118.0 20.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.922 0.391 . . . . 0.0 111.253 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 44.2 t -98.44 -51.3 4.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 172.02 167.15 31.74 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.163 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -118.92 106.3 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.853 0.358 . . . . 0.0 110.143 -177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -105.51 89.08 3.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.045 0.45 . . . . 0.0 109.844 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -130.83 38.62 3.68 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.074 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.614 -178.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.667 ' O2 ' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.691 1.991 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.596 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C3'-C2'-C1' 103.373 2.081 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.913 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.982 1 P-O3'-C3' 124.539 4.033 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.913 ' N7 ' " H1'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.678 0 O4'-C4'-C3' 103.142 -1.684 OUTLIER-EPSILON 0.013 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.904 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 P-O3'-C3' 123.542 3.202 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.49 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 O4'-C1'-C2' 107.538 0.813 . 0.51 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.744 0 C3'-C2'-C1' 100.612 -0.986 . 0.0 OUTLIER '7D dist 5z' 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.25 57.6 1.74 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.988 0.423 . . . . 0.0 109.966 178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 24.5 mmt 59.11 60.92 2.24 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.466 -176.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -110.95 169.73 13.48 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.31 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.93 -28.3 35.92 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.036 2.491 . . . . 0.0 112.075 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.8 p -85.01 56.37 3.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.383 0.611 . . . . 0.0 110.305 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.0 p -72.39 97.63 2.09 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.489 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.9 t -81.94 78.99 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.701 0.762 . . . . 0.0 109.232 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.7 m -88.82 88.36 7.57 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.402 -175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.7 128.29 3.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.979 176.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.48 104.53 11.08 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . 58.7 84.77 0.2 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.282 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.76 -20.81 22.33 Favored 'Trans proline' 0 C--O 1.234 0.3 0 C-N-CA 122.856 2.371 . . . . 0.0 112.537 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 63.68 37.08 10.31 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.988 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.9 p -89.57 74.52 7.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.269 0.557 . . . . 0.0 110.999 -178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.7 m -93.18 161.28 14.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.879 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -84.32 48.98 1.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.433 0.635 . . . . 0.0 110.623 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 27.1 ttt -175.47 108.93 0.26 Allowed Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.765 178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.409 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 3.2 Cg_exo -81.36 108.28 1.95 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.296 2.664 . . . . 0.0 112.231 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 4.3 Cg_exo -80.19 133.01 9.62 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 123.13 2.553 . . . . 0.0 112.032 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' O ' HG23 ' A' ' 74' ' ' THR . 1.0 OUTLIER -92.52 37.02 1.0 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 -179.13 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 46.33 -123.45 1.27 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.825 179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -96.07 123.56 39.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 73.6 m -138.85 128.06 24.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.066 0.46 . . . . 0.0 111.372 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.861 HG12 HG22 ' A' ' 109' ' ' ILE . 17.0 m -106.67 159.23 6.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.429 176.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.628 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 48.4 m170 -124.34 111.99 16.45 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 171.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.721 HG12 HG22 ' A' ' 71' ' ' VAL . 8.2 p -122.39 136.8 58.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.932 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' HB3' ' A' ' 70' ' ' MET . 40.4 m-85 -102.67 123.8 47.04 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.34 -0.846 . . . . 0.0 111.585 -171.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.559 HG12 ' HB3' ' A' ' 69' ' ' ARG . 8.5 pt -98.67 157.24 34.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.146 -0.934 . . . . 0.0 108.912 174.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.544 ' HG2' ' CZ ' ' A' ' 97' ' ' PHE . 46.7 Cg_exo -57.38 136.76 78.05 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.188 1.925 . . . . 0.0 111.22 174.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -61.65 -12.47 16.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.882 -177.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -76.98 -25.81 53.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.055 0.455 . . . . 0.0 111.155 177.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.532 ' HB3' HD12 ' A' ' 29' ' ' ILE . . . -85.67 -14.48 45.38 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -170.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' CG1' ' HD3' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -64.7 -24.97 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 120.387 -0.525 . . . . 0.0 111.064 177.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.24 -41.74 98.41 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.84 174.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.52 37.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.048 0.451 . . . . 0.0 111.834 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.604 HG21 HH12 ' A' ' 69' ' ' ARG . 42.7 mm -79.28 -51.04 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.792 -176.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.832 HD11 HH11 ' A' ' 69' ' ' ARG . 14.6 mm -86.24 -30.91 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.747 -172.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.27 -44.73 94.87 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.135 -0.555 . . . . 0.0 114.103 -168.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.967 ' HB2' ' HB2' ' A' ' 44' ' ' HIS . 5.4 m-20 -60.95 92.9 0.03 OUTLIER 'General case' 0 C--O 1.236 0.381 0 CA-C-N 117.108 0.454 . . . . 0.0 111.508 -175.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.08 5.35 2.39 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.973 175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 63.02 17.65 59.08 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.833 -172.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -119.79 -21.29 7.28 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.921 0.391 . . . . 0.0 110.59 -176.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.967 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 21.0 t-160 -57.67 -26.08 61.16 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.33 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.51 ' HB ' HD13 ' A' ' 38' ' ' ILE . 4.1 tp -67.53 -37.75 79.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.371 177.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -68.0 -18.85 64.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.387 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -58.07 -37.42 74.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.117 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -51.01 71.66 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.54 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.557 ' HB3' HG22 ' A' ' 56' ' ' ILE . 67.5 p -61.3 -47.43 86.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.656 -176.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -72.67 -38.05 67.72 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.053 -171.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -67.64 -35.02 78.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.419 ' HA ' ' HD2' ' A' ' 82' ' ' LYS . . . -88.24 -5.26 58.48 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.73 -177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.4 t 67.41 37.98 3.34 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.507 0.67 . . . . 0.0 110.394 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.809 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -130.64 173.11 11.21 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.754 -174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 19.9 m -108.36 126.82 53.29 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 171.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.557 HG22 ' HB3' ' A' ' 49' ' ' SER . 17.1 tt -117.58 135.02 59.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.32 0.581 . . . . 0.0 111.649 -173.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -123.88 144.98 49.43 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 171.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.648 ' HB ' ' HD2' ' A' ' 69' ' ' ARG . 36.2 pt -122.86 144.33 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.513 -178.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.507 ' CB ' ' HG2' ' A' ' 70' ' ' MET . . . -102.59 103.33 31.48 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.643 176.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HB2' ' HD2' ' A' ' 61' ' ' PRO . 57.3 Cg_endo -92.89 -165.71 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.385 2.723 . . . . 0.0 111.156 176.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.688 ' HA ' ' HB3' ' A' ' 66' ' ' SER . 81.8 Cg_exo -49.56 -16.54 1.38 Allowed 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.349 2.033 . . . . 0.0 112.798 171.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 28.2 tt0 -51.06 -37.15 43.79 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.414 0.686 . . . . 0.0 111.107 171.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 47.4 p -96.54 161.04 28.09 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.995 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -72.61 -9.44 23.98 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 123.033 2.489 . . . . 0.0 111.468 174.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -94.73 31.23 1.85 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.379 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.688 ' HB3' ' HA ' ' A' ' 61' ' ' PRO . 13.2 p -69.23 4.59 1.59 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -172.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -72.79 -23.7 60.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 0.0 110.384 172.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.416 HG23 ' HD2' ' A' ' 28' ' ' PHE . 2.8 m -149.58 179.92 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.39 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.832 HH11 HD11 ' A' ' 38' ' ' ILE . 45.0 ttp180 -120.98 109.7 15.39 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.478 -0.489 . . . . 0.0 111.311 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.61 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 22.1 ptp -77.97 125.83 29.93 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 172.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.721 HG22 HG12 ' A' ' 27' ' ' VAL . 3.9 m -97.08 135.92 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 173.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.517 ' HB ' ' HB2' ' A' ' 57' ' ' LYS . 40.6 t -100.33 100.01 9.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.157 176.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 ' O ' ' HA ' ' A' ' 24' ' ' THR . 48.2 mm -102.12 104.26 16.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.656 -178.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.493 HG23 ' O ' ' A' ' 21' ' ' GLU . 96.5 m -98.55 117.99 34.23 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.895 175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 170.74 174.72 38.89 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.664 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.428 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . 72.6 Cg_endo -76.27 -179.68 5.51 Favored 'Trans proline' 0 CA--C 1.533 0.436 0 C-N-CA 123.102 2.534 . . . . 0.0 111.897 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.428 ' HD2' ' HB2' ' A' ' 76' ' ' PRO . 1.3 Cg_endo -44.43 -36.73 9.94 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 123.136 2.557 . . . . 0.0 112.781 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.452 ' O ' ' HB2' ' A' ' 82' ' ' LYS . 61.3 mm-40 -51.48 -50.49 59.76 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.398 0.618 . . . . 0.0 111.207 176.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.809 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.29 -39.33 59.76 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.691 -175.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.408 ' OE1' ' HA ' ' A' ' 80' ' ' GLN . 12.0 mm-40 -62.83 -42.84 99.9 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.532 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -73.3 -49.76 25.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.621 0.248 . . . . 0.0 110.983 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 78' ' ' GLU . 11.4 mtmm -62.73 -51.3 67.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.859 -176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.519 ' O ' HG13 ' A' ' 87' ' ' ILE . . . -60.86 -50.96 71.32 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 121.124 -0.23 . . . . 0.0 111.201 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -61.16 -40.75 95.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.028 0.442 . . . . 0.0 110.655 -177.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -70.24 -37.47 71.47 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.802 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.558 ' NE ' ' HA ' ' A' ' 86' ' ' ARG . 0.6 OUTLIER -68.77 -47.54 65.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -177.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.632 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 61.5 mt -56.18 -48.56 79.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.303 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.522 ' CE1' ' HG ' ' A' ' 105' ' ' LEU . 4.8 m-85 -58.89 -41.96 88.4 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.236 0.541 . . . . 0.0 110.285 177.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -64.64 -36.33 93.02 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.155 -0.93 . . . . 0.0 112.589 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 9.8 mmmm -58.58 -44.76 89.91 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.793 HD11 HD21 ' A' ' 105' ' ' LEU . 12.4 mt -59.11 -39.68 83.02 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.073 -174.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.797 ' HD3' ' HA2' ' A' ' 98' ' ' GLY . 13.2 tppt? -70.42 -41.25 73.17 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.284 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.7 pt-20 -80.47 -31.21 37.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.656 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 90' ' ' LYS . 70.4 mm-40 -68.3 -16.21 63.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.185 0.517 . . . . 0.0 110.201 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 64.8 t30 65.14 23.7 12.36 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.568 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.411 ' HB3' ' CD1' ' A' ' 97' ' ' PHE . 33.8 m-85 -64.44 -52.43 58.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.708 ' CE2' ' HB3' ' A' ' 91' ' ' LEU . 0.3 OUTLIER -146.59 84.65 1.62 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.541 -1.208 . . . . 0.0 109.235 177.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.797 ' HA2' ' HD3' ' A' ' 92' ' ' LYS . . . -102.12 -91.38 2.15 Favored Glycine 0 N--CA 1.44 -1.079 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.605 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 98' ' ' GLY . 18.0 Cg_exo -70.17 -37.25 8.43 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.821 2.348 . . . . 0.0 112.086 176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -76.44 -25.37 54.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.612 -170.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.22 143.17 23.06 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -80.56 140.77 35.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.702 HG12 ' CD2' ' A' ' 97' ' ' PHE . 16.5 m -72.94 123.05 26.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.157 0.504 . . . . 0.0 109.777 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.415 ' HE2' HG22 ' A' ' 157' ' ' ILE . 14.0 mmmm -124.89 117.18 23.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.889 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.793 HD21 HD11 ' A' ' 91' ' ' LEU . 29.0 mt -118.43 132.5 56.24 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 173.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.441 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 10.6 pt-20 -84.07 108.26 16.9 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.108 0.48 . . . . 0.0 110.097 176.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 5.1 m -90.41 112.86 24.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.937 -176.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.3 m170 -101.67 120.56 40.53 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.861 HG22 HG12 ' A' ' 25' ' ' VAL . 33.6 pt -118.05 155.53 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.238 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -93.44 118.55 31.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.126 -176.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.547 ' HB ' ' HD2' ' A' ' 112' ' ' PRO . 26.0 m -135.0 161.27 64.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.552 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.8 Cg_endo -74.76 141.7 27.72 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.286 1.99 . . . . 0.0 111.572 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.406 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -61.74 -35.45 78.1 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.637 -174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 t -68.33 -30.0 68.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.484 0.659 . . . . 0.0 110.235 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.552 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -86.87 -25.0 24.69 Favored 'General case' 0 C--O 1.215 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.406 -178.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.406 ' HB2' HG21 ' A' ' 152' ' ' VAL . . . -52.19 -44.03 64.48 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.805 0.336 . . . . 0.0 111.8 -176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -69.13 -28.5 72.79 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.3 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.857 ' HD3' HG22 ' A' ' 177' ' ' VAL . 69.4 ttt180 -84.45 -29.58 25.98 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.044 0.45 . . . . 0.0 110.059 178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.609 HG13 HG12 ' A' ' 170' ' ' ILE . 24.3 t -61.41 -44.17 98.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.181 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.74 HD13 HG23 ' A' ' 140' ' ' VAL . 7.1 tp -74.14 -26.07 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.721 179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 105.36 -177.06 22.84 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.833 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -76.19 66.71 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 175.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.45 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 93.22 -155.01 22.11 Favored Glycine 0 N--CA 1.445 -0.721 0 N-CA-C 111.109 -0.797 . . . . 0.0 111.109 -173.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -82.38 47.69 3.8 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.929 -178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -84.8 -69.15 0.67 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.852 0.358 . . . . 0.0 110.274 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -29.07 70.51 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.802 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.7 t -62.62 -50.41 79.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.255 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 49.1 t30 -63.66 -45.89 88.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.624 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.436 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 8.2 mm-40 -56.91 -49.12 76.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.232 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.27 -26.27 64.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.072 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 135' ' ' ALA . 82.8 mt-30 -78.36 -49.45 13.55 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 129' ' ' GLU . 7.0 p30 -75.21 -34.81 61.51 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.143 -174.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 133' ' ' LEU . 1.3 tm? -92.74 -48.73 6.43 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.77 0.319 . . . . 0.0 110.444 -175.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 2.6 m -99.59 -17.1 18.0 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 131' ' ' GLN . . . 61.39 33.19 18.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.714 -175.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -100.12 127.47 46.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.856 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.673 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 4.0 tp10 -88.05 111.21 21.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 39.6 t -110.64 106.8 21.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.88 128.7 75.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.462 -175.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.74 HG23 HD13 ' A' ' 120' ' ' ILE . 57.6 t -106.07 143.12 26.27 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 170.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -57.45 114.03 1.76 Allowed 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.135 1.89 . . . . 0.0 112.114 175.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 44.4 tpt85 -61.93 122.78 16.3 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.491 ' HB2' ' O ' ' A' ' 142' ' ' ARG . 0.5 OUTLIER 74.38 115.36 0.06 Allowed 'General case' 0 CA--C 1.515 -0.396 0 O-C-N 124.294 0.996 . . . . 0.0 109.741 -169.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.425 ' HG3' HG11 ' A' ' 152' ' ' VAL . 24.1 tt0 -117.13 136.69 52.83 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.056 -165.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.509 ' HA ' ' HD3' ' A' ' 146' ' ' PRO . 10.0 t -125.95 125.21 24.8 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 167.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.509 ' HD3' ' HA ' ' A' ' 145' ' ' THR . 3.3 Cg_exo -80.44 144.83 16.3 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.674 2.25 . . . . 0.0 112.99 -177.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.499 ' HB3' ' H ' ' A' ' 151' ' ' GLN . 14.2 t70 -62.64 171.13 2.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.997 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' HG3' HD22 ' A' ' 149' ' ' ASN . 8.9 pt-20 -56.53 -34.36 66.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 118.231 0.468 . . . . 0.0 110.787 178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.421 HD22 ' HG3' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -88.74 23.58 2.26 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.821 177.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 47.96 52.55 12.84 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.186 0.994 . . . . 0.0 110.988 -173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.499 ' H ' ' HB3' ' A' ' 147' ' ' ASP . 22.8 mt-30 -116.24 155.55 28.14 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.493 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.425 HG11 ' HG3' ' A' ' 144' ' ' GLN . 14.4 m -142.66 -178.34 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.704 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 42.0 mm -118.77 125.12 74.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.659 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.86 140.68 34.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 174.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 107' ' ' THR . 10.2 pttt -124.96 136.51 53.81 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.115 0.483 . . . . 0.0 112.117 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 69.8 mt -120.23 125.15 73.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.442 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.417 HG12 ' HB3' ' A' ' 137' ' ' GLU . 1.9 mm -112.13 119.54 60.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 178.53 -120.82 0.73 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.675 -1.25 . . . . 0.0 113.174 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.531 ' HE2' HG22 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -131.58 172.16 12.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -61.49 -41.75 97.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.405 -176.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -71.62 -49.65 38.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.83 0.347 . . . . 0.0 110.133 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.488 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -56.01 -46.62 78.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.645 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 t -62.33 -46.02 90.6 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.397 -178.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 76.7 mm-40 -59.84 -44.33 94.13 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 54.5 ttm -60.28 -45.57 92.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.844 0.354 . . . . 0.0 110.997 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.429 ' HB3' HD13 ' A' ' 156' ' ' ILE . . . -64.26 -49.21 72.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.053 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 171' ' ' ARG . 96.7 mt-30 -56.56 -39.73 73.96 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.172 178.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -59.83 -44.58 93.98 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.698 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -58.99 -47.19 86.05 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 175.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.609 HG12 HG13 ' A' ' 119' ' ' VAL . 65.9 mt -56.0 -48.47 78.72 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.232 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.662 ' HG3' ' O ' ' A' ' 167' ' ' GLN . 51.2 mtt180 -61.63 -44.71 96.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.931 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -61.52 -50.86 70.98 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.072 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.509 ' O ' HG23 ' A' ' 177' ' ' VAL . 79.6 mt -59.55 -44.85 94.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.758 177.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 170' ' ' ILE . 3.8 tt -56.42 -47.22 79.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.596 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.13 -42.37 85.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.211 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -63.35 -42.33 98.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.857 HG22 ' HD3' ' A' ' 118' ' ' ARG . 93.9 t -60.57 -52.23 63.86 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.811 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 178' ' ' LYS . 36.0 mtpt -55.82 -40.64 73.04 Favored 'General case' 0 CA--C 1.519 -0.238 0 O-C-N 123.365 0.416 . . . . 0.0 111.349 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -60.09 -56.25 23.97 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.241 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.647 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 15.0 mt-30 -66.22 -24.61 66.64 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.118 0.414 . . . . 0.0 112.118 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -63.89 -50.32 69.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.812 0.339 . . . . 0.0 110.157 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -79.07 -57.8 3.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.045 0.45 . . . . 0.0 110.104 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 20.3 ttpp -163.04 91.43 0.72 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.339 0.59 . . . . 0.0 109.995 -176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -94.49 -17.72 38.23 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.763 -175.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -79.13 91.98 4.99 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.328 0.585 . . . . 0.0 110.406 178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 14.2 m -73.63 85.3 1.6 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.547 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 178.22 101.73 0.15 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.802 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -84.28 86.64 7.22 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.297 0.57 . . . . 0.0 110.504 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.6 mt -85.6 78.46 9.63 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.354 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.06 -58.31 2.82 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.588 -175.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.731 -178.053 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.628 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C4'-C3'-C2' 105.992 3.292 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.506 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C3'-C2'-C1' 103.168 1.853 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.554 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.965 1 P-O3'-C3' 124.665 4.138 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.955 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 O4'-C4'-C3' 103.181 -1.657 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.955 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 P--O3' 1.616 0.79 0 P-O3'-C3' 123.83 3.441 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.557 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.857 0 O4'-C1'-C2' 108.134 1.238 . 0.112 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.761 0 C3'-C2'-C1' 102.959 1.621 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.38 105.95 14.35 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.876 0.369 . . . . 0.0 110.646 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -107.81 96.2 6.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.132 0.491 . . . . 0.0 110.17 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.79 -176.76 19.07 Favored Glycine 0 N--CA 1.441 -0.987 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.851 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -64.3 110.34 1.36 Allowed 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.942 2.428 . . . . 0.0 112.229 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.6 t -96.41 -56.25 2.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 p 39.75 62.14 1.28 Allowed 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.184 0.927 . . . . 0.0 112.897 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.3 t -109.9 76.47 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.477 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.4 m -74.83 73.99 2.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.668 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.84 -118.09 6.07 Favored Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.642 -178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.38 -61.26 0.06 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.944 0.402 . . . . 0.0 110.291 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -122.51 120.6 27.9 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.37 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.21 66.13 8.37 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.746 2.297 . . . . 0.0 112.541 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -74.06 83.22 1.77 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.092 0.472 . . . . 0.0 110.837 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 32.3 m -71.62 -62.32 1.46 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.391 175.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 18.4 m 46.3 42.97 11.04 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 123.754 0.659 . . . . 0.0 111.644 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -86.39 89.35 7.85 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.424 -176.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -138.93 76.62 33.53 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 121.196 0.522 . . . . 0.0 111.197 177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.572 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 51.1 Cg_exo -57.62 -44.41 41.81 Favored 'Trans proline' 0 CA--C 1.547 1.151 0 C-N-CA 122.813 2.342 . . . . 0.0 114.232 173.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 19' ' ' PRO . 19.6 Cg_endo -58.48 153.93 45.02 Favored 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.334 2.022 . . . . 0.0 113.526 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -95.55 10.38 36.82 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.754 0.788 . . . . 0.0 110.298 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -87.92 147.22 25.17 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.68 -1.146 . . . . 0.0 109.427 177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -77.42 140.73 39.93 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.523 ' HB ' ' HA ' ' A' ' 74' ' ' THR . 5.9 t -139.48 136.25 34.38 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.241 0.543 . . . . 0.0 111.355 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG12 HG22 ' A' ' 109' ' ' ILE . 21.7 m -105.54 147.79 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.486 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.519 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 11.9 m170 -117.51 112.54 20.75 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.531 HG12 HG22 ' A' ' 71' ' ' VAL . 9.3 p -113.2 141.89 27.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.65 -179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 96.0 m-85 -105.29 115.34 30.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.044 -174.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.6 pt -98.2 160.99 26.91 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 169.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -51.23 119.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 121.727 1.618 . . . . 0.0 110.672 172.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.592 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.31 -18.74 65.3 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -79.55 -18.54 51.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.322 0.582 . . . . 0.0 109.663 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -93.96 10.54 33.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.605 -174.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 31' ' ' ALA . 1.5 m -65.02 -24.97 36.57 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.053 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.57 -30.69 72.62 Favored Glycine 0 CA--C 1.522 0.474 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.109 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.676 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.59 -50.58 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 O-C-N 122.714 -0.286 . . . . 0.0 111.671 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.605 HG22 HD13 ' A' ' 38' ' ' ILE . 20.9 mm -77.99 -51.55 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.088 0.471 . . . . 0.0 111.648 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.605 HD13 HG22 ' A' ' 37' ' ' ILE . 4.9 mm -85.34 -32.31 7.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.877 -172.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.21 -30.72 64.58 Favored Glycine 0 C--O 1.229 -0.191 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.851 -165.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 29.8 t70 -62.98 95.08 0.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 117.669 0.735 . . . . 0.0 110.278 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 31.3 t70 68.56 -8.96 0.57 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.749 -176.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.52 -13.85 53.78 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.694 -176.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -109.99 6.45 23.1 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.621 -0.341 . . . . 0.0 111.651 -177.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 40' ' ' ASP . 6.0 t60 -65.6 -23.73 66.9 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.269 0.557 . . . . 0.0 110.181 -178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.48 ' CG2' HG23 ' A' ' 38' ' ' ILE . 8.7 tp -77.51 -36.86 23.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.803 174.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 29.7 mtpp -67.45 -27.62 67.2 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-O 120.916 0.389 . . . . 0.0 110.364 -178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -52.66 -31.8 38.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.536 -0.757 . . . . 0.0 110.952 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HD12 ' A' ' 56' ' ' ILE . 9.0 tp -59.35 -30.82 68.67 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.662 -174.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.612 ' HB3' HG22 ' A' ' 56' ' ' ILE . 58.0 p -57.48 -59.87 4.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.033 0.444 . . . . 0.0 111.191 -176.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -79.27 -32.53 43.71 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.452 -177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -58.92 -43.1 91.07 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.579 -177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.443 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -106.2 5.16 29.66 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 40.3 t 68.54 41.14 1.78 Allowed 'General case' 0 CA--C 1.536 0.419 0 O-C-N 123.448 0.468 . . . . 0.0 111.524 173.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.465 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.09 170.0 16.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.989 0.423 . . . . 0.0 111.576 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 29.9 m -96.61 102.73 14.56 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.991 178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.941 HD12 HD23 ' A' ' 48' ' ' LEU . 6.2 tt -103.42 137.11 33.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.565 0.698 . . . . 0.0 111.862 -176.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -130.27 117.94 20.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.051 172.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -83.1 125.81 40.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 172.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.56 127.08 93.36 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.311 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.4 151.94 70.99 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.977 2.452 . . . . 0.0 111.348 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -54.9 91.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.357 2.705 . . . . 0.0 112.279 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -64.14 -50.41 68.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.581 -176.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.6 p -124.24 153.59 68.56 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.071 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.24 -5.05 16.16 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.41 2.074 . . . . 0.0 111.951 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -123.74 26.85 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.666 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.3 m -59.34 113.51 2.2 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.943 0.401 . . . . 0.0 110.392 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -73.68 -38.2 64.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.63 -178.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.558 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 3.1 m -133.05 148.89 31.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.153 -176.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -109.95 124.82 52.08 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -178.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.537 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 21.6 ptp -94.62 137.03 34.24 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 0.0 111.296 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 HG22 HG12 ' A' ' 27' ' ' VAL . 18.1 m -109.05 134.82 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.936 171.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 26' ' ' HIS . 21.5 t -98.12 100.55 10.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.167 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.3 mm -96.1 93.9 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 177.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.523 ' HA ' ' HB ' ' A' ' 24' ' ' THR . 12.4 m -92.56 120.07 32.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.433 176.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.91 -170.4 40.65 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.157 -179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 8.3 Cg_exo -72.41 153.64 55.66 Favored 'Trans proline' 0 CA--C 1.532 0.396 0 C-N-CA 123.067 2.511 . . . . 0.0 112.424 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -43.39 -47.08 9.36 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.484 2.79 . . . . 0.0 114.327 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -66.87 -34.05 76.94 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.465 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -74.23 -28.55 61.3 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.522 ' O ' ' HG2' ' A' ' 84' ' ' GLN . 91.0 mt-30 -61.11 -48.96 79.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 171.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.767 ' HA ' HE21 ' A' ' 84' ' ' GLN . 77.8 t80 -68.15 -38.24 81.9 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.563 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.1 mmtm -61.59 -51.27 69.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.851 0.358 . . . . 0.0 110.087 176.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.38 -53.79 52.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.384 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.767 HE21 ' HA ' ' A' ' 81' ' ' PHE . 29.7 pt20 -66.74 -38.15 86.07 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 120.876 -0.33 . . . . 0.0 110.889 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.521 ' HA2' ' HD2' ' A' ' 88' ' ' TYR . . . -64.56 -34.24 89.38 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.136 -0.555 . . . . 0.0 112.042 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 1.7 tmt_? -59.42 -38.76 81.47 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.651 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 94.0 mt -72.04 -47.67 53.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.725 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.521 ' HD2' ' HA2' ' A' ' 85' ' ' GLY . 47.0 m-85 -51.76 -49.98 61.55 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.901 0.381 . . . . 0.0 111.107 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -32.75 63.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.609 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 86' ' ' ARG . 8.9 tmtm? -66.6 -37.68 85.4 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.651 ' HG ' ' O ' ' A' ' 87' ' ' ILE . 11.0 mt -62.92 -32.14 73.36 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 178.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.2 mtmt -63.46 -47.79 80.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.019 177.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.436 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 7.4 pt-20 -79.0 -29.67 43.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.572 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.676 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 24.3 tp10 -87.85 9.43 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.137 0.494 . . . . 0.0 111.052 -175.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 64.33 42.47 5.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.771 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.648 ' CE2' HD22 ' A' ' 91' ' ' LEU . 4.0 m-85 -74.0 -29.16 61.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 170.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.61 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 93.9 m-85 -134.24 129.63 35.95 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.053 -177.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.484 ' C ' ' H ' ' A' ' 100' ' ' LYS . . . -74.7 -41.75 33.91 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 160.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 85.6 Cg_exo -49.29 9.64 0.01 OUTLIER 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 125.127 3.885 . . . . 0.0 115.586 161.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.61 ' HB3' ' O ' ' A' ' 97' ' ' PHE . 0.0 OUTLIER -70.1 22.15 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -162.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -68.87 -19.85 64.25 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.947 1.356 . . . . 0.0 107.488 160.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.548 ' HB2' ' CD2' ' A' ' 159' ' ' HIS . 10.2 pt-20 -151.59 145.71 25.31 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 112.447 -2.16 . . . . 0.0 109.118 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.485 HG12 ' CD2' ' A' ' 97' ' ' PHE . 27.2 m -116.31 133.8 61.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 173.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.72 107.44 19.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -176.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD11 ' CD1' ' A' ' 91' ' ' LEU . 47.7 mt -129.29 162.01 28.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 -178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -111.7 109.84 19.92 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.088 -176.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 17.6 m -94.07 131.09 39.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.812 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -108.47 123.43 48.87 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.383 -0.198 . . . . 0.0 110.557 176.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.827 HG22 HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -126.61 172.42 13.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.99 0.424 . . . . 0.0 111.172 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.7 ' HG3' HH11 ' A' ' 110' ' ' ARG . 9.9 mmt85 -111.04 128.07 55.74 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.407 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.618 HG12 HD11 ' A' ' 174' ' ' LEU . 32.5 m -137.93 150.14 66.52 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.387 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.634 ' HD2' HD13 ' A' ' 174' ' ' LEU . 72.7 Cg_exo -41.81 104.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 123.498 2.799 . . . . 0.0 111.036 168.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.521 ' CB ' HG13 ' A' ' 152' ' ' VAL . . . -67.22 -25.49 66.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.808 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.0 p -70.4 -10.76 59.96 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.419 0.628 . . . . 0.0 109.839 174.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.57 ' HB1' HG11 ' A' ' 177' ' ' VAL . . . -122.17 18.4 10.75 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.811 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.93 -41.52 91.97 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.985 0.421 . . . . 0.0 111.3 -177.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.461 ' HA3' ' N7 ' ' B' ' 4' ' ' ' G' . . . -66.11 -28.81 73.96 Favored Glycine 0 C--O 1.228 -0.271 0 CA-C-N 115.954 -0.567 . . . . 0.0 112.267 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.651 ' HG3' HG22 ' A' ' 173' ' ' ILE . 12.9 tpt180 -71.05 -36.58 72.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 177.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.64 HG12 HG11 ' A' ' 138' ' ' VAL . 70.1 t -60.19 -53.77 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.018 177.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.642 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -72.22 -17.73 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.103 -176.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 97.87 143.08 14.15 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.613 177.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.476 ' HE3' ' HB2' ' A' ' 122' ' ' LYS . 17.7 ptmt -64.33 93.96 0.1 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.545 0.688 . . . . 0.0 110.712 -179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 94.83 21.63 25.48 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.291 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.642 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 79.1 21.5 67.66 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.041 -0.6 . . . . 0.0 112.695 178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.556 ' O ' ' HG3' ' A' ' 129' ' ' GLU . 46.0 mmtm -59.51 -49.87 76.11 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . . . . . . . . . 91.7 m -54.08 -48.29 70.8 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 15.5 t -68.22 -34.31 65.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.986 -174.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.17 -44.93 82.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.696 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.556 ' HG3' ' O ' ' A' ' 125' ' ' LYS . 35.3 mt-10 -60.95 -48.14 83.17 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-O 122.014 0.912 . . . . 0.0 109.425 176.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 22.4 mt -63.64 -48.27 77.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.197 -1.365 . . . . 0.0 112.517 -174.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -64.37 -51.2 64.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 0.0 111.444 -176.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -69.1 -26.87 65.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.042 -170.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 97.2 mt -105.51 -49.73 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -178.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.99 -10.03 15.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -167.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 71.46 16.18 6.03 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.281 0.632 . . . . 0.0 110.661 -172.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.704 ' HA ' ' O ' ' A' ' 157' ' ' ILE . . . -86.34 154.07 21.49 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.787 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.625 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 30.4 tt0 -153.46 114.73 4.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.33 -174.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 119' ' ' VAL . 64.5 t -90.25 106.37 17.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.105 0.479 . . . . 0.0 109.96 175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 36.6 t -107.44 116.65 51.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.251 -178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 26.9 m -96.83 157.22 35.5 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.106 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.37 135.33 64.5 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.085 1.856 . . . . 0.0 110.46 173.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 142' ' ' ARG . 16.6 tpt180 -57.59 119.33 6.39 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.918 0.389 . . . . 0.0 110.76 -175.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 16.0 t70 75.66 -90.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.585 -1.189 . . . . 0.0 110.18 -175.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.922 ' HG2' ' HD3' ' A' ' 146' ' ' PRO . 42.9 tt0 -175.37 140.01 0.47 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.735 0.302 . . . . 0.0 110.518 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 4.6 t -163.74 56.79 0.56 Allowed Pre-proline 0 CA--C 1.545 0.765 0 CA-C-O 121.857 0.836 . . . . 0.0 110.957 177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.922 ' HD3' ' HG2' ' A' ' 144' ' ' GLN . 58.9 Cg_endo -71.62 161.88 43.91 Favored 'Trans proline' 0 CA--C 1.52 -0.208 0 C-N-CA 123.385 2.723 . . . . 0.0 113.54 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -69.09 158.18 35.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 166.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -69.53 -2.71 12.07 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.93 0.395 . . . . 0.0 111.55 -175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -94.37 22.52 5.98 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 172.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 47.45 52.19 12.65 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.002 1.321 . . . . 0.0 112.322 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -134.19 130.68 37.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.01 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.666 HG13 ' HB3' ' A' ' 146' ' ' PRO . 1.8 m -108.03 168.28 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.333 0.587 . . . . 0.0 111.747 -177.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mm -100.63 111.3 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.054 172.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.627 HG23 HG12 ' A' ' 109' ' ' ILE . 21.1 m -122.43 142.13 40.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.329 -173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 50.8 mttt -105.63 147.24 28.69 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.772 -171.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.625 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 32.5 mt -127.52 110.73 23.07 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.704 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 15.4 mm -87.46 147.48 5.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 175.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 154.66 -155.65 26.35 Favored Glycine 0 N--CA 1.44 -1.078 0 C-N-CA 119.801 -1.19 . . . . 0.0 112.563 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.798 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 2.2 m80 -118.05 -175.48 2.86 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -178.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -53.69 -47.97 69.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 111.85 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -73.64 -34.72 65.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.444 -178.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.798 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -68.45 -45.68 71.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.313 -178.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 55.6 m -61.54 -42.39 98.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.066 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 81' ' ' PHE . 20.0 tp60 -56.16 -47.06 78.97 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.926 0.393 . . . . 0.0 110.623 177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.25 -51.01 41.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.934 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -62.35 -39.06 91.88 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 60.7 mt-30 -62.52 -47.69 82.83 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 121.288 -0.165 . . . . 0.0 110.625 178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 168' ' ' ARG . 5.0 tmm_? -61.38 -42.17 98.29 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 174.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.535 ' HE2' HD11 ' A' ' 173' ' ' ILE . 24.6 tptm -52.09 -57.76 8.59 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.235 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.47 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 49.8 pt -66.82 -40.06 85.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 10.7 mmm180 -62.55 -37.21 85.25 Favored 'General case' 0 C--O 1.233 0.226 0 C-N-CA 121.157 -0.217 . . . . 0.0 111.242 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -67.83 -47.76 68.11 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.007 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.651 HG22 ' HG3' ' A' ' 118' ' ' ARG . 60.3 mt -57.85 -40.86 78.18 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.944 176.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.634 HD13 ' HD2' ' A' ' 112' ' ' PRO . 74.5 mt -55.31 -52.1 64.57 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.028 174.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.3 76.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.984 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -57.35 -60.04 4.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.57 HG11 ' HB1' ' A' ' 115' ' ' ALA . 8.9 p -67.48 -38.75 81.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.467 ' HD2' ' HG3' ' A' ' 112' ' ' PRO . 11.4 mtpp -57.2 -49.83 74.75 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.666 0.27 . . . . 0.0 110.466 174.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -63.58 -38.13 89.97 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.571 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.436 ' HB3' ' H41' ' B' ' 2' ' ' ' C' . 55.4 mt-30 -63.94 -37.12 86.22 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.718 0.266 . . . . 0.0 111.718 174.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 -68.89 -56.57 7.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.618 -0.264 . . . . 0.0 111.446 -178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -68.95 -57.22 5.78 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 183' ' ' LYS . 2.2 tmmm? 49.63 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.315 0 O-C-N 124.196 0.935 . . . . 0.0 112.685 168.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -79.71 -133.48 1.05 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.523 -0.846 . . . . 0.0 112.305 177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 59.33 36.39 23.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.919 0.39 . . . . 0.0 111.139 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.8 t -111.86 139.66 47.15 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 140.6 -129.31 4.11 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.585 -0.816 . . . . 0.0 112.043 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -92.15 36.8 0.98 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.715 0.293 . . . . 0.0 110.948 -176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tt -84.79 88.04 7.36 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -116.16 99.77 7.47 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.139 -173.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.885 178.198 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.659 " H2'" ' O2 ' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 103.575 2.306 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.441 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.754 0 C3'-C2'-C1' 104.815 3.684 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.806 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.966 0 C4'-C3'-C2' 105.854 3.154 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.906 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 O4'-C4'-C3' 103.295 -1.575 OUTLIER-EPSILON 0.01 7a . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.906 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 P-O3'-C3' 123.384 3.07 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.548 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.906 0 C3'-C2'-C1' 103.049 1.721 . 0.356 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.853 0 O4'-C1'-C2' 107.652 0.894 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.88 0 N-CA-C 112.319 -0.312 . . . . 0.0 112.319 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.96 117.1 0.56 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 23.9 mmt -109.98 90.86 3.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.958 0.409 . . . . 0.0 110.72 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 5' ' ' PRO . . . 115.88 -98.22 0.82 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.088 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 4' ' ' GLY . 49.3 Cg_exo -57.0 117.28 3.94 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.033 2.489 . . . . 0.0 112.301 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.2 m -85.33 54.87 3.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.136 0.493 . . . . 0.0 110.763 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.9 t -72.67 -42.5 64.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.164 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 m -122.8 140.76 45.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.312 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 p -102.85 36.9 2.07 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.32 0.581 . . . . 0.0 110.017 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.25 111.0 3.7 Favored Glycine 0 N--CA 1.445 -0.743 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.536 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.93 71.46 1.05 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.398 0.618 . . . . 0.0 109.592 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.18 113.66 10.54 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.421 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.38 66.96 7.86 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 123.009 2.473 . . . . 0.0 111.241 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -55.63 112.76 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.767 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 5.2 p -156.72 93.32 1.36 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.177 -178.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.0 m -82.02 84.32 7.01 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -67.42 113.98 5.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.811 -174.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.4 ttt 59.62 76.73 0.42 Allowed Pre-proline 0 N--CA 1.464 0.232 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.948 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 16.0 Cg_exo -66.92 137.65 45.61 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.667 2.245 . . . . 0.0 111.646 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 2.9 Cg_exo -73.21 86.62 1.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.503 2.135 . . . . 0.0 111.879 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -84.82 29.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.208 176.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 70.0 mm-40 -114.32 -174.21 2.44 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.618 -175.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.629 ' HG3' ' NE2' ' A' ' 80' ' ' GLN . 12.2 tp10 -63.39 107.1 1.02 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.556 177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 28.4 m -139.71 133.33 30.39 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -172.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.697 HG12 HG22 ' A' ' 109' ' ' ILE . 13.0 m -112.27 151.43 14.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.093 171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.65 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 30.6 m170 -121.66 113.14 19.32 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 176.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.513 ' H ' HG22 ' A' ' 71' ' ' VAL . 40.1 t -93.53 129.15 44.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.577 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.717 ' HB2' ' HG3' ' A' ' 106' ' ' GLU . 81.8 m-85 -114.71 126.41 54.84 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.088 0.471 . . . . 0.0 110.819 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.545 ' HB ' ' HD2' ' A' ' 30' ' ' PRO . 21.3 pt -128.53 173.4 5.63 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 36.2 Cg_exo -58.72 120.28 8.07 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 121.65 1.566 . . . . 0.0 111.236 176.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.611 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -67.7 -13.62 62.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.878 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.76 -14.1 58.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.22 0.533 . . . . 0.0 109.604 173.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.438 ' HB1' ' CE2' ' A' ' 96' ' ' PHE . . . -106.39 10.88 31.41 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.868 -174.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.7 OUTLIER -66.76 -29.17 45.52 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.348 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.012 174.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -55.15 -33.05 57.39 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.308 175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -78.21 -57.59 3.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.845 0.355 . . . . 0.0 111.255 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.609 HD13 ' HD2' ' A' ' 90' ' ' LYS . 23.4 mm -61.32 -48.4 89.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.49 -176.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.607 HG23 HG21 ' A' ' 45' ' ' ILE . 7.8 mm -81.22 -38.47 16.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.292 -175.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -59.77 -20.38 52.42 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.836 -177.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 21.1 t0 -61.68 90.67 0.03 OUTLIER 'General case' 0 C--O 1.238 0.48 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 14.9 m-20 69.69 -10.51 0.59 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.036 0.934 . . . . 0.0 111.739 -173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 64.61 13.73 56.26 Favored Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.453 ' O ' ' HG2' ' A' ' 47' ' ' GLN . 60.0 tt0 -135.56 -20.87 1.56 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -174.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 2.5 m80 -58.59 -37.99 76.99 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.026 0.38 . . . . 0.0 112.026 -175.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.607 HG21 HG23 ' A' ' 38' ' ' ILE . 8.6 tp -63.57 -32.58 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-O 120.991 0.424 . . . . 0.0 111.226 174.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -81.38 -29.38 34.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.982 0.42 . . . . 0.0 110.831 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 43' ' ' GLN . 14.7 mm-40 -64.72 -30.46 71.47 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.929 174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.531 HD23 ' CD1' ' A' ' 56' ' ' ILE . 10.6 tp -50.3 -29.55 10.0 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.781 -175.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.495 ' HA ' HG22 ' A' ' 56' ' ' ILE . 14.2 m -59.96 -62.98 1.47 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.743 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -80.36 -33.54 37.2 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.319 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -56.87 -41.97 78.96 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.223 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . -103.67 2.92 33.76 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.725 -0.39 . . . . 0.0 111.736 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 52' ' ' ALA . 33.1 t 65.28 47.07 2.46 Favored 'General case' 0 C--O 1.235 0.315 0 O-C-N 123.575 0.547 . . . . 0.0 110.138 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.79 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -135.91 151.65 50.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.079 0.466 . . . . 0.0 111.851 -173.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 38.4 m -89.75 98.95 12.06 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 172.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.653 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 1.9 tt -118.96 131.97 70.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.45 -174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.541 ' HG2' ' HB ' ' A' ' 72' ' ' VAL . 63.4 pttt -124.39 130.0 51.7 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.619 169.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.405 HD12 HD11 ' A' ' 38' ' ' ILE . 0.7 OUTLIER -96.92 126.89 49.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.255 0.55 . . . . 0.0 110.674 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.86 104.15 12.27 Favored Pre-proline 0 N--CA 1.447 -0.603 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.151 172.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.87 168.33 23.32 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.885 2.39 . . . . 0.0 111.608 -178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.98 91.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.836 2.357 . . . . 0.0 111.862 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -55.85 -43.26 76.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.627 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.3 p -130.79 169.39 13.79 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.611 -176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -65.02 -9.7 22.65 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.285 1.99 . . . . 0.0 111.969 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.41 2.05 54.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.543 178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.484 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 14.7 m -75.85 101.62 5.2 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -90.74 -21.79 21.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.956 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.52 148.95 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.256 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.498 ' HG2' ' CG1' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -116.93 140.56 49.32 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 176.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.612 ' HB3' ' CE2' ' A' ' 28' ' ' PHE . 26.1 ptm -110.71 142.11 43.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.997 0.427 . . . . 0.0 111.965 -174.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 2.8 m -110.34 140.04 31.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.324 170.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.7 t -106.02 104.69 17.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 24' ' ' THR . 41.0 mm -102.26 96.34 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 O-C-N 123.607 0.567 . . . . 0.0 110.05 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 57.3 m -103.42 126.4 50.55 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.469 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' O ' ' HB3' ' A' ' 23' ' ' GLU . . . 158.13 -152.33 23.5 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.698 178.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 12.3 Cg_exo -70.48 152.87 65.87 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.54 2.16 . . . . 0.0 111.393 176.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 76' ' ' PRO . 46.0 Cg_exo -56.45 -27.82 70.24 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.972 2.448 . . . . 0.0 112.372 178.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' ' 82' ' ' LYS . 1.7 mp0 -58.83 -46.88 86.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.079 0.466 . . . . 0.0 110.103 174.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.79 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -63.91 -32.07 73.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.959 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.629 ' NE2' ' HG3' ' A' ' 23' ' ' GLU . 99.1 mt-30 -57.77 -54.52 46.0 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 173.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -68.04 -35.72 78.73 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.739 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 78' ' ' GLU . 99.5 mttt -66.64 -54.52 22.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.793 0.33 . . . . 0.0 111.144 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.38 -44.61 78.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.573 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -66.4 -45.32 80.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.626 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -65.16 -33.12 86.11 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 121.106 -0.569 . . . . 0.0 111.929 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.475 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -61.38 -44.44 97.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.579 ' O ' HD22 ' A' ' 91' ' ' LEU . 76.0 mt -71.9 -48.59 49.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.989 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 10.1 m-85 -55.7 -38.77 70.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.026 0.441 . . . . 0.0 111.068 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -71.81 -28.3 69.2 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.165 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.609 ' HD2' HD13 ' A' ' 37' ' ' ILE . 7.5 tmtm? -66.0 -37.56 86.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.361 0.124 . . . . 0.0 110.812 -177.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.757 ' HB3' ' HB2' ' A' ' 96' ' ' PHE . 0.3 OUTLIER -59.0 -30.08 67.72 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.837 -0.539 . . . . 0.0 111.649 175.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -70.47 -47.39 60.85 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.162 0.506 . . . . 0.0 109.893 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 11.0 pt-20 -74.35 -29.52 61.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.363 -178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.458 ' HB2' ' HD3' ' A' ' 90' ' ' LYS . 6.6 tp10 -95.55 7.62 45.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.23 0.538 . . . . 0.0 111.145 -176.068 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 61.68 35.96 16.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.789 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.757 ' HB2' ' HB3' ' A' ' 91' ' ' LEU . 3.0 m-85 -68.9 -60.19 2.54 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 169.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.989 ' HB3' ' HG3' ' A' ' 101' ' ' GLU . 0.2 OUTLIER -142.95 97.67 3.14 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.216 -1.357 . . . . 0.0 108.037 174.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -133.75 -88.2 0.33 Allowed Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.147 -1.025 . . . . 0.0 112.769 -175.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -66.35 -24.5 50.18 Favored 'Trans proline' 0 CA--C 1.527 0.15 0 C-N-CA 123.009 2.473 . . . . 0.0 113.156 -178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 10.3 mmmm -104.43 -26.29 12.47 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.532 -172.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.989 ' HG3' ' HB3' ' A' ' 97' ' ' PHE . 12.0 pt-20 -158.66 168.32 27.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.814 0.34 . . . . 0.0 110.1 -177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.407 ' OE2' ' HB3' ' A' ' 159' ' ' HIS . 0.0 OUTLIER -101.99 150.53 23.12 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.692 ' HA ' ' CD2' ' A' ' 97' ' ' PHE . 2.7 m -68.01 130.8 33.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.397 0.618 . . . . 0.0 111.803 -169.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.847 ' HD2' HG22 ' A' ' 157' ' ' ILE . 14.9 tptp -121.29 96.85 5.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.322 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.644 HD11 HD21 ' A' ' 91' ' ' LEU . 57.4 mt -121.32 161.29 22.3 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.892 -176.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.717 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 10.1 pt-20 -113.64 123.65 50.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.641 0.734 . . . . 0.0 111.251 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.8 m -111.39 122.68 48.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.499 177.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 21.4 m170 -99.67 120.99 40.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.562 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.697 HG22 HG12 ' A' ' 25' ' ' VAL . 14.1 pt -127.38 169.76 18.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.869 0.366 . . . . 0.0 110.955 -178.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -111.62 118.64 36.24 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.776 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.476 ' HB ' HD21 ' A' ' 174' ' ' LEU . 34.1 m -124.62 154.48 70.0 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.807 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.811 ' HG2' HD22 ' A' ' 174' ' ' LEU . 5.4 Cg_exo -44.35 106.73 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.03 2.487 . . . . 0.0 110.21 168.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -62.22 -25.23 67.68 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.342 -170.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 40.6 t -69.42 -8.32 45.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.824 0.345 . . . . 0.0 110.463 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -117.13 21.83 12.93 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.694 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.571 ' HB1' HG11 ' A' ' 140' ' ' VAL . . . -61.18 -50.69 72.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.922 0.391 . . . . 0.0 111.104 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -76.33 -0.7 67.37 Favored Glycine 0 C--O 1.227 -0.328 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.096 178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.648 ' HG2' ' CG2' ' A' ' 177' ' ' VAL . 11.6 tpt180 -91.18 -45.06 8.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.66 0.267 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 35.9 m -74.86 -20.71 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.016 0.436 . . . . 0.0 111.156 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.581 HD13 ' HA2' ' A' ' 124' ' ' GLY . 0.0 OUTLIER -78.69 -17.28 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.611 0.72 . . . . 0.0 109.723 178.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 92.91 157.02 33.24 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.529 -0.759 . . . . 0.0 112.397 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt -67.85 96.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.264 0.554 . . . . 0.0 110.703 -177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.477 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 86.74 11.53 70.71 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.329 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.581 ' HA2' HD13 ' A' ' 120' ' ' ILE . . . 84.24 18.57 62.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.516 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -60.04 -34.31 73.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.37 0.129 . . . . 0.0 111.099 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 64.6 m -56.74 -49.57 74.85 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.453 176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 131' ' ' GLN . 14.8 t -63.98 -48.83 84.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.79 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -56.87 -50.01 73.78 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.565 -177.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.92 -48.25 18.73 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.973 0.416 . . . . 0.0 111.341 -175.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.964 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 15.6 tp -71.37 -27.46 63.35 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.287 -172.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 127' ' ' VAL . 6.2 tm0? -76.6 -43.49 38.36 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.428 HD22 ' HA ' ' A' ' 132' ' ' ASN . 3.2 m120 -64.54 -30.87 71.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.721 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.56 -52.56 4.25 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -176.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 1.7 m -109.88 -11.05 14.72 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -171.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . 70.93 26.55 3.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.382 0.673 . . . . 0.0 110.836 -172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.964 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -93.96 98.07 10.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.508 0.671 . . . . 0.0 110.337 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 9.3 tt0 -89.31 134.37 34.09 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.502 -175.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' HB ' HG22 ' A' ' 127' ' ' VAL . 54.0 t -116.53 106.84 21.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-O 121.172 0.511 . . . . 0.0 109.869 176.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.58 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 30.5 t -112.68 116.11 51.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.668 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.571 HG11 ' HB1' ' A' ' 116' ' ' ALA . 61.1 t -109.98 106.06 57.82 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -45.24 112.1 0.36 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 123.415 2.744 . . . . 0.0 112.654 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.663 ' HG3' ' H62' ' B' ' 5' ' ' ' A' . 0.4 OUTLIER -64.43 145.02 56.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.562 -0.744 . . . . 0.0 112.124 -177.541 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.17 46.48 15.87 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.29 177.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.432 ' HG3' HG11 ' A' ' 152' ' ' VAL . 17.4 pm0 -84.48 176.49 8.62 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.333 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.8 p -132.14 110.0 14.04 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.066 0.46 . . . . 0.0 111.318 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.36 135.01 62.4 Favored 'Trans proline' 0 C--O 1.236 0.4 0 C-N-CA 123.058 2.506 . . . . 0.0 112.416 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -75.35 -173.77 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.913 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.87 -46.33 74.7 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.118 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -84.96 22.66 1.35 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.911 0.386 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 45.25 49.51 10.01 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.49 1.116 . . . . 0.0 112.297 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -117.28 144.84 44.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' A' ' 113' ' ' ALA . 12.8 m -127.59 -178.29 2.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.749 177.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 50.2 mm -100.79 135.0 38.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.364 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.4 m -142.97 140.37 27.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.651 ' HB3' HD11 ' A' ' 157' ' ' ILE . 73.4 mttt -107.36 135.42 48.89 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.857 -172.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.569 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 23.1 mt -114.42 111.2 34.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 166.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.847 HG22 ' HD2' ' A' ' 104' ' ' LYS . 2.7 mm -109.39 110.62 32.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.455 -175.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.87 -168.08 28.52 Favored Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 119.047 -1.549 . . . . 0.0 113.545 -177.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.502 ' H ' ' HB3' ' A' ' 162' ' ' ALA . 24.0 m170 -85.15 179.93 7.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.829 -0.686 . . . . 0.0 109.453 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -60.55 -41.9 95.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.882 -0.327 . . . . 0.0 110.917 -177.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -73.94 -38.17 64.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.379 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.502 ' HB3' ' H ' ' A' ' 159' ' ' HIS . . . -63.7 -45.7 88.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.953 -174.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.9 t -57.53 -50.28 73.58 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 123.342 0.402 . . . . 0.0 110.622 -177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -58.33 -45.61 87.77 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.926 0.393 . . . . 0.0 110.579 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 45.9 tpp -61.89 -50.25 72.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.335 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.793 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.63 -42.5 98.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.612 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.694 ' O ' ' HG2' ' A' ' 171' ' ' ARG . 99.6 mt-30 -60.52 -48.37 82.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.481 177.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 20.8 tpp180 -54.56 -42.1 70.57 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-O 121.13 0.49 . . . . 0.0 110.48 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm -59.75 -57.3 13.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.566 178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.447 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -64.07 -34.22 67.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.694 ' HG2' ' O ' ' A' ' 167' ' ' GLN . 9.1 mmm180 -58.85 -41.92 88.12 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 117.866 0.303 . . . . 0.0 111.153 179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -62.11 -48.76 78.72 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.228 0.537 . . . . 0.0 110.481 175.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.614 ' CG2' ' HG3' ' A' ' 118' ' ' ARG . 53.8 mt -57.5 -42.82 81.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.661 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.811 HD22 ' HG2' ' A' ' 112' ' ' PRO . 79.5 mt -60.45 -45.98 91.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.971 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.84 -35.34 70.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.507 178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 180' ' ' GLN . 73.5 mt-30 -57.9 -59.7 4.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.174 0.511 . . . . 0.0 110.51 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.648 ' CG2' ' HG2' ' A' ' 118' ' ' ARG . 3.5 t -63.05 -42.73 97.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.228 -177.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 44.3 mtpt -59.78 -42.56 93.61 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.1 177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -62.58 -44.66 95.77 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.588 0.233 . . . . 0.0 110.991 174.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' A' ' 176' ' ' GLN . 97.9 mt-30 -58.51 -40.94 84.26 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.903 178.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 58.2 m170 -69.72 -42.05 74.52 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.591 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.72 ' HG3' ' HG3' ' A' ' 183' ' ' LYS . 17.5 tp60 -52.88 -52.41 57.56 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 122.94 0.496 . . . . 0.0 111.258 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.72 ' HG3' ' HG3' ' A' ' 182' ' ' GLN . 48.8 mtpt -135.51 91.3 2.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.299 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -104.08 -125.94 5.71 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 171.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 189' ' ' LEU . 42.4 mt-30 -95.08 68.11 3.12 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 172.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 18.4 p -93.75 -44.39 8.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.117 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.61 25.96 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.469 175.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -91.93 56.77 2.99 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.64 0.733 . . . . 0.0 110.039 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.59 ' HB2' ' O ' ' A' ' 185' ' ' GLN . 48.4 tp -108.96 -51.36 2.89 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.288 175.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -134.11 83.29 2.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.051 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.791 -176.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -1.007 0 C4'-C3'-C2' 105.238 2.538 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.547 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O3'--C3' 1.432 0.676 0 C3'-C2'-C1' 103.519 2.244 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.634 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.893 1 P-O3'-C3' 125.127 4.523 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.896 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 O4'-C4'-C3' 103.427 -1.481 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.896 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 P-O3'-C3' 123.852 3.46 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.807 0 O4'-C4'-C3' 104.06 -1.029 . 0.48 1a . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.722 0 C4'-C3'-C2' 103.717 1.017 . 0.118 1m . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.824 0 N-CA-C 112.35 -0.3 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.06 -50.15 36.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.676 0.274 . . . . 0.0 110.702 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.9 mmt -140.51 74.34 1.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.12 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.42 148.96 25.59 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.903 179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.56 -44.15 48.41 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 123.097 2.531 . . . . 0.0 112.384 178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.1 t 60.5 52.59 4.56 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.584 0.706 . . . . 0.0 109.835 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 t -101.14 84.72 2.7 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.417 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -154.41 45.36 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-O 122.505 1.145 . . . . 0.0 109.789 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.3 p -88.9 -2.97 58.85 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.97 -92.8 0.13 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.778 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.87 75.54 9.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.0 0.428 . . . . 0.0 110.673 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -88.53 134.33 34.46 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.118 -177.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.2 Cg_exo -76.27 72.55 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.908 2.406 . . . . 0.0 111.754 177.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -57.94 118.46 5.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.631 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 29.0 m -114.19 129.13 56.63 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.273 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.8 t -80.39 152.58 28.8 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.814 -178.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -124.58 137.26 54.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.336 176.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 57.9 ttp -107.28 107.46 60.45 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-O 120.648 0.261 . . . . 0.0 110.843 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 13.3 Cg_exo -69.96 140.47 42.0 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.746 2.297 . . . . 0.0 111.064 176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 24.3 Cg_exo -65.86 78.17 0.29 Allowed 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.906 2.404 . . . . 0.0 113.48 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.33 1.66 47.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 122.088 0.947 . . . . 0.0 109.405 170.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -113.56 168.34 9.84 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.052 -1.431 . . . . 0.0 108.821 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -63.16 119.06 8.83 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.603 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 38.9 m -139.52 113.73 8.93 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.097 -174.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.795 HG12 HG22 ' A' ' 109' ' ' ILE . 10.4 m -106.67 156.82 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 176.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 26.3 m80 -124.69 112.67 17.03 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -107.03 139.36 28.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.2 -176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.449 ' CE1' ' HB3' ' A' ' 70' ' ' MET . 4.7 m-30 -101.16 106.6 17.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.781 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 9.9 pt -94.67 157.24 37.33 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' HB2' ' CB ' ' A' ' 33' ' ' ALA . 53.1 Cg_exo -53.58 119.42 6.17 Favored 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 121.522 1.481 . . . . 0.0 111.621 174.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 34' ' ' VAL . . . -68.6 -15.52 63.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.068 0.461 . . . . 0.0 111.233 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -87.33 4.37 43.15 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.307 0.575 . . . . 0.0 109.553 174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -121.28 5.68 10.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.605 -178.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -66.84 -27.25 39.2 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.399 0 C-N-CA 120.41 -0.516 . . . . 0.0 109.931 175.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.0 -28.97 69.67 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.679 173.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.616 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -79.56 -58.43 3.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.757 0.313 . . . . 0.0 111.053 176.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.575 HD13 ' HD2' ' A' ' 90' ' ' LYS . 31.7 mm -61.78 -53.42 48.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.394 -177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.565 HD13 HG22 ' A' ' 37' ' ' ILE . 6.7 mm -78.93 -52.74 14.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.713 -176.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.33 -36.48 83.64 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.61 -171.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.45 ' HB3' ' HD2' ' A' ' 44' ' ' HIS . 10.3 t70 -32.24 -54.45 0.31 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.772 0.829 . . . . 0.0 112.237 -176.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -142.64 7.42 1.69 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.598 0.713 . . . . 0.0 109.69 177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.67 -52.02 0.89 Allowed Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.409 -0.814 . . . . 0.0 113.277 -174.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' A' ' 47' ' ' GLN . 27.3 tt0 -65.84 -29.77 70.29 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -173.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.45 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 55.3 m-70 -52.24 -38.05 56.99 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -167.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.544 HG23 ' HG3' ' A' ' 46' ' ' LYS . 8.5 tp -67.42 -41.22 85.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 120.778 0.323 . . . . 0.0 111.829 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.544 ' HG3' HG23 ' A' ' 45' ' ' ILE . 91.4 mttt -82.2 -27.31 32.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.51 0.671 . . . . 0.0 109.786 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.44 ' HB3' ' HA ' ' A' ' 44' ' ' HIS . 27.8 tt0 -59.54 -33.98 72.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.735 -1.121 . . . . 0.0 110.155 171.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.81 ' HB3' HG21 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -50.47 -41.32 52.9 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.986 -178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.598 ' HB2' HG22 ' A' ' 56' ' ' ILE . 37.1 t -59.16 -63.06 1.44 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.532 -173.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -74.81 -32.23 61.92 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.892 -173.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -62.06 -41.33 98.04 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.352 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -103.82 16.58 26.02 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -174.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m 65.62 31.46 9.88 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 173.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.636 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -137.72 -179.49 5.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.004 0.431 . . . . 0.0 111.166 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.8 t -116.62 109.37 17.12 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 173.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.81 HG21 ' HB3' ' A' ' 48' ' ' LEU . 12.8 tt -107.37 127.81 62.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.513 0.673 . . . . 0.0 111.236 -177.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.4 mttm -115.35 114.37 25.04 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.928 175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.0 tt -87.9 122.84 40.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.012 174.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.597 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -67.11 130.42 93.77 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.008 177.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.55 137.31 77.48 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.379 2.053 . . . . 0.0 111.314 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -59.98 89.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.81 2.34 . . . . 0.0 111.723 179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -58.96 -46.9 86.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.836 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . 14.7 p -133.06 135.21 25.38 Favored Pre-proline 0 N--CA 1.444 -0.753 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.454 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 63' ' ' THR . 15.2 Cg_exo -67.74 -14.7 42.55 Favored 'Trans proline' 0 C--N 1.334 -0.196 0 C-N-CA 123.594 2.863 . . . . 0.0 112.808 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -98.2 -1.47 42.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.019 0.438 . . . . 0.0 110.698 -178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 31' ' ' ALA . 47.7 t -61.47 147.36 45.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.358 0.599 . . . . 0.0 111.196 -177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -91.39 -25.7 19.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.005 -177.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' C ' ' HB2' ' A' ' 31' ' ' ALA . 16.2 m -139.1 148.54 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 111.749 -172.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.597 ' HD2' ' O ' ' A' ' 59' ' ' ALA . 6.8 tpp180 -127.87 121.86 31.1 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.449 ' HB3' ' CE1' ' A' ' 28' ' ' PHE . 25.6 ptm -87.79 136.64 32.87 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.986 0.422 . . . . 0.0 111.899 -176.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' HIS . 12.5 m -123.29 144.28 33.41 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.598 172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 57.2 t -97.63 118.26 43.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.307 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.603 ' O ' ' HA ' ' A' ' 24' ' ' THR . 37.3 mm -107.3 94.61 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.772 0.32 . . . . 0.0 110.318 177.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 40.0 m -100.67 124.4 46.21 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.859 0.361 . . . . 0.0 111.15 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.8 -153.54 22.49 Favored Glycine 0 N--CA 1.447 -0.614 0 N-CA-C 111.524 -0.631 . . . . 0.0 111.524 177.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 79' ' ' ALA . 70.5 Cg_endo -85.87 160.68 10.43 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.301 2.001 . . . . 0.0 111.408 174.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.46 -25.38 48.54 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.05 2.5 . . . . 0.0 112.969 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.13 -34.97 66.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.894 0.378 . . . . 0.0 111.027 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.636 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -75.3 -21.92 58.1 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.404 176.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -63.38 -46.17 87.72 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 170.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -61.58 -46.84 88.16 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.714 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -61.2 -54.02 49.53 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.27 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.21 -54.09 45.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.227 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.482 ' O ' ' HD2' ' A' ' 88' ' ' TYR . 19.8 mt-30 -59.24 -48.12 82.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.833 0.349 . . . . 0.0 110.49 -178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -58.99 -36.78 89.85 Favored Glycine 0 N--CA 1.449 -0.487 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.44 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.481 ' C ' ' HD3' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -68.19 -44.93 74.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.403 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.653 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 78.3 mt -60.79 -52.15 64.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.532 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.577 ' O ' ' HG2' ' A' ' 92' ' ' LYS . 47.7 m-85 -53.89 -41.62 67.77 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.403 176.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -62.8 -38.16 96.05 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.504 -177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.626 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.3 tmtm? -71.75 -30.03 65.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.408 0.623 . . . . 0.0 109.401 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 105' ' ' LEU . 15.1 mt -66.0 -32.88 74.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.452 175.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 1.045 ' HD2' ' HZ ' ' A' ' 97' ' ' PHE . 19.1 mmmt -64.02 -52.03 61.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.512 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.626 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 9.8 pt-20 -69.34 -37.63 77.78 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 115.37 -0.832 . . . . 0.0 111.449 -177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 13.4 tp10 -83.23 -1.62 53.56 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 121.313 0.578 . . . . 0.0 111.09 -175.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.7 t30 64.15 50.66 2.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.107 173.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.627 ' CD2' HD22 ' A' ' 91' ' ' LEU . 3.4 m-85 -68.34 -37.59 80.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.602 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 1.045 ' HZ ' ' HD2' ' A' ' 92' ' ' LYS . 25.4 p90 -113.22 -173.67 2.3 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.333 -178.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . . . 166.66 -63.08 0.21 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.858 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' GLY . 6.3 Cg_endo -48.97 -39.75 40.38 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.403 2.735 . . . . 0.0 113.734 -177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 102' ' ' GLU . 4.5 mptp? -100.34 -11.42 20.3 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.783 0.325 . . . . 0.0 111.828 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 101' ' ' GLU . 9.9 tp10 57.19 33.42 23.29 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 122.785 1.279 . . . . 0.0 108.588 -168.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.473 ' HB3' ' HB3' ' A' ' 100' ' ' LYS . 5.0 tp10 -128.47 116.54 19.86 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.929 -176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 159' ' ' HIS . 9.3 p -83.98 120.03 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 170.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.545 ' HD2' HG22 ' A' ' 157' ' ' ILE . 34.9 tptt -118.47 102.71 9.12 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.516 -170.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.724 HD11 HD11 ' A' ' 91' ' ' LEU . 70.9 mt -120.86 158.67 27.12 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.07 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -110.39 104.06 12.78 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.773 -175.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 155' ' ' LYS . 6.5 m -97.87 111.04 23.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.937 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -94.8 128.29 41.41 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.695 -0.23 . . . . 0.0 110.541 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.795 HG22 HG12 ' A' ' 25' ' ' VAL . 36.9 pt -130.51 164.74 32.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.302 176.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.517 ' HD3' HD13 ' A' ' 153' ' ' ILE . 6.4 mmt180 -99.82 119.47 38.23 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.468 HG12 HD11 ' A' ' 174' ' ' LEU . 35.2 m -122.67 153.35 63.02 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.614 ' HG3' ' HD3' ' A' ' 178' ' ' LYS . 7.0 Cg_endo -49.02 111.4 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.864 2.376 . . . . 0.0 110.79 173.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.53 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -66.44 -24.26 66.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.155 -173.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.9 t -59.95 -20.45 57.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.09 173.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -115.06 21.8 13.93 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.161 179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.07 -41.28 87.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.879 0.371 . . . . 0.0 111.564 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 120' ' ' ILE . . . -79.4 -11.99 84.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.001 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.807 ' HG2' HG21 ' A' ' 177' ' ' VAL . 16.6 tpt180 -93.02 -32.86 14.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.722 0.296 . . . . 0.0 111.239 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG23 ' HB ' ' A' ' 170' ' ' ILE . 9.3 p -72.79 -21.79 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.125 0.488 . . . . 0.0 109.703 178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -79.08 -7.5 10.58 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 172.017 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.415 ' HA3' ' OG1' ' A' ' 126' ' ' THR . . . 109.83 -127.65 8.52 Favored Glycine 0 N--CA 1.442 -0.901 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.697 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -126.14 41.35 3.54 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 174.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 125.83 -135.72 9.3 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.374 -1.285 . . . . 0.0 111.148 -175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -93.28 4.54 73.98 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.472 -0.871 . . . . 0.0 111.937 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 129' ' ' GLU . 65.7 mttm -59.96 -48.32 82.2 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.804 0.442 . . . . 0.0 111.584 -176.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 120' ' ' ILE . 46.0 m -61.42 -44.06 97.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.667 -178.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HB3' ' A' ' 131' ' ' GLN . 61.4 t -64.78 -39.4 85.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 120.979 0.418 . . . . 0.0 110.093 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 27.5 t-20 -61.04 -50.66 72.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.935 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 125' ' ' LYS . 9.8 pt-20 -78.15 -49.29 14.15 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.818 -176.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.082 ' HG ' ' HB3' ' A' ' 136' ' ' ALA . 13.8 tp -75.39 -36.57 60.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -170.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.679 ' HB3' ' O ' ' A' ' 127' ' ' VAL . 36.8 tp60 -83.52 -45.65 13.33 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 122.251 -0.28 . . . . 0.0 111.462 -178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 55.5 t30 -67.24 -30.26 70.12 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.429 -0.509 . . . . 0.0 111.104 -176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.4 mt -97.59 -49.2 4.96 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.637 -0.425 . . . . 0.0 112.121 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 5.2 m -105.37 -11.5 16.43 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -170.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.539 ' O ' ' HA3' ' A' ' 158' ' ' GLY . . . 69.64 36.19 2.22 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.143 0.577 . . . . 0.0 111.062 -175.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 1.082 ' HB3' ' HG ' ' A' ' 130' ' ' LEU . . . -109.37 92.33 4.01 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.528 0.68 . . . . 0.0 109.638 175.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.613 ' O ' ' HA ' ' A' ' 156' ' ' ILE . 22.7 tt0 -88.34 111.45 21.73 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.165 -172.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.448 HG11 ' O ' ' A' ' 119' ' ' VAL . 41.3 t -97.91 106.5 18.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.658 ' HB ' ' CG ' ' A' ' 155' ' ' LYS . 18.9 t -117.51 135.41 57.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.126 0.488 . . . . 0.0 111.37 -174.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.435 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 27.7 m -112.86 165.64 12.7 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.475 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.435 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 89.4 Cg_endo -88.63 -0.68 6.6 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.241 1.96 . . . . 0.0 112.484 176.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.448 ' HG3' ' N6 ' ' B' ' 5' ' ' ' A' . 33.9 mtm180 62.25 -176.63 0.13 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.611 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.01 83.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.68 0.612 . . . . 0.0 112.042 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -53.39 102.52 0.06 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.849 -175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 2.6 p -135.87 89.52 20.85 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.044 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.624 ' HB3' ' HA ' ' A' ' 150' ' ' GLU . 27.0 Cg_exo -63.01 141.74 85.07 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.583 2.855 . . . . 0.0 113.152 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' A' ' 151' ' ' GLN . 0.6 OUTLIER -73.88 -166.43 0.38 Allowed 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.663 174.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -48.97 -41.56 34.58 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -179.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -104.96 24.76 11.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.515 -174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.624 ' HA ' ' HB3' ' A' ' 146' ' ' PRO . 2.9 pt-20 57.28 36.42 27.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.218 1.007 . . . . 0.0 111.601 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.416 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 48.2 mt-30 -122.05 150.6 41.89 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.318 178.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.53 HG13 ' HB2' ' A' ' 113' ' ' ALA . 5.7 m -123.48 -179.35 2.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.842 0.353 . . . . 0.0 110.818 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.517 HD13 ' HD3' ' A' ' 110' ' ' ARG . 29.6 mm -101.28 114.96 42.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.117 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.42 HG22 HG12 ' A' ' 140' ' ' VAL . 70.8 t -124.83 140.05 49.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.658 ' CG ' ' HB ' ' A' ' 139' ' ' VAL . 16.0 ptpt -118.73 142.91 47.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.63 -170.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 137' ' ' GLU . 53.9 mt -113.74 112.2 39.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 170.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 3.4 mm -105.88 109.51 28.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.934 -175.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 135' ' ' ALA . . . -179.59 -175.51 46.46 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.335 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.473 ' HA ' HG13 ' A' ' 103' ' ' VAL . 17.8 p-80 -78.28 165.49 23.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.646 0.223 . . . . 0.0 110.621 176.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -51.06 -47.89 61.7 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -169.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -68.14 -29.68 68.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.867 -177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -76.09 -41.8 49.22 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.088 0.47 . . . . 0.0 109.932 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 23.2 t -61.99 -50.43 72.1 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.494 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -61.17 -38.07 85.18 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 120.456 0.17 . . . . 0.0 111.379 -179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 25.8 ttt -66.18 -50.29 64.4 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.636 0.255 . . . . 0.0 110.933 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.795 ' HB2' ' HB1' ' A' ' 136' ' ' ALA . . . -61.06 -45.03 96.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.646 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.512 ' HG3' ' O ' ' A' ' 163' ' ' SER . 94.4 mt-30 -56.95 -46.4 82.13 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.886 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.95 -45.7 89.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.878 0.371 . . . . 0.0 110.958 177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 9.9 mmmm -64.04 -52.33 59.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.975 -176.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.612 HD13 HD11 ' A' ' 156' ' ' ILE . 48.7 pt -61.74 -34.75 63.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.846 -0.341 . . . . 0.0 111.547 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.757 ' HD3' HD12 ' A' ' 174' ' ' LEU . 13.7 mmt85 -63.52 -39.25 93.94 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 121.313 -0.155 . . . . 0.0 111.262 177.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.403 ' O ' ' HG3' ' A' ' 176' ' ' GLN . 37.7 t70 -61.9 -45.77 92.3 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.712 0.291 . . . . 0.0 110.376 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.468 ' O ' HG23 ' A' ' 177' ' ' VAL . 54.3 mt -57.5 -44.98 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.913 176.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.757 HD12 ' HD3' ' A' ' 171' ' ' ARG . 92.3 mt -56.76 -48.54 77.61 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.282 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.13 71.24 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.587 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 172' ' ' ASP . 52.8 mt-30 -62.09 -59.3 5.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.299 177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.807 HG21 ' HG2' ' A' ' 118' ' ' ARG . 3.2 t -64.39 -39.79 86.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.528 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.564 -177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.614 ' HD3' ' HG3' ' A' ' 112' ' ' PRO . 47.3 mtmt -60.23 -45.22 93.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.779 -0.191 . . . . 0.0 110.96 177.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -61.7 -37.57 84.63 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.597 0.236 . . . . 0.0 111.061 175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -69.19 -50.7 45.15 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 14.4 t-80 -60.61 -37.7 82.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.033 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -75.83 -33.45 60.07 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 173.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp 57.64 57.37 4.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.563 -175.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -91.22 164.36 29.57 Favored Glycine 0 N--CA 1.44 -1.079 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.01 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -97.23 47.67 1.04 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 23.3 t 74.11 -55.84 0.66 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.674 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 158.5 -173.61 35.57 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.095 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -111.11 103.23 11.65 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 87.7 mt 57.98 58.2 3.71 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.835 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 65.77 38.53 5.17 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.416 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.843 178.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.745 0 O4'-C4'-C3' 104.442 -0.756 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.501 " C5'" ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.801 0 C3'-C2'-C1' 104.514 3.349 OUTLIER-EPSILON 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.86 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.878 0 P-O3'-C3' 124.216 3.763 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.86 ' N7 ' " H1'" ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.957 0 O4'-C4'-C3' 102.954 -1.819 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.836 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.782 0 P-O3'-C3' 123.861 3.468 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.477 " H1'" HG11 ' A' ' 127' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.94 0 O4'-C4'-C3' 104.334 -0.833 . 0.542 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.669 ' O2 ' " H2'" ' B' ' 7' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 N19-C1'-C2' 116.011 1.632 . 0.131 &a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.902 0 N-CA-C 111.784 -0.526 . . . . 0.0 111.784 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.0 92.7 3.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.06 0.457 . . . . 0.0 110.58 178.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 ttt -106.88 -31.84 8.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.649 -177.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' N ' ' HD3' ' A' ' 5' ' ' PRO . . . 74.94 56.01 5.04 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.785 -178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 4' ' ' GLY . 23.5 Cg_exo -64.51 136.73 51.74 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.495 2.13 . . . . 0.0 111.863 -177.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.7 t 71.86 -44.81 0.6 Allowed 'General case' 0 CA--C 1.535 0.378 0 O-C-N 123.916 0.76 . . . . 0.0 111.612 -179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.5 m -64.08 -41.98 97.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.689 0.28 . . . . 0.0 110.826 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.4 t -116.73 73.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.9 t -169.07 88.82 0.19 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.677 -177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.13 61.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 121.022 -0.608 . . . . 0.0 111.862 -177.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.02 100.89 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.826 0.346 . . . . 0.0 111.41 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . -104.35 112.45 65.42 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.348 178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 3.0 Cg_endo -82.19 134.35 7.98 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 123.147 2.565 . . . . 0.0 112.428 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 62.13 -177.36 0.13 Allowed 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 176.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 51.4 m 70.17 118.97 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.03 -0.986 . . . . 0.0 112.443 176.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 77.4 p 68.47 -18.74 0.16 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.937 1.295 . . . . 0.0 113.516 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -85.18 9.83 13.98 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 121.87 -0.519 . . . . 0.0 111.471 -178.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.444 ' O ' ' HD3' ' A' ' 20' ' ' PRO . 34.3 tpp 177.9 120.12 0.18 Allowed Pre-proline 0 C--N 1.317 -0.828 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.756 -176.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.73 100.95 1.34 Allowed 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.971 2.448 . . . . 0.0 109.865 166.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 18' ' ' MET . 39.4 Cg_exo -59.92 141.24 96.15 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 123.013 2.476 . . . . 0.0 113.005 -170.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -78.08 47.57 0.67 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.946 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -99.63 106.45 18.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -78.98 147.9 32.77 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 64.8 m -124.91 108.65 12.11 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.0 0.429 . . . . 0.0 110.836 -176.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.921 HG12 HG22 ' A' ' 109' ' ' ILE . 35.8 m -115.59 143.03 26.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.402 176.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -118.6 117.05 27.93 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 174.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.748 HG12 HG22 ' A' ' 71' ' ' VAL . 7.3 p -113.94 138.54 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.729 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.734 ' HB3' ' HB ' ' A' ' 68' ' ' VAL . 76.9 m-85 -106.51 133.79 50.65 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.959 -1.019 . . . . 0.0 110.895 -173.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.621 HG12 ' NE ' ' A' ' 69' ' ' ARG . 2.3 pt -119.38 172.12 4.74 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 29' ' ' ILE . 39.5 Cg_exo -54.49 122.04 10.84 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 C-N-CA 121.717 1.612 . . . . 0.0 111.811 177.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -66.94 -12.66 60.29 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.041 0.448 . . . . 0.0 111.418 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -85.2 -8.1 58.73 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.211 0.529 . . . . 0.0 109.902 175.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.601 ' HB1' ' CZ ' ' A' ' 96' ' ' PHE . . . -110.49 2.21 18.7 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.169 -172.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.811 HG21 ' HG3' ' A' ' 61' ' ' PRO . 0.1 OUTLIER -66.36 -22.95 30.84 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.447 174.583 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -56.86 -34.22 64.87 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.703 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB1' ' HG2' ' A' ' 94' ' ' GLU . . . -77.77 -54.07 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.766 0.317 . . . . 0.0 110.989 178.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG22 HD13 ' A' ' 38' ' ' ILE . 30.8 mm -69.3 -52.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.302 -0.408 . . . . 0.0 112.022 -175.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.587 HD11 HD12 ' A' ' 58' ' ' ILE . 18.7 mm -84.72 -34.43 9.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.886 -172.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -58.75 -27.77 62.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.07 -0.586 . . . . 0.0 112.678 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -59.05 87.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.004 0.43 . . . . 0.0 111.038 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.0 t70 68.35 -7.51 0.67 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.16 0.984 . . . . 0.0 111.809 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 38' ' ' ILE . . . 73.94 -39.23 0.96 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.242 -0.504 . . . . 0.0 113.478 -176.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -79.32 -27.74 42.14 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 59.9 m170 -63.49 -25.15 68.13 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -168.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 57' ' ' LYS . 5.0 tp -62.62 -48.51 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.567 172.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HA ' HG12 ' A' ' 56' ' ' ILE . 96.2 mttt -63.5 -34.51 77.94 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 178.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -58.15 -30.0 66.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.062 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.9 HD23 ' HG3' ' A' ' 57' ' ' LYS . 6.2 tp -53.41 -27.62 25.38 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.117 -178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.719 ' N ' HD13 ' A' ' 56' ' ' ILE . 23.1 t -56.21 -62.03 1.99 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.43 . . . . 0.0 111.156 -176.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? -75.49 -33.11 60.77 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.117 -177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -60.44 -34.05 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.393 -179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HG3' ' A' ' 82' ' ' LYS . . . -112.69 14.23 19.98 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -179.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.6 m 60.24 38.8 19.75 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 123.32 0.388 . . . . 0.0 111.835 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 79' ' ' ALA . . . -143.22 168.23 20.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.185 0.517 . . . . 0.0 112.076 -173.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.877 ' HB2' ' HB ' ' A' ' 74' ' ' THR . 27.1 m -80.03 144.81 32.89 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 173.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.001 HD12 ' HG2' ' A' ' 57' ' ' LYS . 3.3 tp -83.47 160.3 3.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.685 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -153.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG2' HD12 ' A' ' 56' ' ' ILE . 1.2 mmpt? -92.03 -162.98 0.98 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 131.11 3.764 . . . . 0.0 110.766 -159.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG13 ' HD3' ' A' ' 69' ' ' ARG . 0.1 OUTLIER -58.9 149.64 5.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -147.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.587 ' N ' HG12 ' A' ' 58' ' ' ILE . . . -86.36 135.1 37.0 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 109.886 -3.324 . . . . 0.0 109.507 178.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 9.6 Cg_endo -52.3 121.0 8.19 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.883 2.389 . . . . 0.0 111.609 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.811 ' HG3' HG21 ' A' ' 34' ' ' VAL . 10.3 Cg_endo -52.44 128.04 26.31 Favored 'Trans proline' 0 CA--C 1.514 -0.483 0 C-N-CA 122.949 2.433 . . . . 0.0 111.047 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -59.32 -35.78 74.45 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.287 -172.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.7 p -141.16 154.98 68.4 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.383 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -70.42 -3.61 12.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.504 2.136 . . . . 0.0 110.397 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -87.17 -10.22 53.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.274 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.6 m -69.48 153.94 42.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 7.3 mtpm? -97.52 -46.95 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.855 -176.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.734 ' HB ' ' HB3' ' A' ' 28' ' ' PHE . 17.1 m -131.71 150.34 33.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.226 -176.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.702 ' HD3' HG13 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -114.1 143.97 43.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.081 178.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.605 ' O ' ' HB ' ' A' ' 58' ' ' ILE . 17.5 ptp -103.65 114.86 29.44 Favored 'General case' 0 C--O 1.249 1.044 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -175.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.748 HG22 HG12 ' A' ' 27' ' ' VAL . 0.7 OUTLIER -84.99 141.9 13.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 O-C-N 123.963 0.789 . . . . 0.0 109.419 172.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.835 ' H ' ' HA ' ' A' ' 57' ' ' LYS . 17.2 t -102.58 113.7 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.638 -176.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.686 HD12 ' HB1' ' A' ' 83' ' ' ALA . 30.2 mm -118.54 94.94 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.585 175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 55' ' ' SER . 59.3 m -115.22 125.13 52.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.152 174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 166.58 -169.74 40.77 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.1 -1.047 . . . . 0.0 112.525 178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.97 173.01 15.24 Favored 'Trans proline' 0 CA--C 1.532 0.392 0 C-N-CA 122.859 2.373 . . . . 0.0 111.767 -177.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.444 ' HA ' ' OE1' ' A' ' 80' ' ' GLN . 91.9 Cg_exo -44.61 -41.79 14.46 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.197 2.598 . . . . 0.0 113.943 -176.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -65.42 -32.25 73.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.37 -178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 54' ' ' ALA . . . -67.69 -29.57 68.86 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.492 -175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.444 ' OE1' ' HA ' ' A' ' 77' ' ' PRO . 2.2 mp0 -59.18 -51.34 70.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -72.96 -43.89 61.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.552 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 26.2 tptp -63.82 -48.95 74.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.495 -175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.686 ' HB1' HD12 ' A' ' 73' ' ' ILE . . . -70.37 -47.83 59.13 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.69 -32.56 73.96 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.973 -0.291 . . . . 0.0 110.901 -176.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.628 ' HA2' ' HE1' ' A' ' 160' ' ' PHE . . . -55.56 -40.8 79.61 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 116.008 -0.542 . . . . 0.0 113.265 -177.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.418 ' HD3' ' O ' ' A' ' 86' ' ' ARG . 3.1 tmt_? -62.85 -45.36 92.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.377 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.65 ' O ' ' HG ' ' A' ' 91' ' ' LEU . 59.5 mt -77.69 -49.21 22.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.234 -176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -55.58 -45.15 77.43 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.03 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -68.12 -39.43 88.55 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.9 -178.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.525 ' HD3' ' O ' ' A' ' 90' ' ' LYS . 6.5 tmtm? -63.03 -32.5 73.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.992 0.425 . . . . 0.0 110.034 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.737 HD22 ' CE2' ' A' ' 96' ' ' PHE . 27.6 mt -61.83 -40.43 95.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.831 0.348 . . . . 0.0 110.743 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -62.03 -51.91 66.09 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.117 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 90' ' ' LYS . 4.2 pt-20 -69.09 -30.31 68.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.412 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.453 ' HG2' ' HB1' ' A' ' 36' ' ' ALA . 6.4 tp10 -86.38 7.11 26.98 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.469 0.652 . . . . 0.0 110.406 -178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 16.1 m120 65.17 40.39 5.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.753 172.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.737 ' CE2' HD22 ' A' ' 91' ' ' LEU . 2.1 m-85 -70.45 -58.79 3.34 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 167.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.85 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -162.15 133.77 5.36 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 113.741 -1.572 . . . . 0.0 108.796 177.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 102' ' ' GLU . . . -164.94 -76.86 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 119.973 -1.108 . . . . 0.0 113.735 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.08 -55.2 4.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.436 2.757 . . . . 0.0 114.455 -172.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -101.98 -1.75 31.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.182 0.515 . . . . 0.0 111.328 -174.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -174.3 106.25 0.11 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.542 ' HA ' ' HA2' ' A' ' 98' ' ' GLY . 50.5 mt-10 -61.79 171.64 1.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 O-C-N 123.571 0.545 . . . . 0.0 111.744 -176.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.85 ' HA ' ' CD1' ' A' ' 97' ' ' PHE . 12.7 m -57.09 129.24 18.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.133 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.582 ' HD3' ' CG2' ' A' ' 157' ' ' ILE . 1.4 tmmt? -127.75 113.42 15.96 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.707 HD11 ' CD1' ' A' ' 91' ' ' LEU . 96.0 mt -129.23 162.86 26.88 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.301 -172.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 61.4 tt0 -103.53 112.16 24.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.631 -174.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.904 HG21 HE21 ' A' ' 167' ' ' GLN . 32.2 m -94.64 130.01 41.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.82 0.343 . . . . 0.0 111.539 177.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -109.62 121.07 44.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.016 173.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.921 HG22 HG12 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -126.71 161.93 32.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.923 0.392 . . . . 0.0 110.744 178.529 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -104.66 119.02 38.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.999 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.61 HG23 HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -115.56 145.29 34.17 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.43 176.026 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 150' ' ' GLU . 7.8 Cg_endo -50.41 99.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.127 2.551 . . . . 0.0 109.335 166.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.47 ' HB2' HG13 ' A' ' 152' ' ' VAL . . . -55.96 -24.01 35.7 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 124.074 0.95 . . . . 0.0 113.439 -166.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.1 t -65.88 -9.57 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.444 . . . . 0.0 110.559 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -118.53 18.9 13.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.31 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -46.79 76.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 -178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -68.14 -27.33 73.75 Favored Glycine 0 C--O 1.227 -0.329 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.508 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.406 ' HG3' HG22 ' A' ' 173' ' ' ILE . 3.2 tpp180 -67.01 -29.64 69.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 0.0 110.735 -179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG12 HG11 ' A' ' 138' ' ' VAL . 96.1 t -59.49 -51.03 77.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.366 -178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 HG23 ' A' ' 127' ' ' VAL . 17.2 tt -92.01 -21.3 6.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.346 0.593 . . . . 0.0 110.7 -176.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 85.5 -149.29 23.49 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.779 175.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -77.07 99.83 5.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.846 0.355 . . . . 0.0 110.131 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.494 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 78.97 -110.74 3.11 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.306 -178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -130.0 42.63 1.39 Allowed Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.133 177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -57.52 -55.03 40.1 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.742 0.306 . . . . 0.0 110.811 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.464 HG22 HD12 ' A' ' 130' ' ' LEU . 99.7 m -54.46 -49.24 70.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.7 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG13 ' HA ' ' A' ' 137' ' ' GLU . 4.2 t -71.15 -33.37 50.88 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.457 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.904 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -60.14 -50.66 72.81 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.419 0.628 . . . . 0.0 110.041 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -68.85 -48.99 62.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.431 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.841 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 14.5 mt -63.91 -45.29 89.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.457 -0.792 . . . . 0.0 112.563 -175.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -68.28 -42.72 79.11 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.474 0.178 . . . . 0.0 111.087 -175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -69.38 -30.23 68.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 -176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -97.79 -50.88 4.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 28.2 p -110.16 -11.03 14.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -173.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.48 14.52 2.29 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.509 0.723 . . . . 0.0 111.103 -172.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.841 ' HB3' ' HB3' ' A' ' 130' ' ' LEU . . . -76.76 134.6 39.1 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.053 0.454 . . . . 0.0 110.478 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HA ' HG13 ' A' ' 127' ' ' VAL . 23.1 tt0 -130.68 111.91 12.62 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.534 -171.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.621 HG11 HG12 ' A' ' 119' ' ' VAL . 96.5 t -95.05 106.52 18.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.311 0.577 . . . . 0.0 110.331 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.526 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 31.1 t -109.54 124.8 66.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.491 -175.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.53 HG22 ' C2 ' ' B' ' 5' ' ' ' A' . 34.6 m -110.26 147.28 35.97 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 120.757 0.313 . . . . 0.0 110.284 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 140' ' ' VAL . 1.7 Cg_endo -83.13 136.17 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 123.059 2.506 . . . . 0.0 112.157 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 10.0 tpp180 -67.72 99.92 0.86 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.498 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 58.58 55.95 4.54 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.443 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 144' ' ' GLN . 1.4 tt0 -74.04 143.33 45.54 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.078 173.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 23.8 p -76.38 108.17 5.84 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.242 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.44 149.76 89.46 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 123.637 2.891 . . . . 0.0 112.92 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.475 ' OD1' ' HG2' ' A' ' 148' ' ' GLU . 7.1 t70 -72.43 171.95 11.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.707 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.475 ' HG2' ' OD1' ' A' ' 147' ' ' ASP . 13.0 pt-20 -53.36 -42.44 66.82 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -175.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 150' ' ' GLU . 91.1 m-20 -93.73 24.92 3.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.372 -175.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 150' ' ' GLU . 6.5 pt-20 62.07 53.43 2.98 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.499 1.12 . . . . 0.0 111.391 178.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 76.8 mt-30 -125.76 133.0 52.21 Favored 'General case' 0 C--N 1.317 -0.838 0 O-C-N 121.597 -0.69 . . . . 0.0 111.164 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.47 HG13 ' HB2' ' A' ' 113' ' ' ALA . 10.3 m -120.11 174.54 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.638 176.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 47.7 mm -100.79 120.51 50.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.108 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.0 m -129.18 142.13 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 59.2 mttt -103.31 138.05 40.6 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 121.05 0.452 . . . . 0.0 111.793 -169.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 ' HB ' ' HB ' ' A' ' 107' ' ' THR . 40.7 mt -119.92 110.0 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 168.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 136' ' ' ALA . 11.3 mm -94.69 160.81 2.68 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 174.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 104' ' ' LYS . . . 154.46 -172.66 32.98 Favored Glycine 0 N--CA 1.44 -1.035 0 C-N-CA 119.167 -1.492 . . . . 0.0 113.406 176.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.679 ' HA ' ' O ' ' A' ' 103' ' ' VAL . 28.1 m170 -95.0 -173.85 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.294 -0.453 . . . . 0.0 109.928 178.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.628 ' HE1' ' HA2' ' A' ' 85' ' ' GLY . 27.1 t80 -54.19 -51.37 64.6 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -175.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -76.68 -31.12 57.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.973 0.415 . . . . 0.0 111.163 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -60.8 -50.89 71.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.719 -174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' A' ' 167' ' ' GLN . 15.3 m -55.75 -47.44 76.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.597 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 160' ' ' PHE . 49.0 mm-40 -56.64 -47.34 79.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.013 0.435 . . . . 0.0 110.859 -177.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 26.4 ttt -67.54 -49.31 63.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.155 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -59.9 -45.38 92.72 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.717 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.904 HE21 HG21 ' A' ' 107' ' ' THR . 89.8 mt-30 -58.82 -51.83 68.33 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.061 0.458 . . . . 0.0 110.476 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 168' ' ' ARG . 17.5 tpt85 -62.37 -37.69 86.68 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.061 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -61.32 -57.1 13.69 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.314 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.596 ' O ' ' HG ' ' A' ' 174' ' ' LEU . 50.1 pt -63.63 -36.73 77.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.761 -175.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HD2' HD12 ' A' ' 174' ' ' LEU . 13.4 mmm180 -61.02 -38.7 87.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.596 0.236 . . . . 0.0 111.404 179.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.8 -48.82 75.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.88 0.372 . . . . 0.0 110.855 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 118' ' ' ARG . 57.7 mt -58.66 -41.67 82.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.942 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.61 HD22 HG23 ' A' ' 111' ' ' VAL . 89.2 mt -57.74 -49.26 77.16 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.806 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -58.94 -44.31 91.35 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.1 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -56.74 -56.97 14.67 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.629 0.252 . . . . 0.0 111.329 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.541 ' HA ' ' HG2' ' A' ' 180' ' ' GLN . 13.6 p -66.7 -37.73 80.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -177.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.649 ' HA ' ' HE2' ' A' ' 178' ' ' LYS . 0.0 OUTLIER -64.65 -45.7 85.62 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 176.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 55.4 mt-30 -61.35 -52.48 64.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.37 0.137 . . . . 0.0 111.37 178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . 0.975 ' HA ' ' HA3' ' A' ' 184' ' ' GLY . 14.2 pt20 -59.28 -35.26 73.43 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.788 0.327 . . . . 0.0 110.681 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -65.92 -45.54 81.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.187 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -64.71 -56.94 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.927 -179.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -167.31 52.2 0.07 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.491 0.662 . . . . 0.0 110.629 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.975 ' HA3' ' HA ' ' A' ' 180' ' ' GLN . . . -80.77 150.29 30.88 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.803 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.46 87.23 6.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 20.7 p 53.62 -81.51 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.096 0.958 . . . . 0.0 111.527 -171.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -100.27 -112.62 3.45 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 172.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -96.13 -66.12 0.93 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 4.5 mm? 58.53 89.22 0.06 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.883 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -85.85 -29.07 24.01 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 176.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.459 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.687 178.735 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.444 " H4'" " O5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 103.842 2.602 OUTLIER-EPSILON 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.561 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 122.506 2.338 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.695 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 P-O3'-C3' 124.443 3.952 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.871 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.93 0 O4'-C4'-C3' 103.457 -1.459 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.871 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.788 0 P-O3'-C3' 123.374 3.062 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.499 " O4'" " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C4'-C3' 103.635 -1.332 . 0.499 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . 0.441 ' O4 ' HG11 ' A' ' 139' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 P-O3'-C3' 120.663 0.803 . 0.048 7r . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.66 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.85 -93.18 0.04 OUTLIER 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 175.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 42.7 ttm 62.91 101.17 0.03 OUTLIER 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.48 0.657 . . . . 0.0 110.169 -171.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.75 110.19 3.47 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 -172.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -49.24 -52.97 7.78 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 123.396 2.731 . . . . 0.0 113.162 -175.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 t -87.68 92.99 9.31 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.7 t -133.52 -160.82 1.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.478 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.403 HG12 ' H ' ' A' ' 10' ' ' GLY . 41.5 t -73.25 -52.71 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 120.967 0.413 . . . . 0.0 110.398 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.4 m 68.6 -3.25 1.42 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.349 174.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.403 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.83 22.79 23.33 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.482 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.64 69.56 7.18 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.574 -0.158 . . . . 0.0 110.574 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . . . 69.12 126.17 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.194 0 O-C-N 124.03 0.831 . . . . 0.0 111.325 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 12' ' ' ALA . 29.1 Cg_exo -63.04 -18.37 64.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.053 2.502 . . . . 0.0 111.747 178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.6 t80 49.27 54.54 10.78 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 123.754 0.659 . . . . 0.0 110.562 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 17.7 m -79.67 69.38 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.713 -179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 48.9 m -99.15 20.31 13.7 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.441 0.639 . . . . 0.0 109.542 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -158.84 102.2 1.66 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.6 177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -96.07 134.81 23.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 35.4 Cg_endo -66.64 117.31 4.64 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.821 2.348 . . . . 0.0 112.241 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 6.7 Cg_exo -74.62 71.06 4.83 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.952 2.435 . . . . 0.0 111.482 177.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.426 ' O ' HG23 ' A' ' 74' ' ' THR . 13.6 pt-20 -83.61 66.12 8.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.979 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 57.85 -146.67 0.53 Allowed 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.601 178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -89.46 119.62 30.06 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 174.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -104.7 121.05 42.78 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.542 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.702 ' HB ' ' HB ' ' A' ' 73' ' ' ILE . 49.7 t -105.93 118.84 54.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 108' ' ' HIS . 37.9 m80 -104.44 112.55 25.64 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.609 ' HB ' ' CG2' ' A' ' 71' ' ' VAL . 44.3 t -111.09 126.21 68.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 120.862 0.363 . . . . 0.0 110.101 177.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' HB2' ' CG ' ' A' ' 106' ' ' GLU . 97.8 m-85 -103.5 107.02 17.69 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.176 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 28.5 pt -103.46 151.0 38.59 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.058 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.42 156.24 61.4 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.001 1.801 . . . . 0.0 110.685 176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.26 -12.95 56.79 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.584 -177.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.425 ' OE1' ' HA ' ' A' ' 32' ' ' GLN . 12.4 mm-40 -82.13 -23.79 35.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.973 0.416 . . . . 0.0 110.885 173.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.02 -34.57 71.43 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.671 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 m -63.11 -26.37 40.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 110.405 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.96 97.87 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.281 -0.962 . . . . 0.0 111.293 174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 40' ' ' ASP . . . -78.09 -46.96 19.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.824 0.345 . . . . 0.0 110.751 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.647 HD11 ' HA ' ' A' ' 87' ' ' ILE . 3.4 mm -68.69 -53.34 27.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -175.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.57 HD13 ' HB ' ' A' ' 45' ' ' ILE . 31.2 mm -67.27 -50.45 62.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.367 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -76.82 -10.82 85.9 Favored Glycine 0 CA--C 1.521 0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 113.984 -172.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.578 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 33.8 t70 -53.36 -35.04 59.85 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.112 0.482 . . . . 0.0 111.05 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 44' ' ' HIS . 32.5 t70 -144.99 33.87 1.11 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.649 0.737 . . . . 0.0 109.424 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.44 -68.17 1.49 Allowed Glycine 0 C--N 1.333 0.407 0 CA-C-N 115.382 -0.827 . . . . 0.0 112.224 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -124.15 47.51 2.06 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.482 0.658 . . . . 0.0 109.24 174.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 41' ' ' ASP . 9.8 t-80 -60.0 -25.27 65.13 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.306 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG12 HD13 ' A' ' 58' ' ' ILE . 10.6 tp -61.21 -33.34 55.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.531 175.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -75.11 -29.6 60.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 44' ' ' HIS . 4.7 tp-100 -59.85 -42.42 93.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.718 173.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.07 -29.73 67.55 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.309 -175.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -59.83 4.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 -177.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.2 mmm180 -79.33 -33.32 43.23 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.491 -0.484 . . . . 0.0 111.209 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -55.94 -46.62 78.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.999 0.428 . . . . 0.0 111.007 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.717 ' HB1' ' HA ' ' A' ' 79' ' ' ALA . . . -91.86 -5.3 53.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.193 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.8 t 62.22 40.97 11.04 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.979 -177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 79' ' ' ALA . . . -134.1 152.15 51.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.443 -175.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 18.8 t -85.52 98.96 10.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 174.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 72' ' ' VAL . 16.7 tt -95.01 112.89 28.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 121.774 0.797 . . . . 0.0 111.014 -176.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.432 ' HB2' ' HB ' ' A' ' 72' ' ' VAL . 61.2 mttt -100.82 113.98 27.38 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.325 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.712 HG22 HG12 ' A' ' 71' ' ' VAL . 17.2 pt -110.6 148.13 14.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.544 ' O ' ' HD2' ' A' ' 69' ' ' ARG . . . -92.98 104.24 11.25 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.241 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 58' ' ' ILE . 3.5 Cg_exo -78.1 170.54 18.58 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.445 2.763 . . . . 0.0 111.944 178.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -39.85 -40.81 2.62 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.87 3.047 . . . . 0.0 114.762 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.51 -35.92 61.19 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.431 ' OG1' ' HB1' ' A' ' 59' ' ' ALA . 74.6 p -70.38 156.12 92.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-O 121.217 0.532 . . . . 0.0 112.117 -173.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -66.72 -12.26 35.2 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.348 2.698 . . . . 0.0 111.564 176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -78.35 33.14 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.914 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.56 ' HA ' ' CZ ' ' A' ' 69' ' ' ARG . 13.9 t -62.58 -28.68 70.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.887 -176.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 6.7 ttpm? -74.78 -55.51 5.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.714 0.292 . . . . 0.0 110.578 -178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.3 m -127.15 146.58 32.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 175.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.56 ' CZ ' ' HA ' ' A' ' 66' ' ' SER . 29.8 mmt180 -103.95 134.07 47.85 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.823 0.344 . . . . 0.0 110.822 -171.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 18.0 ptp -96.52 132.12 42.43 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.712 HG12 HG22 ' A' ' 58' ' ' ILE . 15.5 m -112.4 102.37 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.514 169.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' ILE . 55.2 t -82.61 108.48 15.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.189 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.702 ' HB ' ' HB ' ' A' ' 25' ' ' VAL . 49.3 mm -95.95 100.03 10.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.552 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.426 HG23 ' O ' ' A' ' 21' ' ' GLU . 93.1 m -103.61 116.18 31.88 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.667 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 156.37 -140.21 7.07 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.955 175.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -82.1 164.56 17.43 Favored 'Trans proline' 0 CA--C 1.532 0.398 0 C-N-CA 123.351 2.701 . . . . 0.0 112.694 -176.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.63 -14.92 33.74 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.757 2.305 . . . . 0.0 112.379 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.38 -36.21 78.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.382 0.611 . . . . 0.0 109.589 174.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.717 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . -64.24 -30.71 71.76 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.66 178.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -55.54 -54.49 43.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.069 178.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -77.29 -37.27 53.11 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.658 -177.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 52' ' ' ALA . 78.6 mttt -63.22 -52.4 62.37 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -47.53 79.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.074 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.423 ' HB3' ' HD2' ' A' ' 88' ' ' TYR . 79.7 mt-30 -62.66 -36.6 83.4 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.91 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.562 ' HA2' ' CE1' ' A' ' 160' ' ' PHE . . . -54.93 -32.81 56.28 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 116.009 -0.541 . . . . 0.0 112.922 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.447 ' HD3' ' HA ' ' A' ' 86' ' ' ARG . 12.1 mmt180 -79.92 -47.99 14.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.603 0.24 . . . . 0.0 110.716 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.647 ' HA ' HD11 ' A' ' 37' ' ' ILE . 65.5 mt -66.54 -51.22 59.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.918 -177.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.485 ' CD1' HD12 ' A' ' 105' ' ' LEU . 8.6 m-85 -63.09 -39.22 94.07 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.572 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' O ' ' HG2' ' A' ' 93' ' ' GLU . . . -57.39 -48.83 77.77 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.629 ' HD2' ' N ' ' A' ' 90' ' ' LYS . 0.1 OUTLIER -59.46 -55.96 28.0 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-O 120.533 0.206 . . . . 0.0 110.65 178.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.775 HD22 ' HG ' ' A' ' 105' ' ' LEU . 11.2 mp -56.67 -31.58 64.57 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 16.5 tptp -77.68 -56.6 4.38 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 120.714 -0.395 . . . . 0.0 111.554 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 89' ' ' GLY . 12.9 pt-20 -78.64 -28.7 45.53 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.615 ' HB2' ' O ' ' A' ' 90' ' ' LYS . 0.7 OUTLIER -78.16 -4.26 46.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.795 0.807 . . . . 0.0 109.538 177.736 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 58.7 t30 66.81 51.56 1.02 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.091 -1.413 . . . . 0.0 111.757 172.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PHE . . . . . 0.752 ' CD1' ' HA ' ' A' ' 91' ' ' LEU . 63.5 m-85 -77.44 -58.45 3.27 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.685 ' CD1' ' HA ' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.84 76.62 1.52 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 174.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -105.25 -83.93 1.71 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.008 -1.092 . . . . 0.0 113.482 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.899 ' HB2' ' HD2' ' A' ' 100' ' ' LYS . 32.1 Cg_exo -62.06 -41.62 34.96 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 123.345 2.697 . . . . 0.0 114.509 -172.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.899 ' HD2' ' HB2' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -99.41 -8.91 24.12 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -168.275 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -160.31 158.19 29.32 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.727 -0.389 . . . . 0.0 110.915 -168.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.05 145.7 37.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.146 174.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.776 HG13 ' HD2' ' A' ' 159' ' ' HIS . 26.8 m -72.48 126.83 33.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.147 -176.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 20.3 tptp -72.96 89.89 1.45 Allowed 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 172.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.775 ' HG ' HD22 ' A' ' 91' ' ' LEU . 1.5 mt -142.17 116.85 9.77 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.885 177.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 28' ' ' PHE . 9.0 pt-20 -107.58 107.68 18.61 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 121.604 0.716 . . . . 0.0 111.404 -173.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 88.2 m -90.38 112.76 24.48 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.749 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 26' ' ' HIS . 10.8 m170 -94.74 119.71 33.79 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.13 158.86 21.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.882 0.372 . . . . 0.0 110.758 -179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -88.67 119.04 28.77 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.678 -173.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.42 HG13 ' HD2' ' A' ' 112' ' ' PRO . 82.2 t -136.15 138.2 26.74 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.62 ' HD2' HD11 ' A' ' 174' ' ' LEU . 19.9 Cg_endo -58.68 130.45 37.11 Favored 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.61 2.206 . . . . 0.0 111.024 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . 0.6 ' HB2' ' HB3' ' A' ' 146' ' ' PRO . . . -58.66 -29.62 66.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.548 -175.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 p -81.63 5.66 17.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.045 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.603 ' HB3' ' HG2' ' A' ' 112' ' ' PRO . . . -125.14 -4.35 7.43 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.783 -0.19 . . . . 0.0 110.986 177.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.75 94.47 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.652 -176.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -67.4 -21.0 72.08 Favored Glycine 0 C--O 1.228 -0.268 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.499 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.875 ' HG2' HG22 ' A' ' 177' ' ' VAL . 11.9 tpt180 -85.42 -25.26 27.08 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.582 HG13 ' HB ' ' A' ' 170' ' ' ILE . 88.4 t -59.37 -27.53 37.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.691 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.519 HG13 HG23 ' A' ' 127' ' ' VAL . 13.2 tt -92.74 -3.47 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 121.404 0.621 . . . . 0.0 110.522 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 83.87 -92.71 1.7 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.42 178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 4.2 ttmp? -150.7 94.81 2.14 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.537 ' HA2' " H5'" ' B' ' 4' ' ' ' G' . . . 77.68 -172.06 55.16 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.569 -1.013 . . . . 0.0 110.569 -171.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.585 ' HA3' " O2'" ' B' ' 5' ' ' ' A' . . . -79.89 36.61 2.11 Favored Glycine 0 C--N 1.322 -0.25 0 C-N-CA 120.557 -0.83 . . . . 0.0 113.046 -176.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -67.21 -58.86 4.05 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -175.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.588 ' O ' ' HB2' ' A' ' 130' ' ' LEU . 14.4 t -69.51 -19.88 63.71 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.654 -0.418 . . . . 0.0 111.011 -176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.725 HG22 ' HB ' ' A' ' 138' ' ' VAL . 90.6 t -76.41 -48.73 26.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 176.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -57.74 -48.01 80.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.784 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.29 -47.59 83.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 126' ' ' THR . 0.3 OUTLIER -63.23 -48.11 79.66 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.359 -177.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -67.74 -34.02 76.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.311 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -66.53 -32.43 73.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.923 0.392 . . . . 0.0 110.847 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 87.8 mt -91.52 -49.61 6.22 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 135' ' ' ALA . 55.3 p -107.08 -11.03 15.73 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -171.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 134' ' ' THR . . . 76.15 2.45 3.58 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.448 0.699 . . . . 0.0 111.116 -174.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.769 ' HB2' ' HB1' ' A' ' 162' ' ' ALA . . . -80.58 123.59 28.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.019 0.438 . . . . 0.0 110.858 178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.547 ' HG2' ' HB ' ' A' ' 157' ' ' ILE . 10.4 pt-20 -102.53 143.81 31.76 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.706 -178.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.725 ' HB ' HG22 ' A' ' 127' ' ' VAL . 45.6 t -112.98 107.93 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.435 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.479 ' HB ' ' HB2' ' A' ' 155' ' ' LYS . 42.8 t -99.84 113.65 35.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.119 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' ' HD2' ' A' ' 141' ' ' PRO . 33.2 m -107.18 155.68 38.9 Favored Pre-proline 0 C--N 1.322 -0.608 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.308 178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 140' ' ' VAL . 90.5 Cg_endo -77.36 112.39 3.36 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.783 2.322 . . . . 0.0 112.846 -175.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.28 140.91 58.16 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.292 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.46 ' HA ' ' H22' ' B' ' 4' ' ' ' G' . 7.7 m-20 65.27 11.01 6.92 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 114.849 -1.069 . . . . 0.0 112.537 175.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.56 ' C ' ' HD3' ' A' ' 146' ' ' PRO . 49.7 mt-30 66.55 100.62 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.627 0.58 . . . . 0.0 111.314 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 11.3 p -113.8 67.93 1.48 Allowed Pre-proline 0 C--N 1.325 -0.496 0 CA-C-O 120.88 0.371 . . . . 0.0 110.702 173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.6 ' HB3' ' HB2' ' A' ' 113' ' ' ALA . 69.3 Cg_endo -93.5 165.59 2.33 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 122.936 2.424 . . . . 0.0 113.136 -173.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -85.85 173.27 10.13 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.277 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' HG3' HD22 ' A' ' 149' ' ' ASN . 8.8 pt-20 -44.93 -35.68 2.98 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -169.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.441 HD22 ' HG3' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -88.72 23.31 2.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 65.35 23.7 12.07 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.304 0.573 . . . . 0.0 110.866 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -101.3 122.57 43.92 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.649 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.45 174.6 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.074 -176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 33.8 mm -123.19 135.15 64.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.59 -177.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 32.8 m -123.4 140.73 46.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.491 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 139' ' ' VAL . 80.0 mttt -112.16 124.06 51.62 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.154 -170.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.535 HD11 HD13 ' A' ' 170' ' ' ILE . 62.3 mt -111.61 126.36 69.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.723 176.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.547 ' HB ' ' HG2' ' A' ' 137' ' ' GLU . 11.6 mm -113.98 110.41 32.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 175.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -176.56 155.6 19.07 Favored Glycine 0 C--O 1.22 -0.766 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.726 -179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' HIS . . . . . 0.776 ' HD2' HG13 ' A' ' 103' ' ' VAL . 36.6 m80 -58.97 178.29 0.12 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 120.934 0.397 . . . . 0.0 111.855 -176.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.562 ' CE1' ' HA2' ' A' ' 85' ' ' GLY . 69.0 t80 -49.58 -48.84 48.47 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.541 -177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TYR . . . . . 0.449 ' O ' ' HG3' ' A' ' 165' ' ' MET . 88.5 m-85 -73.95 -43.32 58.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.138 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.769 ' HB1' ' HB2' ' A' ' 136' ' ' ALA . . . -63.19 -45.41 91.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.823 -174.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 19.0 p -65.28 -40.43 93.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.769 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -58.56 -45.99 87.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.639 177.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.449 ' HG3' ' O ' ' A' ' 161' ' ' TYR . 66.3 mtt -62.4 -49.98 73.37 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.466 178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -57.58 -49.42 76.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.411 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -61.56 -47.17 86.77 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.816 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 81.6 mtt180 -62.95 -35.9 81.68 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.784 ' HA ' ' HE3' ' A' ' 169' ' ' LYS . 0.1 OUTLIER -68.3 -53.35 24.9 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.009 -0.276 . . . . 0.0 110.902 178.767 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 119' ' ' VAL . 40.6 pt -61.31 -35.73 68.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-O 120.724 0.297 . . . . 0.0 111.015 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -58.52 -45.24 89.23 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.211 0.529 . . . . 0.0 110.337 175.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -62.72 -46.61 87.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.564 178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 mt -59.91 -42.22 88.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.726 0.298 . . . . 0.0 111.117 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.62 HD11 ' HD2' ' A' ' 112' ' ' PRO . 3.6 tt -57.6 -51.9 67.59 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.273 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 179' ' ' GLN . . . -55.69 -39.88 71.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -60.1 -39.17 85.23 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.678 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.875 HG22 ' HG2' ' A' ' 118' ' ' ARG . 11.0 t -62.51 -48.99 85.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.966 0.413 . . . . 0.0 110.398 176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -55.76 -42.41 75.44 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.795 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 175' ' ' ALA . 71.9 mt-30 -59.21 -46.38 88.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.657 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.23 -31.12 71.62 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -71.45 -48.74 47.5 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.138 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -62.87 -47.0 85.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.97 0.414 . . . . 0.0 111.428 -178.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -101.51 33.91 2.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.683 0.754 . . . . 0.0 110.271 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -136.85 19.8 3.48 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.185 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -91.51 115.59 28.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.047 0.451 . . . . 0.0 110.717 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 17.8 t -108.52 -8.34 15.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.692 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 166.33 170.31 31.08 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.791 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -129.42 50.84 2.12 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.657 0.741 . . . . 0.0 109.132 178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.6 mt -95.0 84.79 4.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.724 -176.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -113.72 107.74 16.17 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.099 177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.187 179.846 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C3'-C2'-C1' 103.866 2.629 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.531 H5'' ' OP1' ' B' ' 3' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.817 0 C3'-C2'-C1' 103.414 2.127 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' G' . . . . . 0.853 " H1'" ' N7 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 P-O3'-C3' 124.256 3.796 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.958 " H4'" " O5'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.925 0 O4'-C1'-C2' 108.258 1.327 OUTLIER-EPSILON 0.0 OUTLIER '7D dist 7a' 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.958 " O5'" " H4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.768 0 P-O3'-C3' 123.866 3.472 . 0.0 OUTLIER epsilon-1 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' C' . . . . . 0.468 " O5'" ' H6 ' ' B' ' 6' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C4'-C3' 104.408 -0.78 . 0.543 1a . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.821 0 O4'-C1'-N19 108.846 0.646 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 stop_ save_